Factors Influencing the Prognosis in Tuberculous Meningitis Treated With Streptomycin by Naismith, James T
FACTORS INFLUENCING THE PROGNOSIS IN TUBERCULOUS MENINGITIS
TREATED WITH STREPTOMYCIN.
C O N T E N T S .
INTRODUCTION
Page
Material
Methods
Results
5
14
18
A. ASSESSMENT OF PROGNOSTIC FACTORS AT THE COMMENCEMENT 
OF TREATMENT.....................
Age .. .. •. .. ..
Duration and severity of illness ..
Mental, nutritional, meningeal and reflex state 
Temperature and erythracyte sedimentation rate 
Radiographic abnormalities in chest 
Abnormalities of the fundus oculi 
Cerebrospinal fluid findings
Cells 
Protein 
Chlorides 
Sugar
Summary
25
26 
29 
35 
38 
40 
43 
45
47
48
49
50 
52
B. INFLUENCE OF THE TREATMENT REGIME
Regimes employed 
Conclusions
Summary .. ..
• • • •
• • • »
• • • •
54
57
72
76
C. TYPE OF RESPONSE TO TREATMENT AX'© ITS EFFECT ON 
THE OUTCOME ..................
General progress 
Individual features
(a) Clinical
(b) Cerebrospinal fluid
summary
78
79
84
85 
89
93
ProQuest Number: 13850329
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13850329
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Page
D. INCIDENCE AND I1OTUENCE OF SPINAL BLOCK .. 95
Frequency and prognostic value .. .. 9^
Time of onset .. .. .. .. .. 99
Treatment .. .. .. .. .. 100
Duration .. .. .. .. .. 100
Factors influencing development of block .. 101
Effect of preceding treatment - .. .. 102
Summary .. .. .. .. .. 105
E. INCIDENCE AND INFLUENCE OF RELAPSE .. .. lo6
Frequency .. .. .. .. .. 110
Factors influencing relapse .. .. .. Ill
Time of onset .. .. .. .. .. 114
Features of relapse illness .. .. .. 115
Treatment .. .. .. .. .. 117
Prognosis .. .. .. .. .. 119
Progress made in response to treatment .. 119
Summary .. .. .. .. .. 120
F. INCIDENCE OF SEQUELAE, ESPECIALLY DEAFNESS .. 122
Incidence of deafness .. .. .. .. 130
Onset .. .. .. .. ., 133
Factors influencing incidence .. .. .. 134
Summary .. .. .. .. .. 137
SUMMARY AND CONCLUSIONS .. . . . .  .. 139
ACKNOWLEDGMENTS .. .. .. .. .. 143
REFERENCES   144
FACTORS INFLUENCING THE PROGNOSIS IN TUBERCULOUS MENINGITIS
  ________ TREATED WITH STREPTOMYCIN.___________
INTRODUCTION.
In 1768, Robert Whytt, during the period when he occupied the Chair of 
Medicine at Edinburgh University, gave the first account of the clinical 
course of the syndrome now recognised to be that of tuberculous meningitis, 
in a paper entitled 1 Observations on the Dropsy of the Brain." His efforts 
to treat the condition were singularly unavailing: he himself admitted,
"I freely own that I have never been so lucky as to cure one patient who had 
the symptoms which with certainty denote this disease", and he added "I suspect 
that those who imagine they have been more successful have mistaken another 
distemper for this". For close on two centuries, his experience was 
confirmed by practically every physician who endeavoured to treat the malady, 
described by Trousseau (1867) as "this cruel and inexorable complaint."
It is true that a few authenticated cases of spontaneous recovery were reported 
from time to time, but so exceedingly rare were such cases that nearly every 
textbook describing the condition in the pre-streptomycin era stated that it 
was "invariably fatal". Death usually ensued within two to three weeks of 
the onset of the meningitic illness. Levinson and his associates (1950) 
reported that 97$ the deaths occurred within 30 days of onset, and the 
longest survival period was 49 days.
In 1944, Waksman and his associates announced the discovery of streptomycin, 
and thus gave to physicians the first weapon ever known to have affected the 
course of this tragic disease. Its use in tuberculous meningitis was first 
reported/
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reported by Cooke, Dunphy and Blake in 194-6, in a paper describing 
successful treatment of a girl aged 1 year admitted with convulsions to 
New Haven Hospital on 12th May, 1945* Although the patient ultimately 
became mentally retarded and probably deaf, she had obviously benefited from 
the treatment. It soon became evident as more and more cases were treated, 
that the new drug would completely revolutionize the outlook in a once uniformly 
fatal condition. The succeeding years have seen the flooding of the medical 
press in all parts of the world with papers on the treatment of tuberculous 
meningitis. For several years, streptomycin itself was the sheet anchor of 
treatment, and even now, while successes have been claimed with isoniazid alone, 
the majority of writers recommend the continued use of streptomycin in addition. 
Adjuvant therapy, for example, sulphetrone, para-aminosalicylic acid (P.A.S.) 
streptokinase, intra-thecal tuberculin, has no doubt contributed to the 
satisfactory results obtained, but of all the drugs used, streptomycin and 
isoniazid are the only effective anti-tuberculous weapons so far discovered.
In streptomycin-treated cases, however, and even when isoniazid is added 
to the armamentarium, the proportion of recoveries from tuberculous meningitis 
falls considerably short of 100$, and a varying percentage of survivors are 
left with mental or physical disabilities of greater or lesser degree. These 
facts raise very pertinent questions to which it is the aim of this thesis to 
endeavour to find an answer.
Why do patients die at all from the disease despite effective 
antibacterial agents?
What factors might possibly indicate the likelihood of survival?
Can /
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Can the illness reach a stage from which the chances of recovery are 
remote?
Are there any features of the initial illness - clinical or laboratory - 
from a consideration of which a prognosis can be made with any degree of 
certainty?
What regime of treatment is most effective?
Can the type of response to treatment be correlated with the end-result?
Are complications arising in the course of treatment likely to affect 
the ultimate outcome?
What factors, if any, determine the incidence of such complications, 
and of sequelae?
One of the most disappointing features of cases treated with streptomycin 
is the liability to relapse. Is this a grave omen, and is it possible to 
determine beforehand, from the type of patient, the features of the initial 
illness, or the response to treatment, which patients will be more liable to 
relapse, and so be able to forecast with greater confidence that recovery will 
be permanent in any given case?
The literature on the treatment of tuberculous meningitis is vast. In 
the course of preparation of this thesis, over one hundred and fifty papers 
from many countries and all continents have been perused, as well as many 
annotations and letters. It is obviously impossible to refer to all of these 
in detail. The relevant literature will be considered in connection with each 
particular section, but a few general observations at this juncture might not 
be out of place. Various factors affecting the prognosis are mentioned by 
many/
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many writers, but there does not seem to be a consensus of opinion as to 
their import, Cohen (1952) for example, suggested that the following factors 
are important:
(1) Duration of illness prior to institution of treatment;
(2) Presence or absence of tuberculomata in the brain - these
being more common in adults than in children;
(3) Presence or absence of miliary tuberculosis;
(4) Age of patient, and
(5) Adequacy of treatment.
In an interim report in 1949» of the Department of Health for Scotland, 
the following factors were stated to be of significance:
(1) Age - A poor prognosis was to be expected in patients under 4
and over 17.
(2) Stage of disease.
(3) Snowstorm appearances in the chest X-Ray.
(4) Presence of choroidal tubercles.
The report indicated that rapid fall in temperature, pulse-rate or 
erythrocyte sedimentation rate (E.S.R.) was not significant, but that a 
persistently low cerebrospinal fluid (C.S.P,) sugar was ominous and a distinct 
rise in the sugar level was favourable. In a subsequent report (Dunlop et al, 
1953) based on a larger series of patients, the earlier impression of the 
significance of miliary mottling in the Chest X-Ray was corrected: the finding
seemed to be ‘of little prognostic value*. MacCarthy and Mann (1950) stated 
that the Minitial response to treatment depends on a combination of several 
factors besides streptomycin - age, mechanical obstruction of the cerebrospinal 
pathways, early diagnosis, innate resistance to tuberculosis and perhaps 
virulence/
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virulence of the tubercle bacilli." They felt that the survival rate was 
not affected so much by the particular rhythm of treatment as by the number 
of initially responsive cases. On the other hand, Robertson and 
Gairdner (1952), in a review of 146 cases treated in the Newcastle area, 
could find no significant effect on survival rate of age, existing miliary 
tuberculosis, length of history, development of meningitis during treatment 
of miliary tuberculosis with streptomycin, choroidal tubercles or papilloedema. 
The only prognostic guide on admission was the clinical picture based on a 
combination of psychological and physical findings. Lorber (1954c) too, 
in a study of 549 cases from 5 different centres in England, found few factors 
of prognostic import and, indeed, felt that the only one of real value was the 
state of consciousness. 80$ of patients who were conscious on admission 
could be saved with combined intramuscular and intrathecal streptomycin 
using F.A.S. as a routine and intrathecal tuberculin as an adjuvant in 
selected cases. This opinion concurs with the view of Smith and Vollum (1950) 
who stated that the only findings of prognostic value at the beginning of 
treatment were the state of consciousness and the presence of neurological 
signs.
MATERIAL.
The present investigation commenced with the introduction of 
streptomycin to Ayrshire, Scotland, in the early summer of 1948, when a 
special supply was obtained from America for a boy of five years admitted 
to Ayrshire Central Hospital (A.C.H.) Irvine, in JUne, 1948, suffering from 
tuberculous meningitis. Thereafter, when supplies became freely available 
for/
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for the treatment of this disease, further 25 cases of tuberculous 
meningitis were admitted to A.C.H. between June 1948 and October 19491 
received streptomycin treatment and are included in this series. These 
patients were completely unselected: all cases of tuberculous meningitis
in Ayrshire were admitted to this unit and in none was treatment refused, 
however far advanced the disease appeared to be. The remaining ~{6 patients 
in this series were treated in Belvidere Hospital, Glasgow, where there was 
a certain degree of selection enforced by the arrangement in Glasgow that 
all female patients and children under five years of age notified as 
suffering from “meningitis1 were admitted to another unit (in Ruchill 
Hospital) only males over 5 years being treated in Belvidere. A number of 
females and of children under 5 are, however, included in this part of the 
series, mainly because patients belonging to these groups notified as 
having “pyrexia of unknown origin” were admitted to Belvidere Hospital.
A proportion of these were proved to be suffering from tuberculous meningitis, 
and were retained and treated. Other cases of tuberculous meningitis 
were admitted to hospital as cases of “pneumonia1 or with other diagnostic 
labels, and still others developed tuberculous meningitis while under 
treatment for some other condition, e.g. whooping cough or measles, or in 
the course of treatment of miliary tuberculosis. For these reasons, the 
76 patients treated at Belvidere included 16 females and 15 children under 
five years of age. Otherwise these patients were also unselected. 
Throughout the period from June 1948 to December 1951# during which these 
patients were all admitted to hospital, treatment was not withheld on any 
occasion even when the patient*3 condition seemed desperate and the outlook 
hopeless./
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hopeless. All except eleven of the 102 patients were under my personal 
care and supervision throughout the course of their treatment and stay in 
hospital* Of the eleven exceptions, one was initially treated by me at
A.C.H*, relapsed after having had a full 6 months1 course of streptomycin, 
and died after a further 9 months, during the last 4 o f which he was under 
the care of my successor. Four of the eleven had commenced treatment in 
the three months before I was transferred to Belvidere Hospital in March 1950, 
and thereafter continued and completed their course of treatment under my 
supervision. The remaining six patients had already been treated by my 
predecessor at Belvidere, but are included in this series because they 
subsequently relapsed and required another course (or courses) of treatment 
while I was there.
Since the results obtained in this series of patients were collected 
and tabulated, there has been one further death - in one of the six patients 
last mentioned in the above paragraph. This is not included in the tables 
presented nor taken into account in the conclusions drawn from the series. 
Death occurred five years after admission to hospital and more than three 
years after complete clinical recovery and restoration of C.S.F. to normal.
The patient had extensive bilateral tuberculosis which was the cause of death: 
the C.S.F. remained normal and there was no recurrence of meningitis. It 
seemed justifiable to retain this patient among the 1 survivors".
The certain diagnosis of tuberculous meningitis is clearly dependent 
on the isolation of viable tubercle bacilli from the C.S.F. It is obvious, 
however, that treatment must be instituted in every case before the results 
of/
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of guinea-pig inoculation or Loewenstein culture of the C.S.F. are available 
in confirmation (or otherwise) of the diagnosis, and in many cases in the 
absence of positive finding of acid and alcohol-fast bacilli in direct films 
of the C.S.F. The clinical and cyto-chemical changes in the C.S.F. - in 
particular, the reduction of the sugar content of the latter - are the 
criteria on which the decision is taken to institute streptomycin therapy, 
since delay in commencing treatment may be costly. It is therefore not 
surprising that very few of the series of cases reported in the literature 
show 100$ bacteriological confirmation. Even cases confirmed histologically 
at autopsy have been negative bacteriologically during life and even after 
death. Thus in an early report by the Medical Research Council in 1948*
6 out of the series of 92 cases did not have bacteriological confirmation, 
but were proven histologically post-mortem; guinea-pig inoculation and 
culture were negative in 5 other patients whose C.S.F. showed tubercle 
bacilli on direct examination; and 3 survivors, who were believed to be 
suffering from tuberculous meningitis were excluded from the series because 
of lack of bacteriological proof. It is to be expected, therefore, that 
confirmation will be lacking in a proportion of survivors, despite the 
assertion by Debre and his associates (1947) that ”it is possible to 
determine the exact nature of the disease with absolute certainty from the 
results of cultures of the C.S.F. on Loewenstein1 s medium, a test which 
practically never fails.”
The proportion of cases confirmed bacteriologically, varies from 
series/
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series to series, usually from 80$ to 100$ as shown in the following
figures abstracted from the literature:
Authors Tear
No.of 
Cases
Number Per- 
Confirmed centage 
bacterio- confirm- 
logically ation. Remarks.
Medical Research 
Council
1948 92 86 93 6 others confirmed 
histologically.
Smith et al 1948 18 15 83 1 proved P.M.
2 survivors unconfirmed.
Lincoln et al 1948 7 5 71
Mann 1948 33 32 97
Dept.of Health 
(Scotland)
1949 81 75 93 2 others confirmed 
P.M.
Rubie & Mohun 1949 67 62 92 4 of the confirmed cases 
on direct film only.
MacCarthy and Mann 1950 43 40 93 1 other confirmed P.M.
Cathie and 
MacEarlane
1950 60 60 100
Cairns et al 1950 93 92 99
Brainerd and Eagle 1950 27 23 85
Calnan et al 1951 48 47 98
Illingworth and 
Lorber
1951 82 73 89 4 others confirmed P.M.
High 1951 22 19 86
Lassen and 
Neukirch
1951 44 39 89 3 others confirmed P.M.
Einberg 1951 35 32 91 Eigures include cases 
only confirmed P.M.
Ruziczka 1952 60 54 90
Jamieson/
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Number Per- 
Confirmed centage 
No.of bacterio- confirm-
Authors Year Cases logically ation. Remarks.
Jamieson 1952 35 30 86 1 other confirmed P.M.
Harvey 1952 150 138 92 3 others confirmed P.M.
Cohen 1952 17 10 59
Havreby et al 1952 40 24 60
Perry 1952 26 25 96
Riley 1953 60 52 87
Lorber 1954c 549 513 93 15 others confirmed P.M.
Present Series 102 84 82 3 others confirmed P.M.
It is evident, therefore, that while the isolation of M. tuberculosis 
from the C.S.F. is desirable for establishing the diagnosis, it should not 
be taken as indispensable for this purpose. Indeed Choremis and his 
fellow workers (1948) have shown that "the finding of tubercle bacilli in 
the cerebrospinal fluid is not inevitably followed by tuberculous meningitis." 
They isolated tubercle bacilli from the C.S.F. of cases of meningism 
associated with primary tuberculosis in children who did not develop 
meningitis and who recovered in a few days without specific treatment. 
Moreover, they showed that the presence of M. tuberculosis in the C.S.F. 
of patients treated with streptomycin for tuberculous meningitis and 
fully recovered is not in itself significant; such patients had remained well 
and did not relapse.
It is certainly unjustifiable, as emphasised by Smith et al (1948) 
to withhold streptomycin until bacteriological proof has been obtained 
even/
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even though some cases are never verified. In the present series,
M. tuberculosis was isolated from the C.S.F. of 84 cases (82$) - in the 
majority of these, by guinea-pig inoculation; in a few, only by direct 
examination of a film of the C.S.F. Unfortunately, the C.S.F. of 9 of the 
18 unconfirmed cases was not submitted for culture or guinea-pig inoculation 
prior to the institution of treatment. In 7 o f these, treatment had been 
commenced before my transfer to Belvidere Hospital, at a time when inoculation 
of guinea-pigs with C.S.F. of cases of suspected tuberculous meningitis was 
not carried out routinely; the other 2 were transferred to the meningitis 
ward from another ward where treatment was commenced without submitting 
specimens of C.S.F. for bacteriological examination. Throughout the 
remainder of the series, 2 specimens of C.S.F. were routinely sent to the 
laboratory for guinea-pig inoculation. In one patient, however, only one 
such specimen was sent, and the inoculated guinea-pig died of intercurrent 
disease. Thus, in 10 of the 18 unconfirmed cases, there was virtually no 
prior bacteriological examination of the C.S.F. 91$ o f the 92 cases 
examined proved to be positive bacteriologically either in life or after death.
Of the 18 unconfirmed cases, 6 died and 12 survived. Permission for 
post-mortem examination was refused in 3 o f the former, but in the other 3 “ 
cases 31* 43 9 72 - autopsy confirmed histologically the diagnosis of 
tuberculous meningitis. (In case 49t the evidence of meningitis was very 
slight; the patient, who died one day after the commencement of treatment, 
had widespread miliary tuberculosis and early meningitis: C.S.F. changes
were typical.)
The/
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The diagnosis was never in doubt in the 3 patients (cases 7» 10, 54) 
for whom autopsy permission was not granted. All had a positive Mantoux 
reaction and evidence of an active primary complex in the chest; in 
addition X-Ray of one (54) showed miliary mottling throughout the lung fields. 
Each gave a history of a meningitic illness, had some degree of meningism and 
typical C.S.F. changes - with persistently low sugar level.
8 of the 12 survivors (28, 29, 32, 33, 35, 36, 85, 87) did not have 
adequate pre-treatment bacteriological examination of the C.S.F.; in another 
(50), 2 specimens of C.S.F. were submitted for guinea-pig inoculation, hut one 
of the guinea-pigs inoculated died of intercurrent disease. Review of all 
these cases revealed that the diagnosis was in doubt in only 3 of them.
All had evidence of present or previous tuberculous infection - lung primary 
in 5, pleurisy in 2, adult pulmonary in 2, miliary in 2, and bone disease 
in 1 - and the Mantoux was tve in all except in the cases known to have had 
adult pulmonary and bone tuberculosis, in whom it was not carried out.
All had a meningitic illness of varying severity except one (85) in whom the 
meningeal inflammation was discovered on routine C.S.F. examination in the 
course of treatment of miliary tuberculosis. The C.S.F. was typical in all 
except two (70, 85). In one of these (70), the illness was at an early stage 
on admission, but he did have severe headache and other typical features of 
tuberculous meningitis; C.S.F. examination showed a raised cell-count and 
protein content and the chloride level was reduced; C.S.F. response to 
streptomycin was typical, as described by Smith and Vollum (1950). The only 
feature that raised doubt was a persistently normal C.S.F. sugar level.
It will be seen later, however, that this has been observed in many 
cases/
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cases in this and other series in whom the diagnosis has been confirmed.
Two Consultants who examined this patient had no doubt about the validity 
of the diagnosis. Case 85, as already stated, was found on routine C.S.F. 
examination in the course of treatment of miliary tuberculosis, to have a 
pleocytosis; unfortunately intrathecal treatment was commenced in another 
ward without prior bacteriological examination of the C.S.F. It is 
conceivable that this was a case of tuberculous serous meningitis, described 
by Lincoln (1947)* At the time of diagnosis, the only abnormal C.S.F. 
constituent was the cell-count which was 85 per c.mm. Within 4 days, 
however, this had risen to 280 per c.mm. and the protein content was 90 mg. 
per 100 ml; and the sugar level fell to 43*4 mg. per 100 ml. after a month. 
This patient has therefore been regarded as a case of tuberculous meningitis. 
The only other case whose diagnosis was at all in doubt was a child of 5 (17) 
with a previous history of primary tuberculosis treated in hospital, who 
developed a mild meningitic illness. The C.S.F., though examined, was 
never positive for M. tuberculosis and the chloride content was normal, 
falling to below J00 mg. per 100 ml. on only 3 occasions - never below 
685 mg. per 100 ml. The C.S.F. sugar level, however, was 35 Per 100 ml. 
on admission and remained low for nearly 6 months. This would appear 
sufficient evidence on which to base a diagnosis of tuberculous meningitis. 
Thus, although bacteriological proof was lacking in 18 of the 102 patients 
in this series, it is highly probable that the diagnosis in all of these 
was correct.
A H  102 patients were treated with streptomycin prior to the introduction 
of isoniazid. While the latter is now an integral part of the therapy for 
tuberculous/
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tuberculous meningitis and the use of streptomycin alone has thus been 
superceded, it seems useful to examine in retrospect the results of 
pre-isoniazid treatment as it is not unreasonable to suppose that such an 
investigation may provide information of value in the study of the effects 
of more potent drugs such as isoniazid on tuberculous meningitis. As 
stated by the M.R.C. (1948) in reporting an early series before the discovery 
of isoniazid Hit is possible that whatever emerges from this study may apply 
also to other more potent chemotherapeutic agents that may be discovered in 
the future." The results here presented may thus serve as a yardstick for 
comparing the results of new regimes of treatment. A series of 102 
patients admittedly is, comparatively speaking, almost minute and 
insignificant; not too small, however, to justify limited conclusions. 
Moreover, in studying a disease such a tuberculous meningitis with its 
prolonged course of treatment and liability to fatal relapses after as 
much as years of good health (Russell and MacArthur, 1953) or even 
5 years after the onset of the initial illness (Oldham et al, 1954) t a long 
period of observation and follow-up is highly desirable if not essential.
In this series, the minimum period of follow-up was five years.
METHODS.
Routine examination on admission of the patients in this series 
included complete clinical examination, Mantoux testing (except in 
patients known to have or to have had tuberculosis), chest radiography 
(in all but 1 patient), ophthalmoscopic examination to detect the presence 
of papilloedema and/or choroidal tubercles (in 92 patients), erythrocyte 
sedimentation/
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sedimentation rate - E.S.R. (in 78 patients) and C.S.F. examination 
(cell, protein and sugar content in all cases, and chloride content in 
90 cases; and bacteriological examination by guinea-pig inoculation as 
already indicated; culture on loewenstein^ medium was also carried out in 
some of the earlier cases in the series). To facilitate subsequent review 
of the features, special stencilled sheets were completed for each patient 
on admission. On each were entered the name, age and address of the patient; 
the dates of admission to hospital and of commencement of treatment for 
meningitis; the duration and severity of the illness; the presence and 
duration of individual symptoms and signs; any history of previous 
tuberculous illness or of contacts (family or other) with tuberculosis; 
temperature, pulse and respiration rates; degree of meningeal signs; 
the state of reflexes and presence of cranial or spinal nerve palsies; 
results of ophthalmoscopic examination; X-Ray appearances and Mantoux state; 
E.S.R.; C.S.F. appearances and pressure and the isolation of tubercle 
bacilli. Further stencilled sheets were used to indicate treatment given 
and progress made. In these, entries were made, at weekly intervals 
throughout the stay in hospital, of the dosage of intramuscular and 
intrathecal streptomycin being administered; general condition; presence 
and severity of headache, vomiting, anorexia, constipation, meningeal signs, 
drowsiness and irritability; temperature; weight (when considered fit 
enough for this to be measured) and level of C.S.F. constituents.
E.S.R. was estimated at monthly intervals and recorded in the sheet.
Tables were compiled with the aid of statistical cards with punch-holes, 
specially/
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specially prepared for the purpose.
Every patient in the series was treated with streptomycin (or 
dihydrostreptomycin) by both intramuscular and intrathecal routes.
With the exception of six patients who were given an initial course lasting 
months and who came under my care when they subsequently relapsed, the 
routine duration of treatment was 6 months; this was maintained even when 
recovery appeared to have taken place by a much earlier date. In a few who 
showed deterioration in the latter half of this period, the treatment was 
continued for longer than 6 months. On the occurrence of relapse, a full 
6 months1 course was repeated. The different patterns of treatment adopted 
will be described later in considering the effect of the treatment regime on 
prognosis.
Para-amino-salicylic acid (P.A.S.) was introduced into the treatment, 
in the dosage shown in Table 33* early in 1950. Consequently the first 26 
patients did not receive any of this drug; cases 27-32 received it only 
when they relapsed; and cases 33”37 commenced treatment with streptomycin 
alone, P.A.8. being introduced later. Apart from mild goitre in 2 patients, 
no toxic effects of this therapy were observed. One patient (33) was 
given sulphetrone until the completion of the streptomycin course. The 
initial doze of 0.25g. twice daily by mouth was gradually increased over a 
period of 3 months to 1 g. three times daily, the haemoglobin level being 
recorded at weekly intervals till treatment was discontinued. No 
complications of this treatment were observed except slight cyanosis. 
Streptokinase/
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Streptokinase and tuberculin (P.P.D.) were used in a proportion of cases; 
their use and effect will be described later.
Accessory treatment included transfusions of blood, plasma and glucose 
saline in some very ill and comatose patients. In one comatose patient, 
feeding by stomach tube was necessary for the first week or two. Vitamins 
were administered routinely, and iron when necessary.
At first, patients were nursed in bed throughout the 6 months of 
treatment and thereafter gradually up-graded. It was soon realized that, 
despite physiotherapy, the danger of stiffness and deformities increased 
with prolonged bed-rest, and so, subsequently, patients were allowed up 
after 3 months if they were making satisfactory progress and there were no 
contraindications. Passive and active exercises were given from the outset 
in all cases, under the direction of a trained physiotherapist, and the 
patients were encouraged to move about and frequently change their positions 
in bed. There is no doubt that efficient nursing care and attention during 
the acute illness plays a very great part, which cannot be measured, in the 
speedy rehabilitation of patients and that the morale of the patients, of 
so great importance in such a severe illness with prolonged treatment, is 
dependent in large measure, on the encouragement of nursing staff and 
other attendants.
As far as possible, patients remained in hospital till 3 months after 
the course of treatment was completed; in a few of the later patients, 
part of this period was spent in a convalescent home. Following discharge 
from/
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from hospital, they were asked to report hack at gradually increasing 
intervals, and nearly all were very happy to do so and be reassured from 
time to time. The C.S.F. was examined at weekly intervals throughout the 
streptomycin course; thereafter the interval between lumbar (or, in some 
cases, cisternal) punctures was gradually extended. On discharge, patients 
(or their relatives) were warned of the possibility of relapse, and 
encouraged to report to hospital should any abnormal symptoms develop.
As a general rule, this advice was carefully heeded.
RESULTS.
The considerable variation in results in published series of 
streptomycin-treated cases of tuberculous meningitis has already been noted. 
The survival rate varies from as little as Ojf> to as high as 8($. As is to 
expected, the series showing these extremes are comparatively small, and 
the average recovery rate seems to be between 40^ and 6($ as shown in the 
following samples of published results:-
Minimum 
No. No.and Per- Period 
of centage of of observ- 
Cases survivors, ation.Country Year Authors
Great 1948 Medical Research 
Britain Council.
1949 Dept.of Health 
(Scotland)
1949 Cairns and Taylor
1950 Cathie and
MacFarlane
1950/
105
81
48
60
34 (32. 
36 (44.
7 months 
4 months
Remarks•
5 survivors in 
unsatisfactory 
condition.
28 (58.356) ?
28 (46.7$) 8 months
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Country.
Great
Britain
Ireland/
Year Authors
Minimum 
No. No.and Per- Period 
of centage of of observ- 
Cases survivors, ation.
1950 Mac Cart hy and Mann 43 13 (30.20) 16 months
1951 Calnan et al 54 16 (29.#) 2^ years
1951 Calnan 114 53 (46.9$) 1 year
1951 Illingworth 
and Lorber
82 36 (43.956) 1 year
1953 Ministry of Health 371 102 (27.$) 2lQ years 
12
1952 Jamieson 35 28 (8056) 1 year
1952 Robertson and 
G-airdner
146 69 (47.30) 2 years
1952 Somner 26 14 (540) 9 months
1953 Russell and 
MacArthur•
33 12 (36.40)49 months
1953 Dunlop et al 266 125 (470) 2_| years
1954a- Lorber 38 28 (73.70) 2 years
1954c Lorber 549 253 (46.10) 2 years
Present Series 102 66 (64-70) 5 years.
Remarks.
7 except two aged 
8. 6 treated with 
I.M.st rept omyc in 
only. - All died.
grossly disabled.
20 in unsatisfactc 
condition.
Children treated 
from Aug.1950 to 
March 1952*
Survey of results 
in 5 centres. 4 
further deaths in 
3rd year and 2 in 
4th year.
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Minimum
Country Year Authors
No. No.and Per- 
of centage of 
Cases survivors.
Period 
of observ­
ation.
Ireland 1950 McSweeney 94 19 (20$) 4 months
U.S.A. 1950a Bunn 78 21 (26.9$) ?
1950 Levinson et al 38 7 (18.4$) 1 year
1951 Lincoln and 
Wilking
39 28 (71.8$) 6 months
1952 Ravreby et al 40 30 (75$) 20 more ) 
than I year) 
3 less ) 
than 6 ) 
months. )
1952 Perry 26 7 (26.9$) ?
1953 Riley 60 4 (6.7$) 2 years
1954 Spies et al 61 11 (18$) ?
1954 Spies et al 38 9 (23.8$) ?
Australia
1952 Beveridge 52 16 (30.8$) ?
1952 Williams 40 9 (22.5$) T
France 1947 Debre et al 118 46 (39$) 2 months
1952b Debre 262 127 (48.5$) 15 months.
Remarks
2 survivors 
moribund.
Children
Treated from 
1946-1951.
Infants and 
children.
Ages 15-76 
1946-1951.
7 treated without 
I.T.streptomycin 
and 1 without 
I .M. 8treptomycin.
12 had no I.T. 
streptomycin.
Included in 
above series.
All had I.T. 
streptomycin.
Total series 57 
- 5 treated.
Greece/
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Country Year Authors
Greece 1948 Choremis et al
1951 do.
Austria 1952 Ruziczka
Denmark 1951 Lassen and 
Neukirch
Italy 1950 Flori
Finland I95I Wasz-Eockert
Holland I95I Hooft and Deneve 
Algiers 1950 Sarrouy et al
Minimum 
No. No.and Per- Period 
of centage of of observ- 
Cases survivors, ation.
63 29 ( 46$) T
132 87 (65.9$) ?
114 60 (52.6$) 1 year
44 13 (29.5$) 1
265 152 (57-4$) T
60 30 (50$) T
143 63 (44.1$)
30 0
Remarks
3 still under 
treatment.
All survivors 
discharged well,
I•M.streptomycin 
only except in 
13 cases.
104 cases 
regarded as cured
Mainly children 
under 7.
No trace found 
of 4. presumed 
dead.
Clearly, several factors may be responsible for this remarkable variation 
in results, apart altogether from the treatment regime employed and, indeed, 
the types of patients treated. Increasing experience would be expected to 
lower the mortality rate in later series reported. This is well demonstrated 
in Lorber‘s review (1954c) of the results of treatment of 549 cases of 
tuberculous meningitis in 5 different centres in London, Oxford, Newcastle 
and Sheffield. Particularly bad results were obtained in 1947 when the 
recovery rate was 31*6$ compared with 49*3$ *n succeeding years. In 1951* 
(when P.A.S. was introduced) 64$ of 89 patients survived, compared with 52$ 
in/
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in the years 1948-50. Calnan's series (1951) of 140 Cases (114 with 
1 year's observation) showed a progressive increase in recovery rate in 
successive groups of 25 cases from 24$ to 68$. Flori also (1950) traced 
a progressive fall in mortality from 77$ ln the first half of 1947 to 15$ 
in the last half of 1948.
Another important factor is the period of observation. While it is 
true that the majority of patients who die, do so within 6 months, a 
proportion of cases die during the second 6 months, and a smaller proportion 
in the second year. Thus, in Lorber»s series of 549 cases already quoted, 
266 (48.4$) survived 1 year; 253 (46*1$) survived 2 years; while 4 more 
patients died in the third year and 2 in the fourth. In the Ministry of 
Health report on 371 patients (195l)» it was stated that in all clinical 
groups the mortality was heaviest in the first 3 months and continued to be 
fairly high for 6 months; thereafter it slackened and ceased after 18 months 
in cases of meningitis alone, 13 months in cases of miliary tuberculosis with 
coincident meningitis; and 9 months in cases of miliary tuberculosis 
developing meningitis. Finberg (1951) ln a review of 30 cases of 
tuberculous meningitis treated between September 1946 and November 1950* 
presented this declining mortality in diagrammatic form. The diagram, in 
which data are presented as though patients were started on treatment 
simultaneously, showed that most of the mortality occurred in the first year 
of therapy; and that after eighteen months, additional mortality was not 
appreciable./
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appreciable. Figure 1 (with table 4) is an application of this mode of 
presentation to the cases in this series and shows similar features.
Table 1 shows that 66 (64*7$) of the 102 patients comprising this 
series survived for at least 5 years. (One of these actually died of 
pulmonary tuberculosis at the end of 5 years as already indicated.)
The first 26 of these, treated at Ayrshire Central Hospital, showed a 50$ 
mortality compared with 30.3$ the succeeding 76 patients treated at 
Belvidere; but the higher mortality in the former series may well be 
attributed, at least in part, to other factors such as the higher proportion 
of younger children included in the series for reasons already stated.
3 of 9 patients (33*3$) admitted in 194$ died, compared with 11 of 26 patients 
(42.3$) admitted in 1949* 14 o f 35 patients (40$) admitted in 1950, and 8 of 
32 patients (25$) admitted in 1951* Thus there is no definite trend in this 
series which could not be attributed to chance variation. Table 4 and 
Figure 1, showing the duration of life in fatal cases, demonstrate that 
five-twelfths of deaths occurred within the first month, over half within 
2 months, and two-thirds within 3 months. Only 6 of the 36 fatal cases 
survived longer than 6 months and only 3 were still alive at the end of a 
year; one of these lived for over 2 years.
When allowance is made for these considerations, there are still obvious 
discrepancies between results obtained by different workers during the same 
time-period and with uniform follow-up. It is the object of this 
investigation to assess the factors that may have been responsible for the
diversity of results in this series. I propose to consider the subject in 
the/
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the following sections
A. Influence on the prognosis of the type of patient, and
his/her condition at the time of commencing treatment.
B. Influence of different treatment regimes employed on the
survival rate.
C. Type of response to treatment and its effect on the outcome.
D. Incidence of complications, especially spinal block, and
assessment of their effect on prognosis.
E. Incidence of relapse and its effect on the ultimate outcome.
F. Factors affecting the incidence of sequelae; in particular,
deafness.
- 25 -
A. ASSESSMENT OF PROGNOSTIC FACTORS AT THE 
COMMENCEMENT OF TREATMENT.________
It was by means easy in pre-isoniazid days - well nigh impossible, 
indeed - to make a confident prognosis when confronted with a patient known 
to have tuberculous meningitis. The writer’s experience on occasions has 
no doubt been shared by most other physicians who have treated the disease, 
namely that patients, who appeared to have an excellent prospect of 
uncomplicated recovery, have failed to respond to treatment, while others, 
who seemed almost moribund on admission and were only given treatment because 
it was considered wrong to withhold it, survived without sequelae.
Nevertheless such cases are the exception rather than the rule, and several 
factors are generally recognized to be fairly reliable prognostic guides.
Tables 5 to JL have been compiled to show the influence of various 
factors on the ultimate outcome of the illness in this series. It will be 
seen later that 4 patients survived the first course of treatment but 
subsequently relapsed and died. Notwithstanding their initial favourable 
response, these are classified in these tables with the other patients who 
died. Further, the survivors include 12 patients who received more than one 
course of streptomycin therapy before they appeared to be finally "cured".
The particular problems raised by all these patients will be considered 
subsequently in section E. Finally, these tables do not take into account 
the sequelae; they are concerned with the quantity rather than the quality of 
results.
AGE/
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AGE.
It was early discovered that the prognosis was worse in children 
under 3 years than in older children and that the disease in adults also 
carried a high mortality; these findings have been fairly uniformly 
confirmed in successive series of cases.
In the early trial of the M.R.C. (1948)* it was found that the 
proportion of older children surviving and making good progress after four 
months was more than three times that in children under 3* Choremis and 
his associates (1948) found that the average age of 21 patients who recovered 
was b years 11 months whereas that of 26 who died was 4 years 8 months; 
and in 1951» reporting on a series of 132 cases, they found the mortality rate 
in 54 patients under 4 years was 40*7$t compared with 24.4$ 78 patients
aged 4 years and over. Rubie and Mohun (1949) treated 54 cases, 18 of 
whom survived; only 1 of the 17 cases under 3 years survived. Calnan (1951) 
reported a mortality of 73-5$ in 34 children under 3 years (25 deaths; but 
6 of 13 under 1 year survived); compared with 45$ 80 patients over 3 years.
In Lincoln and Wilking’a series (1951) 39 patients, 9 (3^$) of 25 patients
under 3 years died, compared with only 2 (14.3$) of 14 patients aged 3 years 
and over. Corresponding percentages in Robertson and Gairdner’s series (1952) 
of 146patients were 68.2$ in 44 children under 3; and 53»9$ I31 102 patients
aged three and over; and in Ruziczka’s series (1952) of 114 children - 
69$ of 42 younger children and 34*7$ of 72 older children. Debre (1952b) 
found a mortality of 75$ ln 16 infants under 1 year; 58$ iu. 118 children 
between 1 and 6, and 37*52 in 128 between 6 and 20.
On the other hand, some writers have not found results less satisfactory
in the younger age-groups. For example, Cairns and Taylor (1949) reporting 
48 cases of tuberculous meningitis, stated that infants under 3 years did 
as well as older children; and in 1950 Cairns, Smith and Vollum wrote that 
the results were the same in all ages except the extremes. Russell and 
MacArthur (1950) found no appreciable difference between the mortality in 
patients under 4 years and that in patients 4 years and over-9 (52.9$) 17
in the former group died, compared with 9 (56.25$) of 16 in the latter.
Perry (1952) reported that 12 (70.6$) of 17 children under 2 years died,
compared with 6 (75$) of 8 of 2 years and over. In reviewing the results
of treatment of 549 cases, Lorber (1954c) found a significantly higher 
mortality rate in children under 3* i*ut he attributed this entirely to 
delayed diagnosis in this group and asserted that, with earlier diagnosis, 
the prognosis for younger children need not be worse than for other groups.
In an earlier paper, in which the effect of delayed diagnosis was stressed, 
Illingworth/
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Illingworth and Lorber (1951) found no significant difference between the 
results in patients under 3 years and those in patients aged 3 and over.
In the present series, the mortality rate of 60fo in 25 children under 
5 years of age was significantly higher than in other age-groups (Table 5); 
Table 6 shows that most of these deaths occurred in the 20 children under 
3 years, the mortality here being 65$, It is noteworthy also that only one 
of the five patients over 30 years of age survived. While the latter numbers 
are too small to be conclusive, the finding corresponds with results in other 
series. Riley (1953) attributed the poor results in adults to the frequent 
association of tuberculous meningitis with actively disseminating widespread 
haematogenous extrapulmonary tuberculosis. The five adults over 30 in this 
series all had pulmonary tuberculosis; in at least four of these it was 
active and only in the one survivor, was control achieved. There seems no 
doubt that the presence of uncontrolled pulmonary tuberculosis at least 
contributed to the fatal outcome in the other three patients.
The higher mortality in young children in this series could not be 
fully accounted for either by increased severity of the illness or delay in 
making the diagnosis in these age-groups. Neither the severity nor the 
duration of the illness differed significantly from the corresponding findings 
in other age groups. Of the 20 children under 3 years 8 (4C$) were severely 
ill on admission, 11 (55$) moderately ill and 1 (5$) mildly ill compared with 
31.9$, 57*3$ and 11$ respectively in other age-groups.
( ^  = 0.953 with n » 2; P * 0*7 - 0*5)• 7(3^) of the 20 children had been 
ill for less than a week; 6 (30$) for 1 to 2 weeks; and 3 (15$) £°r longer 
than 2 weeks (4 others had been ailing for some time and the exact date of onset 
of/
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of the meningitic illness could not be fixed with any certainty), compared
with 32.9$, 51*2$ and 13*4$ the others = 1.206; with n - 2 ;  P = 0*7-0.5)
It was noteworthy, however, that of the 3 patients in the series with an 
illness of longer than 3 weeks, 2 were under 3 years of age* It is true
that difficulties in early diagnosis are much greater in young children. 
Listlessness and irritability, which may be the earliest evidences of the 
disease, are often attributed to other causes. Infants do not complain of 
headaches, and the first manifestations of the disease may be vomiting, 
rigidity, squint, drowsiness or coma.
A factor which may well make a major contribution to the increased 
mortality in young children is that the disease seems to run a more rapid 
course in earlier age-groups. Rubie and Mohun (1949) attributed the poor 
prognosis in patients under 3 years to the rapidity with which they reach 
an advanced stage of the disease. Case 49 this series, a girl of 
2-J- years, was a striking example of this. Although she had a history of 
anorexia following measles 3 months previously, and a cough for one month 
hep main symptoms - vomiting and irritability dated back only 3 or 4 days before 
admission to hospital. On admission she was only moderately ill and drowsy; 
there were no meningeal signs. Despite institution of streptomycin therapy 
on the day after admission, she died suddenly on the following day.
Choremis and his associates (1948) pointed out that tuberculous 
meningitis in very young children is often associated with active primary 
tuberculosis or with miliary tuberculosis and suggested that this may well 
contribute/
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contribute to the diminished prospects of survival. They added that the 
antigenic resistance in infants is lower than in older children. In this 
series the proportion of young children with miliary mottling in the lung 
fields - 11 (57.9$) of the 19 cases under 3 years examined was significantly 
higher than in other age-groups - 17 (20*7$) of the other 82 ft2 = 10.63 
with n = 1; P = 0.01 - 0.001) and this may well have been the major cause 
of the higher mortality in infants, the meningitis in these cases being 
simply a local manifestation of a widespread haematogenous dissemination 
of tubercle bacilli. This was certainly the case in the child already 
referred to (case 49)» post-mortem examination of whom revealed extensive 
miliary tuberculosis, but only very early meningeal inflammation.
Finally MacCartby and Mann (1950) niade the observation that a good 
initial response is dependent to a large extent on a free circulation in the 
cerebrospinal spaces and they suggested that the younger the patients the 
greater would be the danger of mechanical obstruction to the flow of C.5.F.
That this could not have been a factor in this series is seen by the 
comparative infrequency of spinal block in these patients (see Table 94)•
Whatever the factors mainly responsible it is evident that not only 
are young children most susceptible to tuberculous meningitis; they are also, 
by the time they reach hospital, most resistant to treatment. The obvious 
corollary is the value and importance of protection of all infants and young 
children exposed to tuberculosis.
DURATION AND SEVERITY OF ILLNESS.
The paramount importance of early diagnosis and institiition of treatment
has been repeatedly emphasized in the literature on tuberculous meningitis. 
Lorber/
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Lorber (1954b) from his studies of 549 patients in five different centres 
concluded that the most important prognostic factor was the stage of illness 
on admission* The incidence of sequelae, as well as the actual survival rate, 
was related to the severity of the initial illness. In the series,
66.6$ of early cases survived compared with less than 50$ at an intermediate 
stage and 20$ of advanced cases. Moreover, 9$ of early cases, 22.6$ of 
intermediate cases and 54*8$ of late cases showed neurological sequelae.
These findings led to the conclusion that patients with early disease had a 
five times better chance of complete or useful recovery than those with 
advanced disease.
Most writers have followed the M*R.C. (1948) in their classification 
of stages of disease, namely: -
"Early Patients with mainly non-specific symptoms with little or
no clinical signs of meningitis, with no paresis, in good general 
condition, and fully conscious. Diagnosis established mainly on 
findings in C.S.F.
Advanced j- Patients obviously extremely ill, deeply comatose or
stuporose, or with gross paresis.
Medium :- Patients in a condition between those of the first two
groups."
The following are samples of some of the reported mortality rates in 
relation to these categories:
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Mortality Rates.
No* of
Authors Cases. Early Medium Advanced
m.h.c. (1948) 92 46$ 66$ 86$
Mann (1948) 33 40# 80$ 93-3#
Rubie and Mohun (1949) 54 44-4# 68.2$ 92.2#
Department of Health for 
Scotland (1949)
8i 33# 54# 88#
Calnan (I95I) 114 33# 48# 89#
Lincoln and Wilking (1951) 39 14.3# 25# 60#
Robertson and Gairdner (1952) 146 33-3# 47-8# 85.7#
Illingworth and Lorber (1951) 82 26.3$ 64. S# 65.4#
In the last-named series, only 3 of the 9 survivors who had advanced 
disease on admission were mentally normal (and only 1 completely normal, 
mentally and physically) whereas 12 of the 13 survivors who had early disease 
were mentally normal. The Department of Health for Scotland (Dunlop et al,1953) 
reported 60$ recoveries in cases classified as early compared with an 
average of 39$ in a series of 266 cases; the Ministry of Health (1953) 
in a summary of findings in 369 cases, found for early cases a survival rate 
of 48$ compared with 10$ for late cases; and Choremis and his fellow-workers
(1951) reported that 44 patients out of 53 *n good clinical condition survived 
compared with 28 out of 60 with advanced disease.
While there is general agreement on the high degree of correlation 
between the stage of illness and the recovery rate there is not a corresponding 
unanimity about the prognostic value of the duration of illness prior to 
institution of treatment. The M.R.C. (1948) found that, in general, patients 
with a short history suggesting meningitis were clinically at an earlier stage 
than others, but there were many exceptions; 8 patients with a suggestive 
history of more than a week*s duration were still at an early stage on 
admission, while 7 patients with a similar history of less than 4 days1 
duration were at an advanced stage. The length of non-specific illness 
bore little relation to the condition on admission. Ruble and Mohun (1949) 
could find no constant relationship between the length of the period of 
illness before admission and the stage of disease on admission.
Beveridge (1952) could not correlate the prognosis with the length of the 
history/
history; and. Brainerd and Eagle (1950) also found that the duration of 
disease before the institution of treatment did not appear to affect the 
outcome; their patients who had improved with treatment had an average duration 
of illness of 13*5 days, compared with 12.6 days in patients who did not 
improve. Likewise Perry (1952) concluded that early institution of treatment 
had no effect on survival; 4 of 13 cases who were treated within 10 days of 
the onset of illness survived, compared with 3 of 13 cases with an illness of 
longer than 10 days. Of 43 patients reported by Bunn (1948) 11 had less 
than a week's illness - and 5 died, 4 within a fortnight, and 12 had an 
illness of longer than two weeks - and 6 survived; the duration of survival 
in patients who died did not appear to be affected by the promptness of 
therapy. Riley (1953) treated 60 cases and had only 4 survivors; 3 these 
were in the second week of illness when treatment was commenced, and 1 in 
the third week; 9 with less than a week's illness died. On the other hand, 
Howard (1949) found that the average duration of illness before treatment in 
fatal cases was 22 days, compared with 13 days in survivors. Lorber (1951^)* 
making a plea for early diagnosis, asserted that the mortality was considerably 
affected by delay in instituting treatment. In a series of 6b patients, 
the average delay from the first symptoms to the beginning of treatment was 
14*2 days; the mortality rate in cases whose treatment was commenced after 
this was 88.2$; when treatment was begun earlier, the mortality rate was 
47.8$.
Tables J to 9 present the inter-relationships of duration and severity 
of illness and the outcome in the 102 cases in this series. The classification 
suggested by the M.R.C. has been used in estimating the severity of the 
illness but with more emphasis on the general condition than on the state of 
consciousness (which is considered separately in Table 15)« Thus some 
patients who were obviously severely ill - drowsy, confused, irrational, 
obstreporous, with or without pareses - were classified as "severe" although 
they were not stuporose or comatose; and some patients who had no meningeal 
signs or only mild meningism (this, also, being considered later at Table 13) 
were classified as "moderately" ill if their clinical condition justified it. 
With these slight exceptions the "mild'J "moderate" and "severe" categories
correspond/
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correspond with the “early'1, "medium", and "advanced" groups respectively 
in the M.R.C. classification. When considering the duration of the illness 
it was sometimes difficult to differentiate between the vague indefinite 
illness preceding the meningitis and the symptoms that heralded the onset of 
meningitis itself. In 6 patients,indeed, separation was impossible and these 
have been classified as "indefinite". In all others the "duration of illness" 
referred to the period from the beginning of meningitic symptoms to the 
institution of treatment.
The trend, observed in the other series, of progressive increase in 
mortality rates with increasing severity of illness is very evident (and 
significant) in this series as is seen in Table 8. Mortality rates of 10$, 
25*9$ and 58*8$ were recorded in mild, moderate and severely ill patients 
respectively. A similar relationship, however, could not be demonstrated 
between the duration of illness and the outcome (Table 7)• Is noticeable
that the mortality rate (28.6$) in patients whose illness was longer than a 
fortnight was even lower than that (32.6$) in patients who had been ill for 
less than a week; and, further, that 3 o f  6 patients with illness shorter 
than three days died. These latter, as would be expected, were all children 
whose illness may well have been longer had they been accurately observed; 
they were aged 2, 4 &nd 7 years, and died 1 week, 2 weeks and 1 month 
respectively after the institution of treatment. Finally it is clear from 
Table 9 that there was no constant relationship between the length of history 
and the clinical stage of the disease. While there is a suggestive trend, 
this/
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this is not at all significant. It can he seen, for instance, that 3 6
patients with less than 3 days' illness and 9 34 wko had been ill for less
than a week were already at an advanced stage of illness.
Does it follow, then, that early diagnosis is unnecessary and early 
institution of treatment of no value, as Perry (195^) seemed to suggest?
Surely notJ For various reasons, the estimation of the duration of the 
illness must necessarily be inaccurate. Many cases in this series - and, 
doubtless, in most series - came from large families living in poor home 
conditions where parental interest in the children is slight, and ignorance of 
signs of illness is marked; consequently it is very often difficult to 
obtain a satisfactory account of a patient's illness. In children, moreover, 
especially in infants and younger children the difficulties are increased by 
the inability of the child to register specificcomplaints such as headache.
In many cases, as already indicated, the actual meningitic illness is preceded 
by a period of weeks or months of vague ill-health which merges, often 
imperceptibly, into the features of meningitis, so that it becomes well-nigh 
impossible to fix a date when one ends and the other begins. It is obvious,
therefore, that figures given for the duration of illness in Tables 7 and 9
(and in other series) are not by any means accurate or reliable estimates 
and too much stress should not be placed upon them. Added to this is the 
fact, already noted, that the disease seems to progress more rapidly in some 
patients, particularly children, than others; so that without treatment 
while some patients might linger for 3 or 4 weeks or longer, others might
deteriorate rapidly and die within a week of onset.
Despite/
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Despite these figures, then, it is obviously true that, while for 
the assessment of prognosis, the clinical impression of the patient's condition 
is a much more accurate guide than the length of the history of illness, which 
at the best is unreliable, institution of treatment as early in the course of 
the illness as possible will enhance the patient's chances of survival, while 
delay will result in progression of the illness from a mild to a moderate or 
advanced stage with corresponding increase in the mortality rate. As Lincoln 
and Kirmse (1'349) have pointed out, in many cases the danger of hydrocephalus 
and chronic meningitis developing can only be avoided by early recognition of 
symptoms and prompt institution of treatment. Further, since (a) organisms 
seem rapidly to become embedded in granulation tissue (with increasing immunity 
to circulating streptomycin); (b) the organisation of the exudate tends to 
prevent the circulation of the C.S.F; and (c) ischaemic changes resulting 
from endarteritis cause irreversible lesions in the central nervous system 
(see Smith et al, 1948) it is obviously important to commence treatment early 
before these changes develop.
MENTAL, NUTRITIONAL, M3NIN&EAL AND REFLEX STATE.
Of all the particular features of the initial illness in tuberculous 
meningitis, the one which lias been most frequently emphasised as a prognostic 
guide is the state of consciousness.
In a very early paper, Bebre and his co-workers (1947) stated, "Of 
all the unfavourable signs, there is only one which in our opinion has absolute 
value and that is coma, by which we mean complete abolition of consciousness, 
absolute insensitivity to the strongest stimuli. This is the only condition 
in which we consider hope to be lost." MacCarthy and Mann (1950) considered 
that the advancement of the meningitis is probably closely paralleled by the 
height/
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height of the intracranial pressure and the resulting cerebral depression 
is more closely reflected in the child's mental state than in any other symptoms 
or signs* They were of the opinion that the commonly used subdivisions 
(early, medium and advanced) of the stage of the disease were too vague and 
suggested a classification dependent on the mental state. In their series of 
40 patients (3 others being infants not assessable) 8 out of 18 in the first 
stage of normal mentality died, compared with 3 out of 5 second stage
of delirium and confused mental activity and 15 out of 1J ia the third and 
fourth stages of stupor and coma. Smith and Vollum (1950) also regarded the 
state of consciousness as the main factor in prognosis but emphasised that 
some patients who were wholly conscious died whereas some deeply stuporose 
recovered. In a series of 38 cases with 28 survivors, Lorber (1954a) 
found that 25 (92.6$) of 27 who were conscious on admission recovered - and 
neither of the deaths was due to tuberculous meningitis. Beveridge (1952) 
also concluded that the better the state of consciousness on admission the 
brighter the outlook. Very little reference, however, has been made to the 
prognostic value, if any, of other features of the initial illness such as 
the state of nutrition, severity of meningeal signs and the character of the 
reflexes.
In this series too, the state of consciousness was closely related - 
although perhaps to a lesser degree - to the ultimate outcome. Table 10 
shows an obvious and significant trend indicating increasing mortality with 
increasingclouding of consciousness (from 14*8$ of 27 patients who were 
mentally bright on admission to 64*7$ ^7 stuporose and comatose patients).
It is perhaps surprising, however, that 3 6 patients who were comatose
on admission survived, one (13) without any mental or physical upset, 
one (38) totally deaf but without other sequelae, and one (39) mentally deficient. 
On the other hand, of 27 patients who were perfectly clear mentally without 
even any trace of drowsiness, 4 died. It may be concluded, therefore, that 
the initial state of consciousness, while a good guide to prognosis, is only 
a rough one and not altogether reliable.
A clear positive correlation is seen to have existed in this series
between/
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between the nutritional state and the recovery rate (Table 11). All 
5 emaciated patients died compared with only 5 of 26 who were well-nourished; 
80.9$ well-nourished patients but only 46*2$ of poorly nourished or 
emaciated patients survived. Table 12 shows that there was a significant 
relationship between the nutritional state and the stage of the illness;
7 of 10 patients at an early stage were well-nourished and none poorly nourished, 
whereas only 2 of 34 patients at an advanced stage were well-nourished and 
25 were poorly nourished or emaciated; all 5 emaciated patients were at an 
advanced stage of illness. A reasonable hypothesis would be that patients 
with impaired nutrition and consequently, diminished resistance, are more 
likely to have rapidly progressive disease and therefore be discovered at a 
late stage. An obvious corollary is the importance of measures directed 
towards the replacement of nourishment by whatever route possible in order to 
increase the patient*3 ability to counteract infection. In a number of patients 
in this series, oral administration of food and fluids was impossible or 
inadequate on account of unconsciousness, recurrent vomiting or simple refusal 
to swallow; in these cases nasal feeding was used, or transfusions of blood, 
plasma or glucose-saline given.
That the presence of meningeal signs is by no means a constant finding 
in tuberculous meningitis was emphatically stated by Illingworth (1956) 
who found no meningism in 25$ of 173 cases (in a series of 236 cases) in whom 
the presence or absence of meningism was noted. Meningism in his series was 
found much less often in younger children than in older ones and 71$ of early 
cases/
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cases had no meningeal signs. In only 7 (6*9$) the 102 cases in this 
series was there no evidence of meningism hut in one-third of the patients 
the signs were slight (Table 13). The presence and degree of meningism did 
not appear to greatly influence the outlook; indeed it is noteworthy that a 
higher proportion of patients with moderate meningism survived than of those 
in whom signs were absent or slight. The high mortality (51*9$) the  
27 patients with marked meningism is just significant, but, since the difference 
is not gross, it is possible that other factors played a part in this e.g. 
the severity of the illness. One would expect that patients with longer 
history would have more marked meningeal signs, but, while Table 14 does show 
a suggestive trend, this is not statistically significant. It may be 
concluded that while marked meningism was associated with higher mortality, 
lesser degrees of meningism did not seem to affect the outcome.
The severity of the illness is reflected also in the state of the deep 
reflexes; diminution or loss of these reflexes occurs in infective conditions, 
in coma and in the final stages of raised intracranial pressure. In this 
series (Table 15) a significantly higher proportion of patients with average 
or exaggerated reflexes survived than of those with diminished or absent 
reflexes (75*8^ compared with 51*4$)• Taken with other signs the state of 
the deep reflexes could be useful as a prognostic guide; in itself, however, 
it is clearly not reliable - one of the two patients with totally absent jerks 
survived.
T m p m u i m s  aitd ertthrqcite sedimentation rate (e .s .r .)
Fever is one of the well-recognised symptoms of tuberculous meningitis. 
Professor Choremis, at the U-®.I.C.E.F. conference of tuberculosis in childhood 
in/
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in 1950» described fever, vomiting, headache and constipation as the 
principal early symptoms of tuberculous meningitis in young children. It 
is, however, by no means an invariable feature, and a marked pyrexia is 
uncommon. Illingworth (1956) found that 27$ of 276 children with tuberculous 
meningitis had no pyrexia when first seen in hospital. 8 (7*9^) of the 
102 patients in this series were apyrexial prior to the institution of treatment, 
and in only 9 (8.8$) was the initial temperature higher than 102°F. Over 
half of the patients had a moderate fever of between 100°F and 102°F.
Bunn (1948) has pointed out that fever is no guide to the prognosis; he 
reported that several afebrile patients died within a month and patients with 
high temperatures sometimes recovered. These were the findings also in this 
series (Table l6), in which 55% 40 patients with normal temperature or
mild pyrexia (up to 100°F) survived, compared with Jlfc of 62 patients with 
moderate or marked pyrexia, (over 100°F). 2 of 8 patients with normal
temperature died and 8 of 9 patients with temperature over 102°F survived.
This lack of correlation between temperature and outcome may be the result of 
the conflict of two factors; (1) acute and severe illness would be expected 
to be associated with higher temperature> (2) on the other hand the pyrexial
state may be partly a reflection of the response of the patient to infection; 
a high temperature being an evidence of high resistance with adequate response 
to infection. Thus, the 8 survivors whose initial temperature exceeded 
102°F may have been demonstrating a good response to the infection.
The E.3.R. is, rather surprisingly, not consistently raised in 
tuberculous/
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tuberculous meningitis. This was noted by Choremis and his associates 
(1948) who concluded that it was of no help and rather inconstant and 
irregular. In the present series (Table 17) it was under 10 mm. in the 
first hour in one-third of the 78 patients in whom it was carried out at the 
time of admission to hospital; and in over 70$ it was under 20 mm. in the 
first hour. Only 1 (Case 60) gave a reading of over 50 - j8  in the first 
hour; this was a young woman of 19 years with concomitant miliary tuberculosis, 
who died after 6 weeks, in which time the E.S.R. had fallen to 14 iu the first 
hour despite clinical deterioration. It is evident that the initial E.S.R. 
had no bearing on the outcome - of 26 patients in whom the first hour 
reading was less than 10, 6 died while of 13 patients in whom the reading was 
over 30, 8 survived.
RADIOGRAPHIC ABNORMALITIES IN CHEST.
In a high proportion of cases of tuberculous meningitis, chest X-Rays 
reveal tuberculous lesions in the lungs or pleura. There are three types 
of abnormality that may be present; (a) Primary Complex - indicated by 
the presence of definite hilar adenitis with or without evidence of pulmonary 
collapse} (b) Miliary tuberculosis - presenting the typical "snowstorm" 
appearances indicative of haematogenous dissemination of the tubercle bacilli; 
(c) Adult phthisis which may be active or quiescent. In addition, a 
considerable number of patients with clear X-Rays do, in fact, have 
intra-pulmonary disease which is only revealed on careful post-mortem 
examination. A primary complex may be so small or so situated that it does 
not show itself in a straight X-Ray of the chest. It is well known, too, 
that /
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that many cases of miliary tuberculosis, proved at autopsy, have a clear 
X-Ray during life. For example, Illingworth and Wright (194-8) reported 
9 cases (out of a series of 65 with miliary tuberculosis and tuberculous 
meningitis) who did not have radiological evidence of miliary tuberculosis 
during life but in whom post-mortem examination revealed miliary tubercles. 
Emery and Lorber (1950) showed that miliary tuberculosis was diagnosed 
radiologically in only 18 of 52 cases in whom miliary spread was found at 
necropsy. It is clear, therefore, that it is impossible to assess 
accurately the effects on the outcome of the presence of either primary 
or miliary tuberculosis since many of the survivors and also of non-survivors 
in whom necropsy is not performed have abnormalities which are not detected 
in X-Rays taken during life. O11 this account the prognostic significance 
of chest disease should be assessed only on the evidence of radiological 
examination during life and not on combined X-Rays and autopsy findings.
Conflicting views on the prognostic value of radiological appearances 
have been expressed in the literature. It is fairly unanimously agreed that 
patients with adult phthisis have, as would be expected, a reduced prospect 
of recovery, which is largely influenced by the extent and severity of the 
pulmonary lesions and their response to treatment, rather than by the 
meningitic disease. Persistent activity of the pulmonary disease adversely 
affects the prognosis of the meningitis, and, moreover, the presence of 
phthisis may itself be the cause of death in cases where meningitis has been 
cured. Smith, Stevens and Pile (195^ -) found a much higher mortality in 
patients in whom meningitis followed chronic phthisis - 5 of 6 such patients 
died, in a series in which the overall mortality was 52$. The significance 
of a primary complex or even of miliary tuberculosis is not, however, quite 
so clear. Many writers associate the finding of snowstorm mottling in the 
lung fields with a worsened prognosis. In the M.R.C. report (194-8),for 
instance 75$ patients with miliary tuberculosis or a primary complex died, 
compared with 57"$ of others. Robertson and Gairdner (1952) reported recovery 
in 49 of 99 patients with meningitis alone, but only in 20 of 57 whom 
there was associated miliary tuberculosis. Similarly Beveridge (1952) had 
13 recoveries among 29 patients with meningitis alone, but only 3 among 28 
patients/
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patients who also bad miliary tuberculosis; and Finberg (1951) reported 
that 11 of 20 patients with meningitis alone survived, compared with only 
2 of 15 patients with concomitant miliary tuberculosis. Debre (1952) 
reported an overall mortality of 46/* i*1 patients with tuberculous meningitis; 
in 108 cases in whom there was associated miliary tuberculosis, the mortality 
was 6oj&. On the other hand, Illingworth and Lorber (1951) could find no 
significant difference in the outcome between patients with and those without 
miliary mottling in chest radiographs. They pointed out that the prognosis 
appeared much worse in cases of combined miliary and meningeal tuberculosis if 
patients were included in whom the diagnosis of miliary tuberculosis was only 
made at autopsy. In 1953 a sub-committee of the Scientific Advisory Committee 
(Dunlop et al) correcting an earlier impression (IQ49) that the outlook was 
less favourable in cases where the chest X-Ray showed a snowstorm appearance, 
reported that in 266 cases there was no difference in mortality in groups 
with and without miliary tuberculosis - 53/J» compared with 52£u Perry also
(1952) could find no significant difference - 2 of 13 patients with miliary 
tuberculosis survived compared with 4 of 13 without it. Lorber (1954a) 
had similar results in treating 38 children - 8 of the 10 with miliary 
tuberculosis survived.
Of the 101 patients in this series who survived sufficiently long for 
X-Ray examination to be carried out, 11 had evidence of active or quiescent 
adult pulmonary tuberculosis. The remainder could be divided almost equally 
into three groups (Table 18) - (a.) those with miliary tuberculosis as 
indicated by radiological "snowstorm" appearances during life, (b) those 
with a primary complex - hilar adenitis with or without evidence of pulmonary 
collapse, and (c) those with no radiological abnormality. In a few cases 
of miliary tuberculosis X-Ray showed also a primary complex, and in one case 
of adult phthisis there was evidence of fresh haematogenous dissemination 
miliary in type. These were all included in the "miliary" group. It is 
clear that in this series the presence of either miliary or adult pulmonary 
tuberculosis had an adverse effect on the prognosis. More than one half of 
28 patients with the former and 5 out of 11 with the latter died, in contrast
to/
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to less than a quarter of 62 patients without evidence of either - a 
significant difference. Three of the cases of miliary and meningeal 
tuberculosis developed meningitis while having streptomycin treatment for 
the miliary condition, and 2 of these survived. In all the other 25 patients 
the miliary mottling in the lung fields was a concomitant finding - 56$ o f 
these died. The high proportion of children in the "miliary" group has 
already been noted - 11 of the 28 patients were under 3 years - and this may 
well have contributed to the significantly high mortality rate of these patients. 
12 patients in all had evidence of adult phthisis - including the one who had 
also miliary spread and is classified with the "miliary" group. In 2 of these I cl 
the pulmonary disease appeared quiescent or healed; 5 o f the remaining 10 
died (and 1 other since the tables were compiled). In only 2 was collapse 
therapy - in the form of pneumoperitoneum - considered to be indicated.
It is noteworthy that all of 5 patients over 30 years of age had evidence 
of adult phthisis - these included the 2 patients in whom the disease was 
considered to be quiescent (1 of whom survived) and the patient who had 
superimposed miliary mottling. Doubtless the presence of pulmonary 
tuberculosis contributed to the high mortality in this group.
ABNORMALITIES OF TEE FCJNDuS OCULI.
The proportions of patients with choroidal tubercles vary widely in 
different reported series; so much so that one is tempted to suggest that the 
number of patients in whom tubercles were actually present may in many cases 
be quite different from the number in whom they were observed and that the 
differing proportions reported may well result from the varied skill and 
accuracy of observation. In an early paper, (1947) Debre and his associates 
quoted figures supplied by Monbrun and Lavat who observed choroidal tubercles 
in Xdjp of cases of meningitis alone, 75?J o f cases of miliary and meningeal 
tuberculosis and 50$ of cases of miliary tuberculosis without meningitis.
Monbrun/
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Monbrun reporting at the U.H.I.C.E.F. Conference in February 1950 on 
1000 cases gave the following figures for these groups in the same order - 
17/k* 87^ and 5]$. Illingworth and Wright (1948) found choroidal tubercles 
in 1 (5*6^) of 18 cases of meningitis alone; 18 (64.3^) of 28 cases of
miliary tuberculosis with meningitis; and in 7 (50^ >) of 14 cases of miliary
tuberculosis alone. Somner (1952) in a smaller series of 26 cases observed 
choroidal tubercles in 7 of the 10 patients with miliary tuberculosis but in 
none of the remaining lb patients. Smaller proportions were observed by 
Rubie and Mohun (1949) ~ 5 (all with miliary) of 67 cases; the Department 
of Health for Scotland (1949) - 12 of 81 cases; Riley (1953) “ 4 (all with 
miliary) of 60 cases; McGregor (1951 - quoting a figure by Still) - 2 of 150
cases; Lassen and Neukirch (1951) - 5 °f 44 cases; and McSweeney (1950) ~
3 (all with miliary) of 94 cases.
It is clear from these figures that choroidal tubercles occur much more 
frequently in cases of tuberculous meningitis with associated miliary 
tuberculosis, than in uncomplicated tuberculous meningitis. Indeed,
McSweeney (1950) and Illingworth (1950) went so far as to say that they are 
not seen in the latter. That they do occur in cases of tuberculous 
meningitis without clinically recognisable miliary tuberculosis is evident 
from the figures already quoted, but these cases may well be examples of the 
anomaly already noted, namely, the absence of X-Ray changes in cases with 
proven miliary disease.
Of the 12 cases with choroidal tubercles, reported by the Department of 
Health for Scotland (1949) H  died. The conclusion that the presence of
choroidal tubercles adversely affected the prognosis was repeated in 1953
by the sub-committee of the Scientific Advisory Committee, although further 
evidence was not presented. Likewise Russell and MacArthur (1950) found a 
higher mortality in cases showing choroidal tubercles - 6 out of 8 cases with, 
and 12 of 25 without tubercles died. On the other hand, Choremis and his 
associates (1951) were of the opinion that the presence of choroidal tubercles 
was of no prognostic significance; and in Somner*s series, already mentioned, 
5 of the 7 patients with choroidal tubercles survived compared with 9 of fde 
other 19 patients. It must always be remembered, in assessing the prognostic 
significance of choroidal tubercles that they occur in association with 
miliary tuberculosis, the presence of which appears to worsen the prognosis.
Of 92 patients in this series in whom ophthalmoscopic examination 
was carried out, 15 (16.3$*) were found to have choroidal tubercles -
8 unilateral, and 7 bilateral (Table 19). I would hesitate to draw
conclusions from these findings because, while examination of the fundus oculi 
was carried out personally and as carefully as possible at least at monthly
intervals/
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intervals, they were not confirmed by an ophthalmalogist and the number of 
observed cases is almost certainly less than the number of actual cases, 
especially in patients treated early in the series. This is probably 
particularly applicable to the patients who died shortly after admission to 
hospital, and in whom ophthalmoscopic examination was performed only once. 
Choroidal tubercles which had not been visualised at the first examination 
were sometimes detected at subsequent examinations. 8 of the 15 patients 
with choroidal tubercles were not known to have associated miliary tuberculosis 
during life; four of these survived so confirmation (or otherwise) of the 
absence of miliary disease was not possible. Autopsy was carried out in 2 
of the 3 wdo died; in one (with a clear X-Ray) there was a small primary 
focus in the lung and fine miliary mottling throughout the lungs; in the 
other there was no evidence of miliary tuberculosis in the lungs, but a few 
miliary tubercles were seen in the kidneys. It is seen from Table 19 that 
5 (19«2$) of 26 non-survivors examined had choroidal tubercles, compared with 
10 (15*2$) of 66 survivors. The difference is not significant. Nor does it 
appear that the presence of papilloedema was an adverse prognostic sign in 
this series, as might have been anticipated in view of its indication of 
increased intracranial pressure. More than two-fifths of survivors were 
found to have papilloedema - and less than one-fifth of the non-survivors 
ophthalmoscopically examined. The three patients who had marked papilloedema 
all survived.
CERBSROSPINAL FLUID (C.S.F.) FINDINGS.
The value of the cytological and biochemical changes in the C.3.F. as 
a guide to the diagnosis of tuberculous meningitis is not open to question. 
Rubie and Mohun (1949) d-id- observe 3 cases in whom the earliest C.3.F. 
examination/
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examination revealed no abnormalities as much as 5 an4 H  <3ays after the 
onset of symptoms, but these are without doubt exceptional, and a firm diagnosis 
can certainly not be made in the absence of at least a pleocytosis. A 
cell-count varying from 30 to 1,000 per c.mm. is a constant finding; very 
rarely, in fulminating cases, the count is said to exceed 1,000 per c.mm.
Usually the cell type is predominantly lymphocytic, but polymorphs may 
predominate in the early stages and in rapidly progressive cases. Almost 
invariably there is an associated rise in the protein content, which, in 
some cases where spinal block has developed may be 2 or 3 S* Per 100 ml*
Bunn (1948), however, had 5 patients with a normal initial C.S.F. protein,
4 of whom died. Reduction in the C.S.F. chlorides was at one time considered 
to be an important pointer to diagnosis; since the commencement of 
streptomycin therapy, however, it has become increasingly evident that the 
sugar level is a much more valuable diagnostic guide. Rubie and Mohun (1949) 
found that the chlorides were often normal in confirmed cases; Cathie (1948) 
stated that they may never be less than 700 mg. per 100 ml.; Mann (1948)* 
reporting 33 cases, found the chlorides to be normal in 13; and Smith and 
Daniel (1947) considered that the C.S.F. chloride level reflected the plasma 
chloride level and was therefore reduced in patients who had been vomiting - 
they added that "there is no such thing as a pathognomonic chloride level'1.
Most observers concur with Lincoln and Kirmse (1949 an(3- 1950a) 3-11 their view 
that a reduced sugar level is the most characteristic change and the most 
valuable single diagnostic finding, or with Somner (1952) that it is the 
most valuable single factor in the early diagnosis of tuberculous meningitis 
not complicated by miliary tuberculosis (cases with miliary tuberculosis being 
diagnosed earlier before the decline in the sugar content). The finding of 
low C.S.F. sugar differentiates tuberculous meningitis from benign lymphocytic 
meningitis, tuberculous serous meningitis, and indeed all other causes of 
C.S.F. pleocytosis with the exception of purulent meningitis and some cases 
of poliomyelitis (Illingworth, 1956). Harvey (1952) stated that "on no 
occasion when a clear fluid was found deficient in sugar was the diagnosis 
proved not to be tuberculous meningitis." Nevertheless, a low C.S.F. sugar 
is not an invariable finding in proven cases of tuberculous meningitis and 
many cases have been reported in whom the level never fell below 45 or 50 
per 100 ml. before treatment - for example, by Bunn (1948), Mann (1948),
Lincoln and Kirmse (1950 a a*^ b), Cohen (1952), Riley (1953) an&
Alexander (I954). Illingworth (1956) reported as many as 14$ of 236 children 
in whom the initial, level of C.S.F. sugar was 50 mg. per 100 ml. or over.
The value of C.S.F. changes as guide to prognosis as opposed to 
diagnosis, has not been so fully reported, but the few statements that have 
appeared in the literature indicate that they are of little prognostic 
significance. (Brainerd and Eagle, (1950))• Rubie and Mohun (1949) could 
find no relation between the cell count or protein content of the C.S.F. and 
the stage of disease on admission, except that a grossly raised protein 
indicated/
- 47 -
indicated spread of disease down the theca. Bunn (1948) found that the 
sugar level was no guide to the ultimate outcome and also reported that 4 
out of 5 patients with normal protein at the onset died. Somner (1952) 
on the other hand, was of the opinion that the sugar level at the time of 
diagnosis was in accordance with the severity of the illness.
Tables 20 to 31 have been compiled to ascertain, if possible, the 
significance of the initial C.S.F. findings in this series. An attempt has 
been made to discover not only whether the degree of abnormality of each 
constituent bore any relation to the ultimate outcome of the illness but also 
whether the level was affected by the stage of the illness at which C.S.F, 
was examined. The findings recorded are those of the last specimen of 
C.S.F. examined before the institution of treatment.
CELL CONTB33T (TABLES 20 - 23).
The initial C.S.F. cell-count varied from y i to 900 Per c.mm. (the 
patients with the extreme readings survived.) Contrary to \irhat might be 
expected it is interesting to note that there was a significant inverse 
relation between the cell content and the mortality, i.e. the mortality was 
higher in groups of patients with lower cell count. Thus the mortality rate 
of cases with a cell count of less than 200 per c.mm. was 5 whereas that 
of cases with a cell-count of over 200 per c.mm. was only 23.7 of 
66 survivors, and 61.1$ of the 36 w^° died had an initial cell-count of less 
than 200 per c.mm. Further, while half of the 16 patients with an initial 
cell-count less than 100 per c.mm. died, none of the 4 with readings over 600 
and only 2 of 9 with readings over 500 died.
The reason for this apparent anomaly may be that the C.S.F. cell-count
is/
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is not so much an index of the extent to which the meningitis has advanced 
as of the degree of tissue response to the meningeal invasion, A low cell-count 
may thus he evidence of poor meningeal reaction and a high cell-count, far from 
heing an unfavourable sign indicating advanced disease, may well be a good sign 
and evidence of a satisfactory meningeal response. This conclusion is in 
harmony with the results of Tables 21, 22 and 23 which show that the 
cell-count did not appear to be related to the duration or severity of the 
illness or the degree of meningism.
PROTEIN (TABLES 24 - 28).
The protein level in this series varied from 10 mg, per 100 ml, to 
1520 mg, per 100 ml,; a reading below 100 mg, per 100 ml, was recorded in 
exactly half the patients, and in only 2 was it over 500 mg, per 100 ml. It 
might be expected that a raised protein level, being perhaps an indication of 
more advanced and extensive meningeal disease, would carry a poor prognosis.
No relationship could, however, be demonstrated in this series, the 
proportions of survivors in all groups being very similar. The fact that 
there were only 2 patients with a level over 500 mg, per 100 ml, renders it 
impossible, however, to draw rigid conclusions.
In 11 patients, the protein level was 40 mg. per 100 ml. or less, and 
4 of these died - in 2 weeks, 3 months, 4 months, and over 2 years (the latter, 
after 3 relapses). The first 3 of these had associated miliary tuberculosis,
and the one who died after 4 months develojjed meningitis in the course of 
treatment of the miliary condition. All of the 7 survivors with normal
initial/
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initial C.S.F. protein had. 1 snowstorm" mottling in the lung fields and 
2 of these developed meningitis while having streptomycin for miliary 
tuberculosis. Thus all of the 11 patients with normal C.S.F. protein had 
associated miliary tuberculosis. In 3 o f these, however, in whom the 
meningitis was discovered on routine C.S.F. examination, a low protein was to 
be expected in view of the comijaratively early discovery of the meningeal 
invasion.
The higher protein levels tended, as might be anticipated, to be 
associated with longer illness prior to institution of treatment, more advanced 
disease and more marked meningism, but the figures, presented in Tables 25 to 27, 
were not sufficient to show any significance in any of these trends. A 
significant direct correlation was demonstrable, however, between the initial 
cell-count and the protein level. (Table 28).
CHLORIDES (TABLE 29).
As the chloride level was not reckoned to be of either diagnostic or 
prognostic import, this estimation was omitted in 12 patients admitted to 
Belvidere Hospital before 1950 an^ in ©arly months of that year. The 
figures obtained in the remaining 90 patients varied from 5^0 to 740 mg. 
per 100 ml. While both the lowest and highest levels were obtained in 
survivors, and although 4 patients who ultimately died had normal values 
(over 700 mg. per 100 ml.) at the beginning of treatment, Table 29 does show a 
highly significant degree of correlation between the initial C.S.F. chloride 
content/
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content and the recovery rate. Thus it is seen that 75$ of the 56 patients 
whose initial chloride level was over 650 mg. per 100 ml. survived; while 
the corresponding proportion of 34 patients whose initial chloride level was 
under this figure was only 44.1$. Since the C.S.F. chloride level is 
influenced by the plasma chloride level, it is quite probable that the higher 
mortality in patients with low C.S.F. chloride was due to other factors, namely 
excessive vomiting with dehydration and plasma electrolyte depletion.
Moreover, the level cannot be used as a very reliable guide; 4 patients with 
normal readings on admission died after 1 month, 1-| months, 3 months and 
6 months respectively, and the patient with the lowest initial reading made a 
comparatively rapid recovery uninterrupted by exacerbations or relapses.
SUGAR (TABLES 30 AND 31).
If a C.S.F. sugar level of 45 m£* Per 100 ml. be accepted as the 
minimum normal finding, 12 patients (11.8$) in this series had a normal C.S.F. 
sugar wiien treatment was commenced. Even if, as Somner (1952) suggested, the 
line is drawn at 50 mg. per 100 ml. the number is as high as 11 (10.8$).
These findings confirm the statements already gleaned from the literature, 
that a normal sugar level does not of itself invalidate the diagnosis of 
tuberculous meningitis. In view of the emphasis that has been placed upon 
the importance of the C.S.F. sugar, I have reviewed these 12 patients in 
greater detail, with particular reference to the alterations that occurred 
in the sugar levels in the course of treatment.
4 of the 12 died after periods of 1 week, 2 weeks, 3 weeks and 3 months 
respectively. Case 10 had an initial sugar level of 60 mg. per 100 ml. but 
died within a week, before another specimen was examined. In case 65, who 
survived for 2 weeks, an initial value of $ 2 .6 mg. per 100 ml. was followed by 
other/
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other 4 normal readings, hut finally, 4 hays before death by a reading of 
43*4 Per 100 ml. Case 84, who died after 3 weeks of treatment, had an 
initial C.S.F, sugar of 58.8 mg. per 100 ml; the level never fell below 
52.6, varying between this and 76*9 despite steady downhill progression.
Case 47 survived 3 months, during which period 12 C.S.F. sugar estimations were 
made. Initially the figure was 55.8 mg. per 100 ml; after 1 week it had 
fallen to 40 mg. per 100 ml. but by the next week it had risen to 66.6 mg. 
per 100 ml; on only 3 other occasions was the level below 50 mg. per 100 ml.
8 patients with normal initial C.S.F, sugar survived. In Case 5> with 
an initial level of 58 mg. per 100 ml., normal values were maintained for the 
first month, but after this the figure fell to 41, remained low for a month 
and then, apart from 2 or 3 occasions, was normal throughout the rest of the 
course. Case 6 had an initial level of ~\2 mg. per 100 ml; one week after 
the institution of treatment it had fallen to 38 mg. per 100 ml. but returned 
at the next estimation to normal where it remained, with 3 exceptions, for 
6 months. In Case the original figure was 50 and for 2 months the level 
fluctuated between 50 and 65; then, for no apparent reason, it fell to 23, but 
returned to normal for a further fortnight; for the next few months, the level 
was persistently low (between 30 and 40 mg. Per dOO ml.) Ho abnormal finding 
was ever recorded in Case 70» in whom the initial reading was 66.6 mg. per 
100 ml. Cases 83 and 85 were both found to have meningitis on routine 
examination of the C.S.F. in the course of treatment of miliary tuberculosis.
The pre-treatments C.S.F. sugar levels were 62.5 and 78.9 m§* Per dOO ml. 
respectively. In the former, only 2 abnormal findings were observed 
throughout 6 months during which estimations were carried out weekly - 
43. 4 and 4d.6 mg. per 100 ml., both occurring 2 months after the institution 
of treatment. In the latter the only abnormal figure, 43*4 mg. Per md.» was 
obtained 1 month after treatment v/as commenced. Case 88 showed a steady fall 
in the C.S.F. sugar level from 58.5 mg. Per dOQ ml. before treatment, to 
45*4 after a week, 40 after a fortnight, ana 38.4 after 3 weeks, thereafter 
the level returned to normal and remained so. In case 98 the initial C.S.F. 
sugar level was 45*4 Per dOO ml; one week later it had fallen to 40 mg. 
per 100 ml., this being the only abnormal reading throughout the course of 
treatment.
These findings emphasise the necessity of exercising caution in drawing 
conclusions from the level of the C.S.F. sugar, whether in the initial specimen 
or during the course of treatment. Hot only is it fallible as a diagnostic aid; 
in this series, at any rate, the initial C.S.F. sugar content was totally 
unreliable as a prognostic guide. This is evident from the fact that 3
patients/
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patients (of the 4 non-survivors) who had a normal finding on admission died 
within a month, and also that the patients who had the lowest recorded C.S.F. 
sugar on admission - 7 mg. per 100 ml. - survived. Moreover, Tables 30 and 31 
do not show any relationship in this series between the initial C.S.F. sugar 
level and either the outcome or the severity of the initial illness. Further, 
it is clear that, while the development of recrudescence or relapse is often 
heralded by a drop in the sugar reading, such a finding is not always a 
serious omen; nor on the other hand, is a normal reading necessarily a 
favourable finding since it was obtained in this series in moribund patients.
SUMMARY.
It is not possible to forecast with certainty how any given patient 
with tuberculous meningitis will respond to treatment with streptomycin. 
Doubtless many factors play a part which cannot be ascertained when the 
patient is seen for the first time; for example, the sensitivity of the 
invading organisms to the anti-tuberculous drugs, and the innate or acquired 
resistance of the patient to tuberculosis. Nevertheless, in this series, 
certain factors seemed to be of prognostic value, among which were the 
following:-
(1) Age: A higher mortality occurred in children under 3 years, and
(although the numbers were too small to be significant) in adults 
over 30 years.
(2) Stage of In general the more advanced the disease, the poorer was 
Disease:
the prognosis. In assessing this factor, however, the clinical
impression of the patient's condition was much more accurate than 
the/
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the length of history, which was neither related to the severity 
of the illness nor to the ultimate outcome.
(3) State of Increasing clouding of consciousness was associated
Consciousness:
with increasing mortality.
(4) State of A significantly higher proportion of recoveries occurred
Nutrition;
in well-nourished than in poorly nourished or emaciated patients.
(5) Chest X-Ray: The presence of miliary tuberculosis or of adult
phthisis seemed to adversely affect the prognosis.
(6) C.S.F. Cell The mortality rate was significantly higher in patients
Count:______
with a low cell-count than with a high reading. The reason for 
this may have been that the cellular reaction in the C.S.F. 
reflected the meningeal response to invasion.
(7) C.S.F. Chlorides: Lower figures were associated with a higher mortality,
but this may have been due to the depletion of plasma electrolyte, 
the level of which influences the C.S.F. level.
Among the factors which did not seem to influence the prognosis were: 
duration of illness, temperature, E.S.R., C.S.F,. protein and sugar.
B. INFLUENCE OF THE) TREATMENT REGIME.
A study of the literature on tuberculous meningitis reveals almost as 
many different courses of treatment as papers written, suggesting that there 
is no optimal course which should be prescribed in each case. Indeed, the 
occurrence of exacerbation, recrudescence, and relapse necessitates variations 
in treatment in a single unit where the same average course is used. In 
general, however, in the pre-isoniazid era, it was almost a universal practice 
to give streptomycin both intramuscularly and intrathecally, to continue the 
intramuscular therapy for a period not less than 6 months, and to treat relapses 
with further full courses of streptomycin. The daily intramuscular dosage 
for adults, which at first waw very high - quantities of 4» 5 or 8 g. being 
reported - was later reduced to 2 g. and even this is now recognised to be 
in excess of requirements and probably a factor contributing to the incidence 
of toxic complications and sequelae.
The necessity for intrathecal streptomycin has, however, been disputed 
by a number of writers who not only regard it as having no special benefit but 
as leading to undesirable complications such as hydrocephalus. While 
streptomycin does not normally reach the cerebrospinal fluid in adequate 
concentrations, it is argued that, when the meninges are inflamed, sufficient 
does cross the blood-brain barrier to prevent multiplication of bacteria.
Perry (I952), for example, drew the conclusion from rather a small 
number of cases that intrathecal therapy did not influence the outcome - 
of 8 patients treated without intrathecal therapy, 3 survived, compared with 
4 of 13 in whom intrathecal streptomycin was used. Lassen and Neukirch (1351) 
strongly supported the viewpoint that intrathecal therapy was unnecessary, 
maintaining/
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maintaining that, in the presence of meningitis, the intrathecal 
concentrations of streptomycin following intramuscular injection were l6 — 32 
times that required to prevent resistance developing. Levinson and his 
co-workers (1950) in a pathological description also stated that intrathecal 
streptomycin was unnecessary for healing and caused undesirable complications; 
they demonstrated that zones in which least healing had taken place were at the 
periphery of the exudate — which would be in freest contact with the cerebro­
spinal fluid. Hoyne (1948) gave a variety of reasons why intrathecal therapy 
is contraindicated in all types of meningitis (including tuberculous); these 
included discomfort to the patient; risk of secondary' infection, of injury to 
the interverteoral discs with consequent permanent disability and of haemorrhage 
or thrombosis of vessels; increased liability to adhesions and consequent 
block and to relapses; and the absence of any lowering of fatality rates. 
Certainly from all points of view - patient, doctor, and nurse alike - it would 
be most advantageous to be able to dispense with intrathecal streptomycin and 
the advent of isoniazid has, in the conviction of many physicians, made this 
possible. Prior to that, however, it was considered by most, particularly in 
this country, that intrathecal administration of streptomycin was a necessary- 
evil, and indeed a corner-stone of treatment. The Medical Research Council, 
in one of the earliest reports in 1948, concluded that intrathecal therapy 
was indispensable, pending further research. Intramuscular treatment had 
been tried alone in 33 patients in view of the possible trauma of injections 
and the irritant effect of streptomycin on the meninges. 5 these did not 
respond and were given intrathecal treatment. Of the other 28, 22 (78$) died, 
compared with 42 (58$) of 72 patients on combined therapy - a statistically 
significant difference. Not one of 9 children treated by intramuscular 
streptomycin alone survived. It was noted that patients having intramuscular 
treatment only showed a favourable initial response - uncomplicated by the 
irritation of intrathecal therapy; the general infection was controlled for 
several weeks, but it seemed that the meningeal infection was controlled only 
at borderline level, and the suggestion was made that the streptomycin 
concentration in the C.S.F. was only at a bacteriostatic, not a bactericidal 
level. Many other writers have confirmed these findings. Choremis and his 
associates (1948) for example, expressed their belief that "intrathecal therapy 
is indispensable in the treatment of tuberculous meningitis". Mann (1948) 
reported uniformly bad results with intramuscular therapy alone. At the 
Ministry of Health conference reported in the British Medical Journal in 1950 
it was stated that only exceptionally did a patient suffering from tuberculous 
meningitis respond satisfactorily to intramuscular treatment alone, and even 
more rarely when the patient also had miliary tuberculosis. Taylor (1954) 
reporting a series of 60 patients from Oxford, considered intrathecal 
streptomycin to be a sine qua non of satisfactory therapy, and Lorber (1954b) 
stated a case for using intrathecal treatment even in isoniazid treated 
patients; the best results had not been achieved without intrathecal treatment.
The duration of treatment of tuberculous meningitis has not been the 
subject of much difference of opinion. Regardless of initial response, a 
course of 6 months is generally considered to be essential. In this series 6 
patients/
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patients received an initial course lasting only 3§‘ months. They were 
representative of many who had been given such a course, enri who, with few 
exceptions, relapsed and required further treatment. The clinical condition 
is no indication for stopping treatment and cessation before 6 months must he 
regarded as premature.
Somner (1952) found that most patients who had only 2 - 4  months of 
continuous streptomycin relapsed and died, but reported better results with 
continuous 6 month courses. Relapse occurred in 5 of 10 of his patients in 
whom treatment was stopped before the end of 6 months and only one responded 
when it was resumed. Bunn (1950b)) in a review of the literature on tuberculous 
meningitis concluded that the duration of the ideal course was not less than 
120 days and probably 6 months. Cairns, Smith and Vo Hum (1950) summed up 
the position when they stated that there was "ample evidence that streptomycin 
can be stopped too soon, none that it can be continued too long".
There are, however, considerable variations in the length of courses 
and frequency of injections (particularly intrathecal) that have been used in 
the treatment of tuberculous meningitis. The M.R.C. report (1948) suggested 
that the best results were obtained with least intrathecal streptomycin, but 
Smith, Vollum and Cairns in the same year felt that long continued intrathecal 
treatment was indispensable. Choremis and his associates (1948) advocated 
rest periods, but MacCarthy and Mann (1950), comparing 3 treatment regimes, 
concluded that there was little to be said for interrupted treatment and 
suggested that the best treatment for most cases was a 3 months’ course of 
combined intramuscular and intrathecal streptomycin followed by intramuscular 
treatment until C.S«F. was normal on 2 occasions. At the Ministry of Health 
Conference reported in the British Medical Journal in 1950 it was stated that 
appreciably poorer results were obtained if intrathecal streptomycin was given 
on less than 50$ of intramuscular treatment days; and Jamieson (1952) used 
continuous daily intramuscular and intrathecal treatment for 6 months.
On the other hand, Lorber (1954a), claiming the hipest long-term survival 
figures published in this country, obtained them with shorter intramuscular 
courses and fewer intrathecal injections than in other series. The incidence 
of relapses, spinal blocks and hydrocephalus was less, the condition of the 
survivors was better and there were fewer sequelae and late deaths. 45 
intrathecal injections were given in the first 2 months and more were given only 
if tubercle bacilli were found in the C.S.]?. or if the cell count did not fall 
below 100 shortly after. Likewise, Cathie and MacFarlane (1950) presented 
figures showing as good survival rates with 24 intrathecal injections as with 
much longer courses.
The/
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The use of adjuvants has also met with varying success in 
different centres. Sulphetrone, streptokinase and intrathecal tuberculin, 
have all had their advocates and also their opponents. Sulphetrone was 
used in only one patient (Case 33) I31 this series - a survivor - so it is 
not possible to draw any conclusions about its use. The place of streptokinase 
and tuberculin will be considered when the courses including them are 
described.
In this series the necessity for intrathecal therapy was accepted 
from the outset and all patients without exception were given combined 
intramuscular and intrathecal treatment. It is not possible therefore to 
assess here the influence of intrathecal injections on the ultimate outcome. 
Farther, in all but the 6 patients already referred to, the minimum duration 
of treatment was 6 months. Over the period of 4 years during which the 
patients were treated, several major changes of policy were made in treatment 
in order to achieve the best results - for example, the introduction of 
dihydrostreptomycin, streptokinase, tuberculin - but in the end, the circle 
having been completed, the treatment regime was not much different from 
that originally adopted. The different regimes are summarised in Table 32*
It should be noted, however, that the courses described here were those 
given to the average patient in each group. As is well recognized, there 
are wide divergencies in individual response to treatment necessitating 
alteration in the course of treatment in some cases - for example, when 
deterioration occurs while treatment is being tapered off. On the whole,
however/
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however, changes were infrequent, and the majority of patients received 
almost exactly the treatment regime of the group to which they belonged.
Table 33 presents the dosage of streptomycin and p.A.S. administered to 
children. The adult dose of 1 g. streptomycin given by intramuscular 
injection twice daily for 3 months is now known to be in excess of 
requirements but, at the time when these patients were treated, it was the 
dosage generally recommended. The amount given to children is correspondingly 
greater than that now known to be required. It should be observed that the 
intramuscular dose is the quantity given at each injection, which is not 
necessarily the daily dose - in the first 3 months in all patients this was 
given twice daily. In Table 34 are presented the numbers of patients who 
received each course as their initial treatment. A number of these later 
relapsed and required a further complete course of treatment. Such 
additional courses were often different from the initial course but this has 
not of course been taken into account in Table 34* Table 135 gives a 
more comprehensive summary of all the courses of treatment given. The 
apparent discrepancy in the total number of cases in Table 34 (101 instead 
of 102) arises from the fact that the treatment of one patient (Case 33) 
could not be classified with any of the other groups. In addition to 
receiving sulphetrone, this patient - whose treatment was commenced before 
my transfer to Belvidere Hospital - had more intrathecal streptomycin (and 
dihydrostreptomycin) than the others in a quite different regime.
With the exception of the 6 patients in Group 6, the same pattern of 
intramuscular therapy was followed in all patients. Full doses of 
streptomycin (lg. twice daily in adults) were given for the first 3 months, 
followed/
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followed by half of this dose for one month, a quarter in the fifth month, 
the dosage being tapered off during the sixth and final month.
The first 26 patients - Group A - were treated at Ayrshire Central 
Hospital with intramuscular and intrathecal streptomycin (sulphate), and 
without P.A.S. or other adjuvants. Intrathecal treatment consisted of an 
initial fortnights intensive course of daily injections (100 mg. in 
patients over 5 years and 50 mg. in children under 5 years, half dosage being 
given in the first week of treatment throughout the series); followed, 
after a rest period of one week, by a further less intensive course of 
injections every second day for 2 or 3 weeks. Thereafter if no 
exacerbations occurred, intrathecal medication was confined to one injection 
weekly given at the time of the routine weekly lumbar (or cisternal) puncture 
for C.S.F. examination. Early in the series the practice of giving 
streptomycin at each lumbar puncture Was continued even after the 6 months1 
intramuscular streptomycin had been completed, but it soon became evident 
that intrathecal streptomycin without intramuscular streptomycin gave 
rise to symptoms such as headache, vomiting, dizziness, diplopia, and in 
one patient, convulsions - which did not occur while intramuscular 
streptomycin was being given. Consequently, throughout the series, 
intrathecal streptomycin was terminated at the end of 6 months.
Group B consisted of 6 patients whose initial course of 3"g months 
proved to be inadequate and who subsequently relapsed and required 
subsequent 6 months courses. The mortality rate among patients treated 
with/
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with this regime was high and relapses were very frequent. Some of the 
patients appeared to make good progress, were well clinically and showed 
satisfactory improvement in the levels of the C.S.F. constituents when 
treatment was stopped. Some, indeed, were allowed to return home but kept 
under observation. Nevertheless, the fact that relapse was the rule 
rather than the exception showed that there was a persistent smouldering 
infection, that jj? months was too short to achieve complete control, and 
that even the reduced intramuscular therapy of the last 2-gr months in the 
remainder of the series seemed sufficient to control the infection in most 
cases.
The treatment of patients in Group C showed four distinct 
differences from previous regimes; by a remarkable coincidence, and not by 
any design, all of these changes were introduced simultaneously. Indeed, 
it was only on retrospective investigation that it was discovered that the 
first of these, the replacement of streptomycin by dihydrostreptomycin, 
coincided with the others. This alteration was made because 
dihydrostreptomycin was available in purer form and was considered to be 
less toxic to the vestibular apparatus than streptomycin. Too late - 
for the patients in this and other series — it was found to be more toxic 
in its effect on the cochlear component of the eighth cranial nerve. The 
second feature of treatment in this group was the intensification of 
intrathecal therapy. Comparison of the regime that had been adopted in 
Group A with those reported to have been used in other centres showed that, 
while the results obtained in Group A compared favourably with those obtained 
elsewhere/
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elsewhere, the intrathecal dosage was much smaller than that generally 
recommended. It was just at this time (early I950) that MacCarthy and 
Mann published their results in the “Lancet” and showed the advantage of 
continuous intrathecal therapy without any intervals. Consequently it was 
decided to intensify the intrathecal course and abandon the rest period 
that had previously been considered desirable in view of the unpleasant 
side-effects resulting from the irritation caused by intrathecal streptomycin. 
Daily injections for a fortnight were followed by injections on alternate 
days for 8 weeks, as shown in Table 32* In practice, the latter period 
was divided into 2 equal parts; in the first 4 weeks intrathecal 
dihydrostreptomycin was given on four days in the week - Monday,
Wednesday, Friday and Saturday - after which the Saturday injection was 
omitted for the next 4 weeks. A total of 42 intrathecal injections was 
thus given over a period of 10 weeks and a further 14 at weekly intervals 
until the end of the course. At the same time it was becoming evident 
that para-aminosalicylic acid (P.A.S.), while not possessing marked anti- 
tuberculous properties when given alone, did act synergistically with 
streptomycin, and in particular, delayed the emergence of strains of 
tubercle bacilli resistent to streptomycin. The third alteration in 
Group C, therefore, was the addition of oral P.A.S. in the doses shown in 
Table 33 - an addition that was continued throughout the remainder of the 
series.
The final and most distinctive feature of the treatment in Group C
was/
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was the use of intrathecal streptokinase. It had for some time been 
recognised that one of the main obstacles to successful treatment of patients 
with tuberculous meningitis was the formation in the meninges of fibrinous 
exudate in which tubercle bacilli lurked, and were comparatively inaccessible 
to streptomycin. Further, this fibrinous exudate was responsible for the 
development of one of the main complications arising during therapy, namely, 
spinal block - a complication associated with a high mortality rate.
Endeavours to overcome this obstacle led to the introduction of 
streptokinase, a product of some strains of streptococcus with the ability 
to activate a naturally occurring profibrinolysin to produce fibrinolysin.
Cathie (1949) wa>s the first to describe its use and was “greatly 
encouraged" by the improvement in recovery rate following its introduction. 
Using a course in which the duration of intrathecal treatment was reduced 
to 6 weeks, he obtained 11 recoveries in 19 cases, compared with only 3 iu 
14 treated with streptomycin alone. In a subsequent paper (1950) Cathie 
and MacFarlane describing the treatment of 60 children with tuberculous 
meningitis, reported that only 5 o f the first 20 were alive, compared with 
23 of the succeeding 40 patients. Streptokinase was in their judgment the 
most important single factor in this improvement. They showed that its 
main effect was the reduction of raised intracranial pressure; they also 
pointed out the life-saving value of ventricular drainage whenever there 
were any indications of raised intracranial pressure. They emphasised 
the necessity of giving streptokinase from the beginning of treatment; it 
was of no value late in the disease since it had no effect on already formed 
fibro’us tissue. On the other hand, Lorber (1951a) found that streptokinase 
was of no benefit and suggested that the improved results obtained by Cathie 
and MacFarlane could have been attributed to factors other than streptokinase - 
the use of intrathecal sulphetrone, frequent ventricular catheterisation, 
and particularly increased experience; he went so far as to “suggest that 
streptokinase probably played no part in the good results obtained in the 
second series." He undertook a controlled investigation to determine 
the value of intrathecal streptokinase, 12 patients being treated with and 
12 without streptokinase. The two groups were otherwise strictly comparable. 
Streptokinase did not appear to have any value in reducing the number of 
blocks occurring during treatment - indeed, more blocks occurred in the 
streptokinase treated patients than in those receiving streptomycin alone. 
Further/
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Further it seemed to cause toxic features such as headache, listlessness, 
drowsiness, vomiting and marked C.S.F. p'leccytosis. Necropsy findings 
in 3 patients treated with streptomycin and streptokinase did not differ 
from those in patients treated with streptomycin alone, the exudate being 
no different in nature and extent. High (1951) gave intrathecal 
streptokinase and streptodornase on 3 occasions to each of 2 patients and 
reported increased irritability following its use; fever occurred on 
4 of 6 occasions, and convulsions once; white and red blood cells in the 
C.S.F. were increased for 48 to ~[2 hours and the streptomycin level was 
increased for 24 to ~[2 hours. The ultimate response was unsatisfactory, 
but the patients had been comatose and decerebrate for a month before, and, 
in any case, no conclusions can be drawn from its use in 2 patients.
Craddock and Haddock-Suarez (1552) reported one case who had made little 
or no response to intramuscular and intrathecal streptomycin, and who was 
given an injection of streptokinase and streptodornase intrathecally;
6 hours later, the temperature rose to 106°F; a second similar injection 
was followed by pyrexia of 108°F and 2 days later the patient died.
The introduction of intrathecal streptokinase into the regime of 
treatment at Belvidere Hospital was also associated with alarming reactions, 
which were at first quite puzzling and difficult to explain. Initially, the 
intrathecal administration of the enzyme (6 units or 1 ampoule given with 
the intrathecal streptomycin) on successive days to 7 different patients 
produced no upset whatever. After a period of 9 days, supplies of 
streptokinase were exhausted and no more was given till 3 days later when 
fresh supplies arrived. All the patients on this occasion developed severe 
reactions beginning, within 3 hours of lumbar puncture, with excruciating 
pain in the back and legs, violent headache necessitating potent analgesics 
for control, vomiting, pain and stiffness in the neck and, in most cases, 
pyrexia in the region of 100°F - 101°F, but in one case reaching 104°F.
Cn the following day, general symptoms were less, with sickness predominating; 
temperature began to settle; there was no leucocytosis in the blood but the 
C.S.F./
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C.3.F, was turbia, in some cases yellow and purulent, with marked 
pleocytosis (up to 9»000 per c.mm.) and raised protein content (usually 
200 - 5^0 mg* per 100 ml. but in one case 3*2g. per 100 ml.) Succeeding 
days saw a gradual return to normal in the patients1 condition sad in the 
C.S.F. While streptokinase was immediately considered as the cause of these 
reactions, it was difficult to incriminate it in view of the fact that it
had been given for several days without upset. An intensive but vain
search was therefore made for a possible irritant factor - the particular 
batch and type of dihydrostreptomycin, the adequacy of sterilisation of 
syringes and needles etc., the presence of impurities such as pyrogens in 
the diluent, and even the possibility of contamination with powder used with 
the gloves worn during lumbar puncture. It was only when streptokinase 
was again injected after an interval of more than 2 days that the
development of similar reactions - in rather milder form in those patients
who had already suffered - led to the conviction that it was the responsible 
factor. It seemed that continuous administration, day after day, or even, 
in most cases, on alternate days, was not associated with upset but 
reactions occurred if there was a lapse of more than 2 days between injections. 
The explanation appeared to be that streptokinase, like all toxins and 
enzymes, was antigenic and stimulated the production of antibody. So long 
as it was injected daily, an excess of antigen probably persisted, but after 
an interval in the course of injections, antibody was present in the C.S.F. 
which reacted violently when antigen was next injected. Whatever the 
explanation/
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explanation, it was clear that the meninges developed a hypersensitivity 
to streptokinase if more than 2 days elapsed between the injections of the 
enzyme. Whether such reactions are desirable in the treatment of tuberculous 
meningitis - by causing an inflammatory reaction and so allowing streptomycin 
to penetrate into the exudate - it is difficult to say. At the time, such 
a possibility was given little, if any, consideration. From a humanitarian 
standpoint, in view of the torture experienced by patients, who were, 
literally, writhing in agony, avoidance of reactions was of prime importance. 
It was partly for this reason that the rest period in intrathecal treatment 
was abandoned, the initial fortnight of daily injections being followed by 
a month of injections given on 4 days of the week. Streptokinase - 
1 ampoule, or 6 units - was injected on each of these occasions during the 
first 6 weeks of treatment, and then discontinued. Its use on succeeding 
weeks would obviously have precipitated reactions on the Mondays after the 
lapse from Friday to Monday. In any case, Cathie and MacFarlane had 
suggested that 6 weeks* treatment was adequate.
Regime D. It soon became obvious that streptokinase was not achieving the 
end for which it had been introduced into the treatment regime. As will be 
seen later, it seemed to be able neither to prevent the development of spinal 
block nor to remove any obstructions that developed. Moreover, the overall 
results, while not unfavourable, were not convincingly satisfactory. 
Accordingly it was decided to abandon streptokinase without altering the 
rest of the treatment. Treatment in Group D, then, was exactly the same as 
that in Group C with streptokinase omitted.
Regime 3B./
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Regime E . In August 1950* Smith and Vollum reported successes following 
the use of intrathecal tuberculin in what had been considered to be hopeless 
cases of tuberculous meningitis, manifesting decerebrate rigidity. In view 
of the continuing mortality rate of the uncertainty in prognosis except
in cases with decerebrate rigidity ( a sign that invariably indicated a fatal 
outcome), and the constant necropsy finding of a thick collar of exudate 
round the midbrain, in which organisms were protected from streptomycin in 
the blood and C.S.F., they postulated a factor other than the drug organism 
relationship and suggested that it was related to the host response.
They noted the remarkable day to day fluctuations in the C.S.F. cell count 
and protein content in the first few weeks of treatment, beginning between 
the Zj-th and 14th day of treatment and gradually flattening out in successful 
cases. They found that these changes were specific for tuberculous 
meningitis treated with streptomycin and were not due to infection or 
streptomycin irritation. Their development when organisms were disappearing 
from the C.S.F. suggested that they might be caused by the liberation and 
accumulation of bacterial breakdown products, i.e. tuberculin, into the 
C.S.F. of sensitised patients. In order to confirm this hypothesis they 
injected tuberculin intrathecally into 2 patients in whom treatment with 
streptomycin had failed and all fluctuations in C.S.F. cells and protein 
had disappeared. Both, developed marked clinical and C.S.F, reactions, 
but the commencement of tuberculin marked the turning points in the illnesses 
of these patients, both of whom thereafter made gradual improvement.
Another child, in whom tuberculin (P.P.D.) was started on the 15th day of
treatment/
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treatment on account of her rapid deterioration, survived for 25 weeks 
and autopsy showed no exudate in the cisterna ambiens or Sylvian fissure — 
a result quite different from those treated without P.P.D. It seemed 
clear to the writers, therefore, that tuberculin caused a resolution of the 
intense exudate, and they proceeded to use it in other cases with a bad 
prognosis. They felt that the acute inflammatory reaction was in itself 
beneficial in that it might result in a fibrinolytic process which would 
bring streptomycin into closer contact with the organisms. They suggested 
that, when using tuberculin, bilateral cranial burr-holes should be made 
as soon as the diagnosis was confirmed; the Mantoux should be done and the 
severity of the reaction noted - the more strongly positive the reaction, 
the greater the dilution of the P.P.D. solution used intrathecally; 
beginning with minute doses of P.P.D., these should be increased continuously 
till reactions were obtained; thereafter the dose should be repeated and 
gradually increased to avoid too severe reactions; and injections should be 
continued until convalescence when patients were free of signs and symptoms 
of active meningitis.
Reports on experience with P.P.D. from different centres have been 
rather conflicting. Atkins and Cummings (1952) described the treatment of 
one patient, a negro male aged 24, who was given 5 doses of intraventricular 
P#P.D., no imjjrovement having occurred f  weeks after the commencement of a 
second course of treatment for tuberculous meningitis. There was a marked 
reaction following each instillation of P.P.D. and dramatic clinical 
improvement occurred after the completion of therapy. P.P.D. was discontinued 
after a block in the posterior fossa had been relieved. The writers 
recognised that, while the results in this case were good, the type of 
therapy could be dangerous and should be used very cautiously. Lorber (1954a) 
used P.P.D. in 12 of 38 children with tuberculous meningitis; 9 o t these were 
at an advanced stage on admission; and 3 who had been at an intermediate 
stage on admission had deteriorated progressively despite routine treatment.
Burr-holes/
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Burr-holes were made in all cases in whom the fontanelle was already closed.
6 patients survived, including the 3 who were in the intermediate stage on 
admission - the writer felt that these were probably helped by P.P.D.;
2 of the other 3 were decerebrate at the time of writing. The writer 
concluded that P.P.D. seemed to be of little benefit in most of the advanced 
cases, in 1 of whom death was probably accelerated by its use. In his 
opinion, the routine use of intrathecal tuberculin was unjustifiable.
Choremis and his associates (1951) reserved P.P.D. for severe cases and 
applied it periodically, each period lasting not longer than 3 to 4 weeks. 
Beveridge (1952) found it disappointing, and Fletcher (1951) who used it in 
6 patients, saw no evidence of benefit; his results suggested that, instead 
of causing any lysis of the exudate, tuberculin may have contributed to its 
formation - 2 cases developed fresh blocks during treatment and 1 other 
developed transient sub-tentorial block during the phase of acute hydrocephalus. 
He adduced clinical and laboratory evidence to show that any possible benefit 
of intrathecal tuberculin treatment in tuberculous meningitis was not 
apparently derived from specific lysis of fibrinous exudate.
At the beginning of October 1950* when supplies of P.P.D. were 
obtained at Belvidere Hospital, it was decided to give the benefit of this 
treatment to 2 patients (Cases and 45) who had been doing badly on 
routine measures. The farmer had relapsed twice and a third course of 
streptomycin was having little apparent effect; he was steadily deteriorating, 
had severe headaches and troublesome vomiting and was incontinent. The 
latter had just completed one course of streptomycin to which he had never 
shown a satisfactory response; mental deterioration was so marked that he 
was by that time almost vegetating; the C.S.F. cell count was under 20 per c.asn. 
but the sugar level was 20 mg. per 100 ml. suggesting a poor meningeal 
cellular response in the presence of persistent infection. Both of these 
patients were given a course of streptomycin with intrathecal tuberculin 
(Course 53), but the results were disappointing. neither showed any 
clinical or C.S.F* reaction for fully a month, by which time undiluted
standard solutions of P.P.D. were being used in both patients. After more
than/
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than a month both developed reactions of mild severity, with C.S.F, 
pleocytosis more marked in Case 31. When P.P.D. was discontinued at the 
end of 4 montxhs, Case 45 bad deteriorated further and he died 2 months 
later. Case 31 began to improve after the first month, and at the end 
of treatment he was slightly better. After treatment was discontinued he 
seemed to make good progress and was eventually able to go home.
Unfortunately he relapsed within a fortnight and died 2 months later.
•This case may be regarded as a partial success for P.P.D.
Intrathecal tuberculin was used as a routine in 9 patients 
admitted from October to December, 1951* anb ih 1 other patient who relapsed 
during this period. The regime x^ as similar in all cases and was modelled 
on the scheme outlined by Smith and Vo Hum, with the exception that burr-holes 
were not made in the skull, the lumbar or cisternal intrathecal route being 
used in every patient. The standard solution of P.P.D. containing 
7.5mg* Per was diluted 10 fold, 100 fold and 1000 fold, and regardless 
of the Mantoux reaction which was performed in each patient, the first 
intrathecal dose in each case was 0*5ml* ^be 1000 fold solution. This 
was repeated on the following day, then doubled if no reaction occurred.
Sach dose was similarly given on 2 successive days and then doubled if no 
reaction took place, - the dose after 4 ml» being 0 .5 ml. of the lower 
dilution. If a reaction occurred - vomiting, headache, C.S.F. pleocytosis - 
a rest of a day to several days was given, depending on the severity of the 
reaction; on resuming treatment the same dose was usually repeated.
Sometimes/
Sometimes rest periods of 1 to 5 days were given in the absence of srjecific 
reactions if it was evident that the patient was generally reacting badly 
to the P.P.D. injections. Intramuscular dihydrostreptomycin and oral P.A.S. 
were used exactly as in other courses and intrathecal dihydro streptomycin 
was given with each injection of tuberculin, and also on days when tuberculin 
was withheld, a course similar to that in Group C being adopted.
Within 4 months of introducing P.P.D. it was evident that no 
dramatically good results were being obtained. Indeed, on the contrary, 
it seemed that patients who were expected to do well were deteriorating.
The frequency of occurrence of spinal block was becoming alarming, and, 
on the whole, the progress made was most unsatisfactory and in marked contrast 
to that of patients in pre-tuberculin days. This, together with the 
disturbing reactions, completely transformed the atmosphere in the 
meningitis ward from one of brightness, cheerfulness and hope, to one of 
gloom, disappointment and despair. The final straw was a very genuine 
threat of resignation by an excellent ward sister whose efficiency, brightness 
and insight were such that her loss at this stage would almost have spelt 
disaster. It was therefore decided to abandon Course S and revert to
Course D. By this time, 3 patients (including the 2 described above) had
been treated with tuberculin for 4 months, 1 for 3 months and 5 for 1 month;
2 others had died at the end of a month and 1 after a fortnight. 2 of the 5 
who had been treated for a month were in a moribund condition and died, one 
in a few days and the other a fortnight later. Done of the survivors was
- 71 -
in very good shape and all were most grateful to be relieved of the
torture of intrathecal tuberculin. Probably as relieved as any was the
ward sister, who, happily, withdrew her resignation.
Regime P. The years 1950 an<^  1951 saw an alarming increase in the 
incidence of deafness in survivors and in non-survivors who lived sufficiently 
long to develop it. Careful review of the patients developing deafness 
led to the discovery that it occurred mainly in patients in the treatment 
groups C, D and E, and only in 2 patients in groups A and 33. The common
factors in Groups C, D and E were (a) the use of dihydro streptomycin
(b) more intensive intrathecal therapy, and (c) the introduction of P.A.S.
The latter factor was discounted as it had been widely used in the treatment 
of all forms of tuberculosis without apparently causing deafness. The 
suggestion that dihydro streptomycin - probably particularly by intrathecal 
administration - was responsible for the high incidence of deafness was 
greeted with absolute incredulity by representatives of manufacturing firms. 
After all, it was the purest form of streptomycin yet manufactured; 
moreover its use in large doses and in prolonged courses in other forms of 
tuberculosis had not been reported to cause deafness, and patients treated 
with it were remarkably free of vestibular upset. Accordingly it was 
decided, before incriminating it, to exclude the possibility that the 
intensification of intrathecal streptomycin therapy was the cause. Eor 
this reason, regime P was introduced, which differed from D only in the 
reduction of intrathecal injections - 28 injections in 6 weeks instead of 
42 in 10 weeks. In practice, after an initial fortnight of daily injections, 
intrathecal/
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intrathecal dihydrostreptomycin was given on Monday, Wednesday, Friday 
and Saturday for a fortnight, on Monday, Wednesday and Friday for a further 
fortnight, and, thereafter, weekly until the end of the 6 months1 course. 
Regime G* It was not long before it became evident that deafness was 
still occurring just as frequently as with the three earlier courses and 
therefore, that dihydrostreptomycin must be the responsible factor. On 
this account the latter was abandoned and. replaced by the calcium chloride 
complex of streptomycin, the course (G) otherwise remaining unaltered.
CONCLUSIONS.
For several reasons, it is not possible to evaluate accurately the 
effectiveness of each particular regime in this series. It is obvious 
from Table 34 that the numbers in each group are too small to permit of 
comparisons being made and rigid conclusions drawn. Moreover, as already 
pointed out, the table presents only the ultimate outcome in patients 
treated initially by each regime; some patients, classified as '‘dead" 
responded to the initial course of treatment, but later relapsed and 
received another - often a different course; others "alive" also relapsed 
and required another course - often different - to complete their "cure".
It is obviously neither justifiable to incriminate the initial course 
completely in the former cases, nor to give it the total credit in the 
latter. Table 34 would suggest, for example, that treatment B is a very 
adequate and effective regime, being associated with a high recovery rate; 
but, in point of fact, all the 6 patients in this group required at least 
1 further course before recovery was complete, and it was quite evident 
that/
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that the course was inadequate. The factor has been incorporated in 
Table 135 and will he considered in the section dealing with relapse.
Finally, since this was not a planned or controlled investigation to 
assess the relative values of particular courses of treatment, the patients 
in the series being treated with the course that was considered to be the 
best at the time of diagnosis, it is clearly impossible to draw any 
deductions unless it can be shown that the samples in each group were 
similar in all important respects. That this was not so is seen from 
Tables 35 to 39 which have been compiled in an attempt to evaluate the 
influence in each group of several factors which have already been shown 
to have some bearing on the outcome.
The only factor which seemed to show major differences from group 
to group was age (Table 35)* It is noteworthy that of the 24 patients 
under 5 years of age (1 other was unclassified) 22 were among the 66 patients 
in Groups A, D and F and all of the 5 adults over 30 also belonged to these 
categories. The proportions of young children in Groups A, D and F - 
38.55©, 30.8jS, 28.655 respectively - wer e significantly higher than in the 
remaining groups - 5*7$ °£ 35 patients. As would be expected, the 
highest proportion of young children was in Group A where there was no 
selection of cases. Three of these died within a week of commencing 
treatment; and obviously the outcome in these cases could not have been 
affected, whatever regime was adopted (it is significant that only 1 other 
in the series died within a week). Two others in this group died within 
the/
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the first month, and it is unlikely that alternative treatment (without 
isoniazid) could have influenced the results in these. Thus it is clear 
that this single factor must very largely account for the comparatively 
high mortality in Group A - 50$, compared with 30.3$ in the remainder of 
the series.
The slight differences observed in Tables 36 to 39 are incorporated 
in the following brief review of each group;-
Group A - Only 505" survived of 26 patients in this group whose treatment 
showed remarkably little difference from that of the final group in whom 
the recovery rate was 100$. Inexperience in the treatment of tuberculous 
meningitis may have been a factor in the high mortality in this group, and 
the lack of P.A.S. may have contributed slightly, but it seems most likely 
that, from the start, the scales tended to be weighted against a high 
survival rate in these patients compared with the rest of the series.
Thus, in addition to the fact that 11 of the 26 patients in the group were 
under 5 years or over 30 years, a comparatively higher proportion were at 
an advanced stage of illness and in poor nutritional state. It would 
therefore not be justifiable to draw any conclusions from the higher 
mortality associated with this early treatment.
Group B. Sufficient has already been said to indicate that this 3^ months « 
course of treatment 'was unquestionably inadequate.
Group 0. As many as 7 of the 10 patients treated initially with 
streptokinase survived (and, indeed, only 3 deaths occurred on the 14 
occasions/
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occasions in which streptokinase was included in a treatment course -
Table 135)• Only 1 however was under 5 years - a child of 2 years
(Case 39) wk° survived but was mentally deficient; none were over 30 years; 
only 2 had radiological evidence of miliary tuberculosis (compared with an 
average of 27.7^ for the series) and none had adult phthisis. On the other 
hand, 3 of the 6 comatose patients were in this group, and also a higher 
proportion of severely ill and poorly nourished patients than in other 
categories. From the small numbers of patients, it is obviously wrong to 
be dogmatic on the place streptokinase should or should not have in the
treatment of tuberculous meningitis. Its value in relation to the problem
of spinal block - the main reason for its introduction - will be discussed 
later.
Group D . The 26 patients in this group included 8 children under 3> 3 °£ 
the 5 adults (all of whom died) and 7 of the 10 patients with adult pulmonary 
tuberculosis, but none of the 6 patients who were comatose on admission.
In view of these high proportions of “poor-risk11 patients, the recovery of 
16 of the 26 patients seems fairly reasonable and does not suggest that the 
use of dihydrostreptomycin raised the mortality rate.
Group E. The high mortality rate in this group - 5 out of 9 who received 
P.P.E. as initial treatment, and 6 out of a total of 12 (Table 135) was 
largely responsible for the sma.ll number of patients treated with intrathecal 
tuberculin. It is true that one third of the 9 patients were either 
stuporose or comatose at the time of diagnosis, compared with an average of 
one/
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one sixth for the series as a whole; hut, on the other hand, apart from 
1 child aged b months who died, all the patients were from age groups 
favourable for recovery and in other respects were comparable with the rest 
of the series* It would therefore appear, although the numbers are too 
small to justify firm conclusions, that the type of treatment was itself 
largely responsible for the poorer survival figures. It must be admitted, 
however, that the treatment was not given exactly as described by Smith and 
Vollum, in that cranial burr-holes were not made in any of the cases, and this 
may have had a bearing on the results.
Group g. Apart from the higher proportion of children in this group already 
noted, the initial features were on the whole slightly favourable compared 
with the rest of the series. A recovery rate of 71*4^ I*1 14 patients does 
not suggest that reduction of intrathecal streptomycin was a retrograde move - 
longer courses do not appear to have any special value.
Group G. It is most gratifying, indeed, to have a succession of 10 patients 
with tuberculous meningitis who respond satisfactorily without any mortality. 
That this can perfectly well occur by chance in a condition with over 6ofi 
survival rate is obvious; particularly when, as in this series, there are 
no children under 5, adults over 30> comatose patients or cases of phthisis, 
and when other factors tend to be slightly favourable. These facts must 
modify any conclusions one might wish to draw from such results.
smfflARY.
Seven different regimes of treatment were used in 101 patients in 
this series, the other patient being unclassified and receiving sulphetrone. 
Int ramus cular/
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Intramuscular and intrathecal streptomycin or dihydrostreptomycin was 
given to all, and in all but 6, treatment was continued for a minimum of 
6 months. months1 treatment proved to be quite inadequate and was
associated with a high relapse rate and a high mortality rate. Even in the 
presence of satisfactory clinical and C.S.F. findings, intramuscular treatment 
should not be discontinued before the end of 6 months. The necessity for 
intrathecal treatment was assumed. The courses used varied somewhat from 
group to group but even the most intensive were shorter than those described 
in most of the reported series. On the whole, it did not appear that 
prolonged or interrupted intrathecal therapy had any special advantages over 
a shorter continuous course with injections daily or on alternate days.
The final regime, in which 28 intrathecal injections were given in the first 
6 weeks and only weekly injections thereafter, seemed perfectly adequate and 
as satisfactory as any. The use of dihydro streptomycin was not associated 
with any rise in mortality, but its continued use in view of the incidence 
of deafness seemed unwarranted. It could not be demonstrated that the 
addition of P.A.S. had any marked effect on the recovery rate, but, even 
although bacterial resistance is not a very great problem in tuberculous 
meningitis, it does sometimes arise and the effect of P.A.S. in delaying the 
emergence of resistant strains may have contributed to the improved results 
later in the series. Streptokinase and tuberculin were used in the initial 
course in 10 and 9 patients respectively and altogether in 14 and 12 courses 
respectively. Prom these small numbers, it is imposside to assess the 
value of these adjuvants but in this series neither seemed to have special 
value and P.P.D. seemed to be harmful.
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C. TYPE OP RESPONSE TO TREATMENT Ai<D ITS EEEECT 
  OR THE OUTCOME.
Perusal of the literature on the treatment of tuberculous meningitis 
with streptomycin and personal experience of such treatment leave a marked 
impression of the different types of response that may he obtained.
Between the two extremes of cases who are completely uninfluenced by treatment 
and those who, from the very outset, respond to it and make a complete and 
uninterrupted recovery, there is a very wide range and variety of courses 
that any given case may follow.
The types of response have been classified in different ways. Thus, 
the Medical Research Council (1948) divided 23 survivors into 3 groups:
(1) 12 who made uninterrupted improvement,
(2) 8 who made continuous improvement after an initial period in
which they were stationary or deteriorating, and
(3) 3 w^° improved after relapse.
Of 60 fatal cases in this series, (1) 20 made no response to treatment, 
deteriorated rapidly and died within the period expected for untreated cases, 
(2) 19 made slow progressive deterioration with no period of improvement - 
death seemed to be merely delayed, sometimes for a long period, (3) 9 » after 
a short initial period of improvement, deteriorated progressively and died, 
and (4 ) 12 relapsed after a long period of improvement.
MacCarthy and Mann (1950) classified their series of 43 patients into 
3 broad groups:
(1) 13 made an immediate response - 3 subsequently died,
(2 ) 10 had a delayed response - 5 died later, and
(3) 20 made no response; 15 of these were stuporose on admission.
Robertson and Gairdner (1952) described 3 main patterns of response:
(1) rapidly successful - clinical improvement within J days; sitting up and 
mentally alert by 14-21 days; (2) decerebrate rigidity in 47 patients, none 
of whom recovered; and (3) a fluctuating course, the clinical and 
C.S.P./
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C.S.I*. state fluctuating for several months, and improvement rarely 
occurring within 4 months; this latter group showed a high proportion of 
mental disturbances.
Spangberg and Granath (195^) divided their patients into other 3 groups; 
(1) those completely uninfluenced by treatment, (2) those who recovered and
(3) those who improved but later relapsed.
In considering the response to treatment, two main questions arise:
(1) What factors determine the type of response to treatment? Can 
the mode of recovery in surviving patients, for instance, be related to the 
clinical or C.3.IT, features at the commencement of treatment, or is it 
affected at all by the type of treatment adopted? This would appear to be 
of more than academic interest since, other things being equal, a treatment 
regime resulting more frequently in a speedy recovery will be preferred to 
one that tends to cause delayed or interrupted recovery,
(2) Has the initial response to treatment any bearing on the ultimate 
course of the disease? In other words, in any given patient, can one 
make a firm prognosis within a few weeks of the institution of treatment,
on the basis of the progress being made? As a corollary to this investigation, 
I have taken individual features and endeavoured to discover whether the early 
disappearance of symptoms or restoration of C.S.F. elements to normal is 
related to the initial features or is affected by the treatment regime; 
and, finally, whether any indication of the ultimate outcome or the 
incidence of relapse can be obtained from such a study.
GhKSRAL PROGRESS.
I have considered the survivors and non-survivors separately and 
divided the types of response in each in the different categories shown
in/
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in Tables 40 and 4 8* Taking, first of all, the 66 patients who recovered, 
it is seen from Table 40 that more than one-third (24) of these showed an 
immediate and sustained response to treatment .(I). Within a few weeks, they 
were clinically improved, temperature settled or settling and meningeal signs 
subsiding, and this progress was maintained until recovery was complete.
Mann (1948) considered that such a course was exceptional occurring, as it 
did, in only 5 (15*2/0 of a total of 33 cases. In this series, just under 
one quarter (23.5^ ) of all patients made steady, rapid progress towards 
complete recovery. A second group of 14 patients in all (1 not included 
in Table 40, because her treatment did not correspond with any of the regimes 
described) took rather longer to recover (11); a sharp line of demarcation 
between these and Group I was for obvious reasons impossible to draw.
12 patients (III) did not appear at first to respond to treatment, and only 
began to improve after an initial phase of deterioration. Lincoln and 
her associates (I94S) described this as the usual mode of recovery; even 
cases treated at an early stage, they found, deteriorated to the meningitic 
phase and might remain in that state for several weeks to several months; 
the comatose stage might develop during treatment and yet be followed by 
complete recovery. Finally, in l6 patients, recovery was punctuated by 
periods of deterioration or relapses. (IV).
From the patient's point of view, Progress I is obviously the most 
desirable, and, since the main object of this investigation is to 
differentiate between this group of patients v/ho progressed rapidly end 
steadily, and those making slow or interrupted improvement, in assessing 
significance/
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significance, I have in general amalgamated Groups II, III and IV.
Tables 4  ^to 47 suggest that the type of recovery in survivors was 
influenced by several factors apart from the treatment given:
(1) A significantly higher proportion of patients aged 5-14 years made a 
steady rapid recovery than in other age-groups - 48. compared with 22.6$.
(2) The milder the initial illness, the speedier was the recovery made, 
patients with a shorter history also tended to recover more quickly, but 
the differences were not significant. (3) The character and speed of 
recovery was apparently directly related to the degree of mental clarity on 
admission. (4) Patients with no meningism or only mild meningism had a 
much better chance of uninterrupted speedy recovery than others. (5) The 
nearer the initial C.8.3F. protein and chloride levels to normality, the 
greater the tendency to uncomplicated recovery. (6) l-Io relationship could 
be demonstrated between the type of recovery and the X-Ray appearances or 
the ce 11-count or sugar-content of the C.S.F.
In view of the small number of ps/tients in each treatment group, it 
is clearly impossible to draw conclusions based on the progress made by 
survivors in individual groups; any deductions must be made on the basis 
of combinations of such groups. The 5 patients in Group 33 all relapsed due 
to the inadequacy of the initial course and so none were in progress group I; 
they should, therefore, be omitted from any assessment. The high proportions 
of cases in columns 3F and G (Table 40) who made steady, rapid recovery are 
noticeable/
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noticeable, ana it is interesting- that these two regimes together with A 
were those with the shortest intrathecal therapy. A significantly higher 
proportion of survivors who were treated with a shorter intrathecal course, 
made a rapid and uninterrupted recovery - 51*5$ 33 cases, compared with
25.9$ of 27 others. However, this may he accounted for, at least in part, 
hy the inclusion, in the groups having prolonged intrathecal treatment, 
of streptokinase and tuberculin treated patients, only 2 out of 11 of whom 
made a rapid recovery. She proportion in the remaining group (D) was 
31.25;j& of 15 patients, and the difference between this and the 51»5fc 
33 cases in groups A, F and G- is not now significant. The figures do suggest, 
however, that intrathecal therapy - particularly streptokinase and tuberculin - 
tends to delay or interrupt the clinical progress made; a finding which 
emphasises the benefit of restricting intrathecal medication to a minimum. 
Finally, once again, no significant differences can be seen between the 
effects of streptomycin and dihydrostreptomycin in relation to the progress 
towards recovery.
Of the 36 patients who died (Table 48) more than half went steadily 
downhill and died within a few days or weeks of admission, showing little or 
no response to streptomycin. In some of these, the drug appeared merely 
to prolong the act of dying ana had no evident influence on the disease 
process. These were undoubtedly the most fortunate of the non-survivors 
because they did not have the prolonged suffering associated with long and 
repeated/
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repeated courses of injections, and their relatives were spared the long 
suspense of anticipating the final outcome. Just under one-third of the 
36 patients showed some initial improvement and appeared for a time to he 
responding to treatment; some of these had successfully completed a course 
of treatment and had even reached the stage of going home, only to relapse 
later, thus hlasting the hopes of relatives and friends. Perhaps the worst 
type of case, from all points of view, belonged to the third category - 
fortunately, in this series, a small proportion - one-sixth of the fatal 
cases and less than one-twelfth of the series. These showed alternating 
improvement and deterioration, lingering on for months, perhaps even a year 
or more; hopes and fears mingling all the while in the minds of physicians, 
nurses and especially relatives.
The second question to be considered is what guidance can be provided 
by the initial response to treatment in the assessment of prognosis.
Choremis and his associates (I94B) concluded that, if the clinical picture 
was normal after 4 or 5 weeks, the prognosis was good; this impression 
had been confirmed when they wrote in 195-*- that, provided the clinical 
improvement was steady, the prognosis was, as a rule#satisfactory.
MacCarthy and Mann (I950) found that the proportion of full recoveries in 
any series depended much more on the number of initially responsive cases 
included than on the particular rhythm of treatment adopted.
Reference lias already been made to the weekly entries, made in 
stencilled sheets, of each patient's general condition, symptoms and C.3.F. 
findings. These have been used in constructing the succeeding tables from
49/
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49 ^0 90* general progress indicated by these charts has been
summarised in Table 49 which shows the number of patients who were well, 
improving, stationary or deteriorating at the end of each month as compared 
with their condition one month before. For obvious reasons, while the 
number of survivors remains constant at 66, the number "dead" diminishes 
from month to month from 21 at the end of the first month (15 having died 
within a month) to 6 at the end of 6 months. It is evident from this table 
that the majority of survivors were already improving by the end of the first 
month, 50 by this time being either well or improved. Some, however, had 
deteriorated, and, at the end of each month up to the 6th, with the exception 
of the 2nd, 1 or more patient had shown some deterioration over the preceding 
month. This in itself, therefore, is not necessarily an ill omen. The 
most remarkable feature, however, in view of the literature just quoted, is 
the proportion of non-survivors who were apparently improving clinically 
at the end of each month. Thus, at the end of the first month, of 60 
patients who were well or improving, 10 ultimately died - and these 
constituted nearly half of the fatal cases who were still alive at that time. 
The findings at the end of other months were similar. Indeed, at the end 
of the 4th month, of 11 non-survivors still alive, 5 were improving and 
1 was actually clinically recovered and symptom-free; by the next month, 
he had deteriorated. Thus, it does not appear that one csn be dogmatic in 
making a prognosis from a consideration of a patient's general response to 
treatment.
INDIVIDUAL FEATURES.
This conclusion being reached, namely that the general progress made
early/
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early in the course of treatment is no certain guide to the future, the 
question arises - are there any individual features, e.g. early settling 
of temperature or disappearance of meningeal signs or restitution of 
C.S.E. normality, which, when they occur, are favourable portents?
Tables 50 bo 89 have been constructed with a view to ascertaining this.
In the columns of non-survivors, only those (21) who lived longer than a 
month, are included. In estimating the return of any feature to normal, a 
transitory return was discounted if it was followed within a short period of 
a week or two by reappearance of abnormality; the time taken for each feature 
to settle refers to the time till normality was re-established for a period 
of several weeks or months or permanently.
(a) CLINICAL.
FEVER. (Tables 50 - 53).
The slow decline of fever has been repeatedly emphasised in the 
literature on tuberculous meningitis; for example, by Lincoln and her 
associates (1948. 1950&) w^o noted its persistence, in some cases, for 
several months, and Brainerd and Eagle (1950) who found that it usually 
persisted for over a month. Rubie and Mohun (1949) pointed out that, 
during streptomycin treatment, a varying degree of fever, loss of weight, 
anorexia, vomiting and skin rashes was to be expected, and Anderson, Eerr 
and Landsman (1953) describing treatment with isoniazid, expressed the view 
that the intrathecal streptomycin might have been responsible for the 
prolonged fever in streptomycin-treated cases. In 100 cases of miliary and 
meningeal tuberculosis reported by Bunn (1948), alleviation of fever occurred 
in both survivors and non-survivors, and he considered it to be of no 
prognostic significance. Any unexplained rise in temperature, however,
(Debre et al, 1947; liacCarthy and Mann, 1950) should arouse attention as 
possibly heralding recrudescence or relapse.
The prolonged persistence of fever in this series is evident from 
the figures presented in Table 50. Only 8 of the 66 survivors were apyrexial 
by the end of the first month (including those who had been afebrile on 
admission,/
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admission, some of whom developed fever in the course of treatment.)
At the end of 3 months, 23 patients who ultimately survived, were still 
running temperatures. Of the 12 patients whose temperature had settled 
within a month, 4 died and 2 of the survivors relapsed. It is clear, 
therefore, that early subsidence of fever did not ensure against death or 
relapse, nor was its prolonged continuance necessarily a grave omen. The 
speed of settling of temperature in survivors was not related, to a 
significant degree, to the initial temperature or the severity of illness, 
although the trend in Table does suggest that, the higher the initial 
temperature, the longer did it take to settle. The small numbers in each 
treatment regime again make it impossible to draw conclusions regarding the 
effect of treatment on the speed of settling of temperature, but there was 
no difference in this respect between the group receiving streptomycin and 
those treated with dihydrostreptomycin.
ANOREXIA. (Tables 54 ~ 56).
It is noticeable that appetite was restored comparatively speedily - 
within 2 weeks in over a fifth of survivors; within a month in over a third, 
and by the end of 2 months in considerably more than a half. This is 
particularly satisfactory in view of the association, already noted, between 
malnutrition and mortality. Provided appropriate measures are taken to tide 
patients over the periods of coma or vomiting with their consequent reduction 
in oral intake of food and fluid, the rapid recovery of appetite in patients 
doing well should maintain nutrition.
The return of appetite to normal in any given time coulci not be used
as /
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as an index of the ultimate outcome or course. Thus, of 30 patients who 
had regained appetite within a month, 6 died (2 after a relapse) and 4 of 
the survivors relapsed. As would he expected, appetite returned more slowly 
in patients in an advanced stage on admission than in those less seriously ill - 
only 2 of 14 of the former compared with 7 of 9 who were mildly ill had 
regained appetite within a month. It is noteworthy, though the numbers are 
obviously too small to warrant conclusions, that none of the 7 survivors 
treated with intrathecal streptokinase bad recovered full appetite within a 
month. Table 58 suggests that the use of dihydrostreptomycin was associated 
with delay in the return of appetite in many patients, but the differences are 
not quite significant and may have been partly due to the inclusion in the 
dihydrostreptomycin group of patients having streptokinase and tuberculin. 
HEADACHE. (Tables 57 - 59 ).
76 of the 102 patients in this series complained of headache as one 
of the manifestations of the initial illness. In 30 of these, the headache 
appeared to be severe, in 31 it was classified as "moderate" and in 15 others 
as "mild". Most of the remaining 26 patients were children who were too 
young to make specific complaints. Disappearance of headache was one of 
the first indications that the drug was having some influence on the course 
of the disease - over 50$ of the survivors were free of it within a fortnight. 
Once again, however, this finding was of no prognostic value for 5 of these 
patients later relapsed, and 2 patients who had no headache after a fortnight 
ultimately died. More patients with mild illness were free of headache at 
an early stage than those with more advanced disease. Treatment regime did 
not /
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not seem uo have any elfect on its early or late disappearance.
VOMITING. (Tables 60 - 62).
Vomiting was a feature of the initial illness in 80 patients in 
this series, and, like headache, was usually one of the first symptoms 
to disappear, one half of the survivors being free of it within a month.
5 patients who were not being sick at the end of a fortnight died and 
2 others relapsed, so early disappearance was not necessarily a good sign, 
apart from enabling nourishment to be retained by the oral route. The 
severity of the initial illness again appeared to be a factor in determining 
the stage at which patients would be free of this symptom. Treatment did 
not seem to have any effect.
CONSTIPATION. (Tables 63 ~ 65).
This symptom seemed to be more intractable than the others - at the 
end of 3 months, 24 of the 66 survivors were still constipated to a greater 
or less degree. Like the other symptoms, its early disappearance was of no 
prognostic value; nor was it apparently influenced in any way by the 
treatment given. The association with the severity of the initial illness 
was less marked, and a slight trend was not in this case significant.
MENINGISM. (Tables 66 - 69).
Early subsidence of meningeal signs was also unreliable as a prognostic 
guide; less perhaps than the other features - in two thirds of fatal cases 
who lived longer than a month, meningism was never absent - a higher proportion 
than for any other single clinical feature. The stage at which patients 
were free of meningism was not only influenced Dy the severity of trie initial 
illness (the more severe the illness, the longer to subside), but also by 
the/
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the degree of meningism already present; more marked meningism persisted 
longer. Patients treated with dihydrostreptomycin appeared to take longer 
to lose their meningism, though not significantly so. However, this was in 
all probability due to the inclusion in the dihydro streptomycin group of the 
patients who had longer intrathecal courses and those who had intrathecal 
tuberculin and streptokinase. Table 69 shows a significant difference 
between the proportion of patients given prolonged intrathecal therapy who 
had persistent meningism after 2 months and that of those given shorter 
intrathecal treatment - 20 of 27 in the former case, and 13 of 33 ^he latter. 
Even omitting from the former group the patients who also had tuberculin or 
streptokinase, the difference is still significant. Intrathecal therapy 
thus appeared to prolong the persistence of meningeal signs.
(b) CEREBBO SPINAL FLUID.
Clinical recovery from tuberculous meningitis is usually in advance 
of the restoration of C.S.P. normality. Choremis and his associates (1943) 
divided the course of cases responding favourably into 2 phases (1) the 
period of clinical improvement, lasting 4 - 5 weeks, (2) the phase of 
laboratory restitution continuing for 2 or 3 months. The fluctuations in 
the cell and protein content of the C.S.P. in the first weeks of treatment 
have been fully described by Smith and Vollum (1950). They pointed out that 
the levels of both constituents rose during this early period, but 
ultimately, in successful cases, as fluctuations ceased, the levels began 
to decline, protein lagging behind cells in this respect. These early 
changes they attributed to the effects of the liberation and accumulation of 
bacterial breakdown products in the C.S.P. It lias frequently been noted 
(e.g. M.R.C. 1948; Bubie and Mohun 1949; Brainerd and Eagle 1950;
Friedman et al, 1953) that a C.S.P. pleocytosis must be expected so long as 
intrathecal therapy is being maintained; the cell-count gradually returning 
to normal after the termination of intrathecal injections. At tne 
U.i'I.I.C.2.F. Conference reported in 1950, however, Honor Smith stated that 
the return of cells and protein to normal was possiole during intrathecal 
treatment. Buziczka (1952), and Cohen (1952) found that the sugar, cells 
and protein returned to normal in that orcier. Mac Car thy ana Mann (1950) 
reported that the sugar might be normal for 6 months or more wnile colls and 
protein/
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protein continued to fluctuate detween normal and abnormal levels,
Levinson (1949) found that in several patients the sugar had returned to 
normal within the first month, whereas the cells usually took 3 to months 
and the protein 4 to 5 months, Lincoln and Kirmse (195<4b) an& Brainerd 
and Sagle (1950) reported similar findings.
As would be anticipated, the prognostic value of C.S.P. changes 
occurring during treatment has received considerable attention. In an 
early report, however, the M.B.C. (1948) found that there were fewer factors 
of value in prognosis than would be expected. The sugar level has, in 
general, been accepted as a fairly reliable guide. Sonmer (1952) was of 
the opinion that it portrayed accurately the progress made and the morbid 
state - the level seemed to fall with progressive disease and rise as the 
disease underwent resolution, and did not fluctuate so widely as the levels 
of other constituents. A persistently low sugar was an unfavourable sign; 
if it was less than RO mg, per 100 ml., despite all other signs, he considered 
there was danger of recrudescence. A falling sugar after the institution 
of energetic treatment suggested a bad prognosis. Although the chloride 
level followed the same course as the sugar, he found it less significant 
and less reliable, while the cell and protein levels were, not comparable 
in value. In general, these findings correspond with those of most other 
writers, e.g. M.H.C. (1948), Shamaskin et al (1943)» Ruble and Mohun (1949)> 
Cathie and MacParlane (1950). borne writers, however, e.g. Debra et al (1947)
emphasised the cell-count. McSweeney (1950), for example, felt that clinical 
improvement or deterioration was more closely related to the cell-count 
than any other factor; an increase in the cells often heralding relapse.
Mac Car thy and Mann (1950) were suspicious of a cell-count fluctuating between 
10 and 20 per c.mm. Bubie and Mohun (1949) f2^  also that a rising protein 
was a bad omen suggesting extension of the disease down the theca. The 
M.B.C. (1948) placed more emphasis on a slowly rising protein as significant 
of impending relapse than on a sudden steep rise suggesting spinal block. 
Taking the C.S.P. as a whole, Choremis and his associates (1948, 1951) found 
that stabilisation of the fluid was a good prognostic sign; while it was 
at all abnormal, exacerbation was probable or even certain. Calnan and 
his co-workers (1951), however, questioned the significance of slight 
abnormalities in the C.S.P. occurring up to 2 years after treatment.
In the patients in this series also, the sugar was the first C.S.P. 
constituent to return to normal in most cases, being followed by the 
chlorides, protein and cells, usually in that order; I have already shown, 
when examining the cases who had normal initial C.S.P. sugar, that the sugar 
level in several of these patients was unreliable as 0, prognostic guide;
normal/
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normal levels were obtained in some who died immediately or shortly after, 
and low readings occurred for no apparent reason in patients who were 
progressing favourably and continued to do well. Review of the other 
patients showed that these findings were by no means isolated but were 
repeated frequently throughout the series. It is true that, in some cases, 
sudden deterioration was heralded by a fall in the C.3.F. sugar, but only 
occasionally was this a lone sign; usually it was accompanied by other 
C.S.F. changes, particularly rising cell and protein content. There were 
occasions, however, when the C.S.F. sugar was the most accurate reflection of 
the patient’s clinical condition; for example, in patients doing badly, the 
cell-count sometimes remained low while the sugar level was markedly reduced. 
As a general rule, a falling sugar level or rising cell or protein content - 
usually in combination - indicated imminent deterioration. Slight fleeting 
abnormalities, however, although rousing suspicion, were usually of no real 
significance.
In Ta.bles JO - 90, an attempt has been made to assess the significance 
of the time taken by any or all of the C.S.F. constituent to return to normal. 
The figures, taken as normal, were; Cells, 0-10 per c.mm;
Protein ; 0-40 mg. per 100 ml; Sugar ; over 45 mg. per 100 ml.;
Chlorides : over 700 mg. per 100 ml. The upper limit of normal for the
cell-count is higher than has Deen often recommended, but it was found that, 
to fix it at a lower level, e.g. 5 per c.mm. would exclude many patients who 
had made a complete recovery and who remained well.
Considering/
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Considering, first of all, the return of individual C.S.F. 
constituents to normal, the findings of Tables 70 — 83 may be summed up 
as follows:
(1) At the end of 3 months, the cell-count had been restored to normal 
in 6 patients (4  survivors), the protein content in 16 patients (all 
survivors), the sugar level in 33 patients (30 survivors) and the chlorides 
in 30 patients (all survivors). By the end of 9 months, in most patients, 
all the elements load returned to normal. At the end of a year, a higher 
number of patients (7) still had raised protein than any other abnormality.
(2) Death did not occur in any patient whose C.S.F. protein had fallen 
below 40 Per 100 ml. Be turn of the other constituents to normal, however,
occurred, even within 3 months, in both survivors and non-survivors. Early
restitution was not necessarily a favourable prognostic sign.
(3) Relapse occurred in-patients in whom the C.S.F. elements had been 
restored to normal even at an early stage.
(4) The initial protein level had a direct bearing on the time it took to 
return to normal. This finding was also noted by Mac Car thy and Mann (1950)* 
The other constituents were not similarly influenced.
(5) ho direct relationship could be proved between the severity of the 
initial illness and the rate at which any given constituent returned to normal.
(6) Significantly higher proportions of patients treated with
dihydrostreptomycin showed delayed restitution of eacn C.S.F. element, but 
this may have been due to the inclusion among these patients of those v/ho 
were given streptokinase and tuberculin; delay was sjjecially evident in 
these groups.
Since/
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Since the C.S.F. protein did not return to normal in any patient 
who subsequently died, it is clear that Tables 84 to 90 relating to the 
restoration of complete normality must apply only to survivors. Table 84 
demonstrates that over 40$ of the survivors had a normal C.S.F. at the end 
of 6 months and, 3 months later, the proportion was over 8o$£. 7 of the 11
survivors who relapsed did so after the C.S.F. had completely returned to 
normal, and, in 4 of these, normality load been reached by the end of 6 months. 
However, the fact that all the patients survived who relapsed after the 
C.S.F. was completely normal, suggests that, in these circumstances, a 
favourable outcome may be expected should relapse occur. Stabilisation 
of the C.S.F. was thus, in this series, (as with Choremis and his co-workers, 
195-) a- good prognostic sign.
The more severe the initial illness, the longer did the C.S.F. appear 
to take to return to normal - but the apparent trend was not statistically 
significant. The speed of restitution did not appear to be affected by the 
initial mental or nutritional state. Surprisingly enough, only 6 of the 23 
patients with a clear X-Hay had a normal C.S.F. at the end of 6 months, 
compared with 9 of 13 patients with "snowstorm" appearances - a statistically 
significant difference. In interpreting this apparent anomaly, it must be 
remembered that these figures relate only to survivors. A higher proportion 
of patients with miliary tuberculosis died and 2 of those who recovered were 
already under treatment for miliary tuberculosis when meningitis developed, 
and were therefore, "early" cases with slight C.o.F. changes.
SUMMARY.
Over one third of the survivors — jusi/ less tnan one—quarter of d h
the /
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the patients in this series - made a steady, rapid recovery without delays 
or interruptions* Such a course was observed in a significantly high 
proportion of patients aged 5 - 14; mildly ill, mentally bright; with mild 
meningism, or with low initial C.S.F. protein or high initial C.S.F. chlorides. 
Courses of treatment with more intrathecal injections were associated with 
delayed or interrupted recovery in a comparatively high proportion of cases.
A good initial response was not necessarily a favourable sign - 10 of the 21
fatal cases still alive at the end of the first month were well or improving 
at that state. Early disappearance or long persistence of any of the main
symptoms could neither be used as an index of the ultimate outcome - nor of
the probability of relapse. A falling C.S.F. sugar level or a rising 
cell-count or protein content was usually ominous, especially when all were 
combined, but a normal sugar level was found on several occasions in dying 
patients, and transient abnormalities of any single constituent were usually 
of no significance. Death did not occur in any patient whose C.S.F. protein 
became normal, but 7 such patients subsequently relapsed. Return to normal 
of any of the other C.S.F. constituents, even at an early stage, was no 
guarantee against either a fatal outcome or the occurrence of relapse.
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D. TEE INCIDENCE AND INFLUENCE OF SPIRAL BLOCK:.
INTRODUCTION.
In the course of treatment of tuberculous meningitis, several 
complications can arise whose development alters the prognosis for the worse 
in cases doing well and confirms an unfavourable outlook in those already 
showing a poor response to treatment. The seriousness of decerebrate 
rigidity is well-known. Smith and Vollum (1950) found it to be the only 
finding in the clinical picture or the C.S.F. which had not been seen in both 
successfully and unsuccessfully treated cases prior to the use of P.P.D. 
Previously, it had been the only indication for stopping treatment and was 
uniformly fatal in 3 to 21 days. 47 patients in a series of I46 patients 
reported by Robertson and G-airdner (I952) developed it and none recovered.
In this series, it was observed as a terminal event in only a few patients who 
were already considered to be beyond hope of recovery, and its development 
merely confirmed a hopeless prognosis.
Convulsions occurring in the course of treatment have also been 
considered to be of bad omen. Illingworth and Lorber (I95I), for example, 
reported that 17 of 23 children (in a series of 86) who developed them had 
died, and 3 others were mentally defective. Epileptiform convulsions were 
a feature of the initial illness in only 1 patient in this series - a survivor, 
but occurred during the treatment of 7 others. 4 of these recovered — one 
without sequelae; one became deaf; one was incontinent of urine for 2 or 
3 weeks after the convulsions, out thereafter made a complete recovery apart 
from/
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from a severe degree of hamstring spasm which required orthopaedic 
measures hut which cleared completely; and the other had occasional 
convulsions after recovery, requiring phenobarbitone for control. In 
addition, one other patient had periodic convulsions after recovery, 
unassociated with any return of meningitis.
Perhaps the most frequent complication which appears to adversely affect 
the prognosis is spinal block.
Lorber (1951a)» in a paper evaluating streptokinase as an adjuvant in 
the treatment of tuberculous meningitis, cited the development of obstruction 
in the circulation of C.S.P. as the most important cause of failure in the 
treatment of tuberculous meningitis, from a pathological point of view.
In another paper (1950) describing the use of penicillin as a trace substance 
in studies of the cerebrospinal circulation, he indicated several possible 
causes of this obstruction - tuberculous granulation tissue, fibrinous exudate, 
reaction to a "bloody tap", irritant effect of streptomycin and herniation 
of the brain into the foramen magnum or tentorium. Doubtless in most cases 
the initial cause of obstruction is gelatinous exudate, or clotted blood 
following the puncture of the spinal theca; later, in the absence of resolution, 
organisation takes place and the persistent block is due to the development of 
fibrous adhesions. It has been reported (Choremis et al, 1951;
Somner, 1952) that in some cases an incipient spinal block may be precipitated 
by C.S.P. pleocytosis caused by streptomycin, and a few days' rest from 
treatment may lead to its resolution. The block may occur around the 
brain-stern in the cisterna ambiens, in the cisterns at the base of the brain, 
or round the cord in the spinal subarachnoid space (Lorber, 1951a).
The development of spinal block is usually recognised by (1) fall 
in C.S.F. pressure at the lumbar region, (2) poor response of C.S.F. pressure 
to compression of the jugular veins (Quenckenstedt's sign), (3) development 
of xanthochromia, (4) rise in C.S.F. protein, usually to over 1,000 mg. per 
100 ml. (see Smith et al, 1948). Lorber (1950), however, found that these 
signs could occur in the absence of true olock and were unreliable if the 
block occurred above the cisterna magna, when the rate of flow and the 
protein content might be normal. It was for this reason that he introduced 
and described the method of injecting penicillin into the lumbar theca and 
assaying/
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assaying the penicillin content of the cisternal or ventricular fluid 
5 or 10 minutes later. In general, however, the signs given above are taken 
as evidence of the presence of spinal block, and further investigations 
were not carried out in this series.
The frequency with which obstruction to the flow of C.S.F. develops 
in tuberculous meningitis varies considerably from series to series.
The M.H.C. (1948) reported its occurrence in 20 (21.7$) of 90 patients;
Smith, Vo H u m  and Cairns (1948) i*1 4 (25$) of 16 patients; Brainerd and 
Eagle (1950) in 2 (7.4$) of 27 patients; Russell and Mac Arthur (1950) in
8 (24.2$) of 33 children; Cairns, Smith and Vollum (I950) in one-third of 93
patients (either partial or complete); Illingworth and Lorber (1951) in 
20 (24.4$) of 82 children; Lincoln and Wilking (1951) in 4 (10.3$) of 
39 children; Ravreby and his associates (1952) in 6 (15$) of 40 patients;
Somner (1952) in 11 (42.3$) of 26 patients; and Riley in 8 (13.3$) of 
60 patients. Wasz-Hockert (1951) found 20 "high blocks" and 17 "low blocks"
in 60 patients - a proportion as high as 61.7$. McSweeney (1950), on the
other hand, in treating 94 patients, found no instances of spinal block.
Repeated efforts have been made to devise some means of preventing the 
development of spinal block and of clearing it when developed. Streptokinase 
was introduced primarily for this purpose, and Cathie and MacFarlane (1950) 
reported considerable success as a result of using this adjuvant, claiming 
that, while it did not dissolve established blocks, it did prevent their 
development. Lorber (1951a) however, disputed this finding. In 2 comparable 
series, each of 12 cases, 5 patients in the group receiving streptokinase 
developed block (a proportion much higher than he had previously observed), 
compared with only 1 in the group in which streptokinase was not used. In a 
subsequent paper (1954a), Lorber advocated less prolonged intrathecal therapy 
and found that, with a reduced course, only 2 of 38 children (5»3$) developed 
block, compared with 24.4$ previously. The use of intrathecal heparin 
in prophylaxis of spinal block was reported by the Department of Health for 
Scotland in 1949, but there was no evidence of benefit and this treatment was 
abandoned in view of the difficulty of obtaining a suitable mixture with 
streptomycin.
In a proportion of cases, spinal block resolves spontaneously.
This occurred, for example, in 4 of the 20 cases reported by the M.R.C. in 
I948 - 2 of these subsequently died, and 2 were making satisfactory progress; 
in a further case, resolution appeared to be taking place. In the early days, 
cessation of intrathecal therapy was recommended when block developed, as it 
was thought to aggravate the obstruction. Some form of intrathecal 
streptomycin, however, was necessary to maintain C.S.F. levels, and so 
administration by other routes — cisternal or ventricular — was attempted 
with apparent success. Thus, Illingworth and Lorber (1951) reported tnat, 
while death occurred in all their first five cases of spinal block, in whom 
intrathecal/
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intrathecal therapy was abandoned, 8 of the last 1R cases, treated hy 
cisternal injections, survived. Somner (1952) found that the only drawback 
to cisternal punctures was the occurrence of haemorrhage, causing severe 
headache, backache and pains round the trunk. Cairns and Taylor (1949) 
strongly advocated the use of ventricular streptomycin through cranial 
burr—holes, and pointed out that it was useless and dangerous to inject 
streptomycin by the lumbar route after spinal obstruction had developed. In
6 cases reported by Debre and his associates (1947)* operations were performed 
to relieve the obstruction and were successful in 2 ; spinal block was found 
to be caused by a tuberculoma in 1 case and leptomeningitis in the other 5» 
This type of treatment has not, however, been used in many centres and has 
obvious difficulties and disadvantages.
m q m c Y  and phognqstic value.
Obstruction to the cerebrospinal circulation occurred in 22 (21.6jfa) 
of the 102 patients in this series, and was recognised by the criteria 
enumerated above, together with the finding, in the 16 patients in whom 
cisternal punctures were done, of gross difference between fluid obtained at 
cisternal and lumbar punctures. In most cases, the first indication of 
developing block was a rising lumbar C.3.F. protein level. The seriousness 
of a protein over 500 mg. per 100 ml. occurring in the course of treatment 
is indicated in Table 91, which shows the maximum protein levels recorded 
during treatment. The proportion of recoveries was significantly less 
among patients whose C.S.?. rose over 500 mg. per 100 ml. at any stage —
45-8$ compared with 70*5$*
All but 2 of the patients whose C.S.F. protein rose above 500 mg. per 
100 ml. were considered to have spinal olock and showed other evidences of 
its presence. The other 2 patients did not show these features and in them 
the rise in protein was transient, lasting only a day or two (in one case, 
after a streptokinase injection). Both survived, and it is probable that
they had a partial, fleeting obstruction. Of the 22 patients who had 
complete/
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complete and lasting spinal block, 13 (58.7$) died, compared with only 
23 (28.75$) o f the remaining 80 patients who did not develop block 
(Table 9^)» i.e. the mortality rate in cases of spinal block was more than 
double that in the remainder of the series. To put this another way, 
nearly 3 times as high a proportion of non-survivors as of survivors 
developed spinal block. This difference assumes added significance when it 
is remembered that many patients who died did so early in the illness and it 
is conceivable that had they survived longer, some at least may have 
developed block.
TIME OF ONSET. (TABLE 93).
In 2 patients, the obstruction was already present at the time of 
diagnosis, and half of the cases of block had become evident by the end of 
the first month. The mortality rate was particularly high in these 
11 patients, 8 of them dying. Incipient spinal block was probably present 
in 2 of these - the C.3.E. protein being 260 and 460 mg, per 100 ml. on 
admission, and the flow of C.S.E. rapidly becoming sluggish; both survived. 
It is noteworthy that there were no survivors among 7 patients who did not 
have complete or incipient spinal block on admission and who developed 
block within a month. 2 other patients (survivors) developed spinal block 
during the second month, 4 (who died) in the third month, and 1 (who died) in 
the fourth month. In the remaining 4 patients, spinal block occurred in 
the course of a relapse, and all survived.
In only 1 case - a child of over 1 year - did the obstruction recur
after being relieved; in this patient there were 3 recurrences of the block 
before he ultimately died.
TREATMENT./
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TREATMENT.
Intrathecal therapy was discontinued when block developed in 3 cases 
treated early in the series. Later, streptomycin was administered by the 
cisternal route as often as possible and, simultaneously, by the lumbar route 
in the belief that it was essential to combat the infection which had obviously 
extended down the spinal theca» The usual routine adopted was that the 
normal intrathecal dose was divided, one half or three-quarters being given 
by the cisternal route and the remainder in the lumbar region. (In no case 
were cranial burr-holes made and ventricular streptomycin given; no 
patient showed evidence of blockage above the level of the cisterna magna.) 
Treatment was otherwise continued exactly as if no block had occurred. On 
occasions, however, when the spinal block developed after the first few weeks 
of intrathecal therapy, a further intensive intrathecal course (cisternal 
and lumbar) was given, usually lasting 2 weeks. 15 patients in all received 
cisternal intrathecal therapy and 7 survived. Cisternal puncture was 
performed unsuccessfully in one other patient who died, and terminally in 
another.
DURATION.
The duration of spinal block varied, in survivors, from 6 weeks to 
1“2 years as follows; 6 weeks, S-g months, 5 months, 6 months (2 cases),
9 months and 18 months in cases who had cisternal treatment, and 5 months 
in the other 2. Cisternal treatment did not itself affect the course of the 
block but its purpose wasto maintain adequate concentrations of streptomycin 
in the C.S.E. - not to influence the actual oostruction. In 11 of the 13 
patients/
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patients who died, spinal block persisted until death - that is, for 
periods of 1 day, 8 days, 2 weeks (3 cases), 17 days, 3 weeks, 1 month,
6 weeics, 3 months, 4sjT months. In the other 2 patients, it subsided during 
life. In one, already referred to, it lasted for a month but recurred on 
3 subsequent occasions, subsiding in 6 weeks and 1 month in the first 2 of 
these, the last occasion being terminally. The obstruction cleared after 
5 months in the other patient, who, however, relapsed later and died without 
developing further blockage.
FACTORS INFLUENCING- DEVELOPMENT OF BLOCK.
The worsened prognosis in patients developing spinal block may 
conceivably be due to one, or both, of 2 factors;
(a) the mechanical effects of the obstruction,
(b) the incidence of block in cases with more severe and extensive disease.
In other words, spinal block and higher mortality may be related as
cause and effect, or as being both effects from a common cause. Tables 
94 to 98 have been constructed to find out if the higher mortality is due 
to the fact that spinal block occurred more often in patients who, because 
of their age, severity of their initial illness, etc. would have been 
expected, in any case, to do badly. In assessing the significance of 
each factor, I have compared the proportion of patients in any given group 
with the corresponding proportion of those who did not develop spinal 
block — obtained by comparison with earlier tables. Since spinal olock 
did not occur significantly more often in younger age groups, in severely 
ill or stuporose and comatose patients, or in patients with miliary or adult 
pulmonary tuberculosis, it would appear that the higher mortality in 
patients/
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patients with spinal block was due to the mechanical effect of the 
obstruction. The tables reveal the following interesting findings
(1) Spinal block developed in a significantly higher proportion of 
patients aged 10—19, and only in 3 o f 25 patients under 5 years who might 
have been expected to be more liable to it in view of their increased 
mortality rate and narrower spinal columns.
(2) Although the figures are not significant, a comparatively high
proportion of stuporose and comatose patients developed spinal block - 
41.2'fb compared with 11 .4$ in other groups.
(3) The significantly high incidence of spinal block in patients whose 
initial C.S.F. protein was between 200 and 500 mg. per 100 ml. is worthy of 
note. More than half of the patients in this group developed block.
It is conceivable that, in some cases at any rate, a C.S.F. protein of 
over 200 mg. per 100 ml. is evidence of partial or incipient obstruction 
to the cerebrospinal circulation. It is interesting that Lorber (1950) 
suggested that a C.S.F. protein of over 300 mg. per ml. arising in the
course of treatment, was an indication for carrying out further investigations
to test the patency of the cerebrospinal canal.
EFFECT OF PRECEDING TREATMENT.
Lorber‘s findings (1951a, 1954a) that prolonged intrathecal therapy 
and the use of intrathecal streptokinase were associated with higher 
incidence of spinal block, have already been referred to. It is unlikely 
that the former factor played a part in this series, since the most 
intensive/
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intensive intrathecal regime used was less intensive than Lorber*s 
shorter course. A study of Table 99, however, reveals that both 
streptokinase and tuberculin, far from preventing block, almost certainly 
played a part in its development. In drawing any conclusions from this 
table, it is obviously necessary to exclude from assessment the 2 patients 
who had obstruction before treatment was commenced (whom I have bracketed 
in the table); one in Group D who died within 17 days during which C.S.F. 
protein steadily rose from 1,520 mg. per 100 ml. on admission to 3,600 mg. 
per 100 ml,; and one in Group F, who recovered but had persistent spinal 
block for 6 months (the C.S.F, protein reaching 5i600 P©r 100 ml. after 
months). Moreover, the 3 patients in Group B and 1 survivor in Group A 
developed spinal block during treatment of a relapse. In 1 of the former, 
streptokinase, and in another, tuberculin, were being used in the treatment 
of the relapse at the time of onset of block. These 2 must therefore be 
added to the patients in Groups C and E who received streptokinase and 
tuberculin respectively, making a total of 6 and 7 patients in these groups 
who developed spinal block. In view of these high figures, I have 
analysed these groups of patients more carefully.
Streptokinase. Two of the patients in this group had developed spinal 
block early in treatment before streptokinase was given, so that altogether 
4 patients developed block while under streptokinase treatment and 2 of these 
died. Table 135 shows that 14 patients received streptokinase either as an 
initial treatment or for treatment of relapse; 3 o f these already had 
spinal block when streptokinase was commenced; 4 (3^*4^) of the remaining 11 
developed/
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developed block during streptokinase therapy. It may reasonably be 
concluded that streptokinase did not prevent spinal block and may well have 
contributed to its development.
One of the 4 patients who developed spinal block while having 
streptokinase did so at the end of 6 weeks of treatment at a time when 
streptokinase was routinely withdrawn from the course. He did not have any 
further streptokinase; he eventually recovered, the spinal block persisting 
for 5 months. In the other 3 patients, and also in 3 who had developed 
cerebrospinal obstruction prior to the use of streptokinase, streptokinase 
was administered from the onset of spinal block but did not appear to 
influence the block. The block persisted for 2-^  months, 5 months and 1 year 
in 3 who survived; and until death in 8 days, 3 weeks, and 5 weeks in the 
other 3* I't seemed, therefore, that streptokinase was of no value either 
in the prophylaxis or treatment of spinal block.
P.P.P. It seems more than suggestive that 2 of every 3 patients treated 
initially with P.P.P. developed spinal block and that all the fatal cases in 
this group had this complication. Altogether 7 (58»3#) o f the ^  patients - 
see Table 35 - who received P.P.P. in the course of treatment, developed spinal 
block, and it is probable that this was the main factor in the high mortality 
in these patients.
Excluding the 2 patients who already had spinal block on admission,
9 (11.7$) of 77 patients who neither had streptokinase nor tuberculin, 
developed block, compared with 4 (3^*4/®) o f 11 who dad streptokinase and 
7 (58.3$) of 12 who had P.P.P. These differences are very highly 
significant/
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significant * 16.19, n ■ 1 , p « less than 0 .001) and there seems no
doubt therefore that tuberculin, and, to a lesser extent, streptokinase, 
at least contributed to the development of spinal block.
SUMMARY.
Spinal block occurred in 21.6fo of patients in this series and was 
associated with a significantly higher mortality rate. The complication 
did not occur significantly more often in patients who were severely ill 
or in whom, for other reasons, a higher mortality was to be expected. The 
incidence was significantly greater in patients with initial C.S.F. protein 
over 200 mg. per 100 ml. and it is suggested that these may have had incipient 
block at the time of diagnosis. The use of P.P.D. and, to a lesser extent, 
streptokinase, was associated with a significant increase in the incidence of 
block, and neither was of any value in relieving it.
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E. THE INCIDENCE AM) INFLUENCE OF RELAPSE.
INTRODUCTION.
The possibility of relapse occurring even after apparently complete 
recovery must make the physician constantly guarded in making a prognosis 
in any given patient. One of the greatest disappointments in medicine must 
be to see a patient, who, after being critically ill with tuberculous 
meningitis, had recovered and was discharged home, returning to hospital with 
fresh evidence of meningitis, with the prospects of yet 6 months more of 
painful treatment and lingering doubt about the ultimate outcome. Yet, 
such must have been the repeated experience of most, if not all, physicians 
concerned in the treatment of this dreaded disease.
The possibility and the danger of reactivation of tuberculous foci 
in other sites - e.g. the lungs - are well-known, and it is, therefore not 
surprising that tuberculous meningitis should also be liable to flare up 
after apparently successful treatment. Various causes have been suggested, 
any or all of which may play a part in the occurrence of relapse. The 
development of streptomycin resistance must always be borne in mind in 
patients who, having at first responded to treatment, begin to deteriorate, 
but it is widely recognised that tubercle bacilli very seldom become 
resistant during the treatment of tuberculous meningitis. The M.R.C. (1948) 
reported the results of tests on. 22 patients several weeks after the 
commencement of treatment; in 19, the organisms were as sensitive as at the 
beginning. The fact that a high proportion of cases of relapse respond 
well to a second, or even third, course of streptomycin, indicates that 
bacterial/
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bacterial resistance must not be a major factor in the occurrence of relapse.
In many cases, relapses are almost certainly due to the breakdown of 
persistent foci of infection inaccessible to streptomycin, as suggested by 
the M.R.C. (1948)* In this report, the frequent autopsy finding of 
obstruction at the base of the brain and internal hydrocephalus led to the 
suggestions that relapse was often due to mechanical obstruction subsequent 
to organisation of tuberculous exudate, and that the number of late relapses 
would be considerably reduced if this were prevented. Levinson and his 
co-workers (1950) found that cases of relapse that came to autopsy usually
had some unhealed caseous focus, e.g. a lymph-node, and they felt that
relapse may frequently be caused by a second haematogenous dissemination of
tubercle bacilli. Other cases, they considered, were due to rupture of
encapsulated caseous foci in the meninges. The importance of vascular 
involvement and endarteritis with consequent cerebral softening was stressed 
in a leading article in the Lancet in 1949* The high relapse rate in 
patients with residual neurological signs and therefore, with areas of 
cerebral softening, was noted and the need for early treatment before 
vascular damage occurred was emphasised.
The frequency with which relapse is reported varies considerably in 
different series, but one of the reasons for this is the lack of uniformity 
in the nomenclature used. A strictly accurate terminology was suggested 
and used by MacCarthy and Mann (1950)» limited the term "relapse1 to the 
occurrence of fresh symptoms and signs in patients perfectly well and with 
normal or nearly normal C.S.F., and used the term "recrudescence" when 
deterioration occurred soon after treatment in a patient otherwise well but 
with abnormal C.S.F. Relapse occurred in 4 &n(3- recrudescence in 8 of 43 cases, 
a total of 27.9$» Illingworth and Lorber (1952-) using the same terminology, 
reported 3 "relapses" and 5 "recrudescences" in 82 children ( a total of 9*8$). 
Cathie and MacFarlane (1950) had 1 "relapse" and 5 "recrudescences" in a 
series of 60 cases (lO^)t and Robertson and Gairdner (I952) 1 "relapse" and 11 
"recrudescences" in a series of 146 (8.2^). On the other hand, the m.R.C. 
report/
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report (194$) used the term "relapse" to include not only return of 
symptoms in any patient who had completed treatment, but also deterioration 
in patients who had been progressing favourably for at least a month but 
were still having treatment; in none of the 17 cases reported had the C.S.F. 
returned to normal. The majority of writers steer a course midway between 
these 2 extremes and apply the term "relapse" (as it is used in this thesis) 
to all cases who show a return of the meningitis illness after the completion 
of treatment, whether the C.S.F. has been previously normal or not.
Indeed, the Ministry of Health (1953) reported no clearly proven case of
relapse occurring (in a series of 37^ patients) after the C.S.F. had been
normal. Most writers, however, have found, with Calnan and his
associates (1951) that relapse may occur after full recovery and return of
C.S.F. to normal - they had 3 cases of relapse in a series of 54 patients 
(5»6$&). In 1948, Choremis and his co-workers reported no relapses in 
21 (of 5 0) cases of tuberculous meningitis who were cured and discharged, 
and observed over a period of a year, but in 1951* & series of 132 cases,
they found 20 (15.2$) relapses in 87 patients who had been discharged.
Other figures, culled from the literature are as followsj Lincoln and 
hirmse (1950a) 3 iu 1$ cases (16.7$)* Flori (1950), only 1 relapse in 152 
recoveries in a series of 265 cases; Brainerd and Eagle (1950) 3 ln 2? cases 
(11.1$); McSweeney (195°)* 6 in 94 cases (6.1/1); Lassen and Neukirch (1951) 
5 in 44 cases (11.4$); Ravreby et al (1952), 3 in 40 cases (7*5$)5 
Perry (1952 ), 5 in 2b cases (19.2$); Russell and MacArthur (1953) 9 33
children (27*3$); Riley (1953) 17 in 60 cases (28.3$). The proportions in 
different reported series must, of course, vary with the proportions who 
survived the initial course of treatment and the length of the period of 
observation.
Little has been written about the type of patient, if any, who may 
be especially prone to relapse. Choremis and his associates (1951) found 
that the incidence of relapse was independent of age. Illingworth and 
Lorber (1951) noted that all but 1 of 8 relapses and recrudescences (out of 
82 children) occurred in cases with miliary tuberculosis, but Calnan and 
his co-workers (I95I) found no evidence to suggest that cases with miliary 
tuberculosis were more liable to relapse. Persistent C.S.F. abnormality 
is widely recognised as being the precursor of relapse in many cases.
Thus, Robertson and Gairdner (1952) stated that "until C.S.F. normality has 
been achieved, the outlook remains uncertain and relapse is an ever-present 
danger". MacCarthy and Mann (1950) pointed out the seriousness of a 
low C.S.F. sugar at the end of a coiirse of treatment and found it a 
precursor, if not a sign, of deterioration. On the other hand, Calnan and
his associates (1951) found occasional slight abnormalities in the C.S.F. 
up to 2 years after cessation of all treatment, unaccompanied by other 
evidences of activity, and were unable to assess their significance. They 
could find no precipitating cause for relapse.
Relapses/
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Relapses usually occur within a short period of discontinuing 
streptomycin treatment. Choremis and his associates (1951) mentioned 
the first 3 months as the most dangerous period, and the second 3 months 
as less "dangerous. Later, the danger was minimal. In MacCarthy and Mann's 
series (1950)» all the recrudescences occurred within the first 3 months 
after treatment (5 within a month); the relapses took place after intervals 
of 3, 4, 4g- and 15 months. The 17 relapses in Riley's series (1953) s^ -  
occurred within a few weeks to a few months of stopping streptomycin. In 
the 5 cases described by Lassen and Heukirch (1951)* relapses occurred 
8 days to 3 months after the completion of treatment. Bunn (1950®-)* 
however, reported that fatal relapse can occur as much as 2 years after 
treatment is stopped, and Russell and MacArthur reported 1 case who 
relapsed after 3i years of good health, and died 6 weeks later.
The features of a relapse resemble, to a greater or less degree, those 
of the initial illness. Its occurrence may be detected either by clinical 
changes or abnormalities in the C.S.F. The M.R.C. report (1948) described 
the following features indicating impending relapse; vomiting (the most 
frequent symptom), drowsiness, irritability, character changes, apathy, 
increasing C.S.F. lymphocyte count and falling sugar. In all 4 cases of 
relapse and 7 of 8 cases of recrudescence described by MacCarthy and 
Mann (1950)» the diagnosis was first suggested by the clinical picture and 
subsequently confirmed by C.S.F. findings; the sugar level, however, 
remained normal in 3 of them. The main clinical features in both relapses 
and recrudescences were headache, vomiting, fever and loss of weight. Loss 
of bladder control occurred in 2 recrudescences and, in 1 patient who had 
2 recrudescences, gross papilloedema was noted both times. Meningism was 
an inconstant feature in both groups. In the report of the Department of 
Health for Scotland on 8l cases in 1949* it wa® also concluded that the 
clinical appearance was the best guide to the diagnosis of relapse. In the 
7 relapses reported by Levinson (1949) the diagnosis was also made on 
clinical grounds - irritability, vomiting and lethargy. Meningism was 
absent or mild, 4 were afebrile, and the C.S.F. sugar was normal. He 
concluded that relapse was due to encephalitis rather than meningitis. 
Choremis and his associates (1951) found papilloedema among the first 
clinical signs.
On the other hand, Lincoln and Kirmse (1949) found that C.S.F. changes 
occurred before clinical evidence of relapse in all 3 of their relapsing 
cases; and Lincoln and Wilking (195^) asserted that recrudescence or 
relapse could only be diagnosed early by frequent lumbar puncture.
Spangberg and Granath (1952) reported that in their 2 cases, relapse was 
first manifested by sudden rise in the C.S.F. cell-count.
In/
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In the early days of streptomycin, it was considered that the onset 
of relapse made the outlook very bleak indeed. The possibility of 
recovering twice from an infection, one attack of which carried a high 
mortality, seemed rather remote, especially in view of the probability 
of bacterial resistance to streptomycin developing. The fact that the 
latter does not occur nearly as frequently as was feared is no doubt 
largely responsible for a statement like this being possible: "The gloomy
prognosis we gave at the time these setbacks were encountered have not been 
fulfilled.1 (MacCarthy and Mann, 1950). If diagnosis is made and 
treatment instituted early, the outlook in many cases appears to be favourable. 
Choremis and his associates (195^) reported that the clinical and laboratory 
evolution of relapse was "usually regular" and the prognosis better than for 
the original illness. The 3 cases of relapse reported by Calnan and his 
associates (1951) all recovered. On the other hand, 6 of the children who 
relapsed in Russell and MacArthur's series (1953) died, and 2 others were 
disabled. Two of the 3 cases of relapse reported, by Ravreby and his 
associates (1952) had died and the other was in very poor condition, and, 
in Robertson and G&irdner’s series (I952), 7 of the 11 patients who had 
recrudescences died and 1 with true relapse was alive and well.
FREQffBNCY.
In this thesis, the term "relapse" is applied to all patients who 
had completed an initial course of treatment and required a further course 
because of recurrence of symptoms or deterioration of the C.S.F. Some had 
shown complete clinical and C.S.F. recovery; others had recovered clinically 
but still had abnormal C.S.F.; still others had persistent symptoms at the 
end of the first course, and subsequent deterioration rendered another 
course of treatment necessary; in one or two cases, the courses of treatment 
were almost continuous, it being evident within a few days or weeks that 
all was not well.
16 (15• 7/^ ) o f the 102 patients in the series relapsed; 2 of these 
relapsed twice and 1 relapsed 3 times but ultimately recovered (Table 100).
In all, therefore, 20 relapses occurred. The proportion of relapses is, 
of course, increased by the inclusion of the 6 patients vrho were initially
treated/
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treated with an inadequate course of streptomycin lasting jjjr months and 
were therefore, on account of this, predisposed to relapse. All of these 
subsequently received a complete course of treatment lasting 6 months, and 
1 relapsed again. It is evident that, in making any assessment of the 
incidence of relapse, the other 5 should he omitted. Thus, of a total of 
97 patients who received 6 months' treatment, 11 (11*3$) relapsed. In 
addition to the patients who relapsed after completion of treatment,
8 patients who developed fresh symptoms or intensification of symptoms 
already present, or showed sudden increase in C.S.F. abnormalities, or 
deteriorated in other ways during the course of treatment^were given fresh 
intrathecal therapy or more intensive intramuscular treatment. These I have 
classified as having developed "exacerbations". One of the 8 patients 
developed 3 such exacerbations before ultimately succumbing.
FACTORS imUENOIKG RELAPSE.
In endeavouring to assess what factors, if any, played a part in the 
development of relapse in some patients and not in others, it is necessary 
to exclude (a) patients who had an inadequate course of treatment at the 
beginning and who, therefore, regardless of all other factors, were almost 
certain to relapse, and (b) patients who died within 6 months and who 
therefore did not live long enough for relapse to occur. Tables 101-119 
are based on the remaining 66 patients in this series who lived longer than 
6 months and were given an initial 6 months' course of treatment. 10 of 
these patients relapsed, with 3 deaths, and 2 of the remaining 56 patients, 
who did not relapse, died (these were included in the group having 
"exacerbations"). Dogmatic assertions on the basis of such small numbers are 
obviously/
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obviously unwarranted, especially since this is virtually a selected series 
and excludes, in particular, a high proportion of fatal cases.
(a) Findings on admission. (Tables 101 - 115)• 3 factors appeared to be
related significantly to the incidence of relapse in this series
(i) Duration of illness (Table 103). Of the 10 patients who 
relapsed, 8 were admitted in the first week of illness, compared with 
less than half of patients who did not relapse. This surprising finding 
can no doubt be explained, at least in part, by the difficulty in 
accurately estimating the length of the initial illness.
(ii) Initial C.S.F. Cell-Count (Table 112). f  of the 10 patients
who relapsed had an initial cell-count under 200 per c.mm. compared with 
only two-S9venths of the others. This finding is in keeping with the 
hypothesis previously suggested that a low C.S.F. cell-count is an index 
of poor tissue response. Such patients had a high mortality and a high 
relapse rate.
(iii) Initial C.S.F. Protein (Table 115)» The incidence of relapse 
was significantly lower in patients with initial C.S.F. protein
100 - 200 mg. per 100 ml. There is no obvious explanation for this 
finding.
Other interesting but not significant findings were:
(iv) Age (Table 101) Half of the 10 patients who relapsed were aged
5 to 9 .
(v ) Severity of illness (Table 102) A trend is evident suggesting 
increasing relapse-rate with increasing severity.
(vi)/
-  113 -
(vi) Nutrition (Table 1Q4)» Half of the 10 relapses occurred in 
patients who were poorly nourished.
(vii) Mental State (Table 107). None of the 10 relapsing patients 
were mentally bright on admission.
(viii)Choroidal Tubercles (Table lo8 ). A relatively higher proportion
of patients with choroidal tubercles relapsed.
(ix) Ohest X-Ray (Table 109) Half of the 10 relapses were in patients 
with either miliary tuberculosis or adult phthisis. In the group of
66 patients, one quarter of the patients with miliary mottling and 
one-half of those with adult tuberculosis, relapsed. This is not 
unexpected, since both of these types of patients have extra-meningeal 
foci from which a second haematogenous dissemination could occur (as 
suggested by Levinson et al, 1950)*
(b) Initial Response (Tables 116 - 119)• No relationship can be proved 
between the speed at which the clinical picture and the C.S.F. 
constituents were restored to normal, and the incidence of relapse.
It did not appear to be possible in this series to judge the probability 
of relapse from the response to initial treatment.
(c) Initial Treatment Regime (Table 135)* Apart from treatment 3 which 
was inadequate, the treatment regime did not appear to have any bearing 
on the incidence of relapse. The 10 patients who relapsed after a
6 months' treatment, were fairly evenly distributed amongst the other 
6 treatment groups, but, of course, the numbers are quite insufficient
to enable conclusions to be drawn.
TIME OF ONSET./
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TIME OF ONSET.
All the relapses occurred within 1 year of the completion of the 
previous course of treatment. 10 of the 16 patients relapsed within 
3 months of terminating the initial course, and 2 of the further relapses 
took place within the same period after the end of the previous course.
In 2 patients, the initial course of treatment had just been completed when 
the clinical condition deteriorated and it became obvious that a further 
complete course of treatment was necessary; the interval in another patient 
was less than 2 weeks. It was difficult to decide whether to classify 
these, and one or two others as "exacerbations" or "relapses", but, since 
they had completed the primary course and had improved, they were included 
among the "relapses". Two patients relapsed 8 months and one 1 year after 
the end of the previous course. Since relapses took place both in 
survivors and non-survivors up to 8 months after the initial course, it 
does not appear that the length of time elapsing before the development of 
a relapse is necessarily any indication of the ultimate outcome.
Eleven of the 16 patients had been completely symptom-free following 
completion of the first course and prior to the onset of relapse (Table 121). 
Complete symptomatic recovery had also occurred before 3 further relapses. 
Thus, 14 of the 20 relapses occurred in patients who were asymptomatic 
and clinically well - confirming what has already been emphasised, namely 
that disappearance of symptoms, even at an early date, is no guarantee 
against the possibility of relapse. The other 6 relapses took place in 
patients who had improved but had one or more residual symptoms (as did 
other patients who did not relapse), suggesting that complete healing had not 
occurred/
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occurred - 3 o f these were in patients who had an initial 3"§‘ months1 
course of treatment. One of the 2 survivors who relapsed twice had been 
completely asymptomatic before each relapse occurred; and the patient who 
had 3 relapses before death had also made a complete clinical recovery 
before the second and third relapses.
It is noteworthy (Table 122) that 7 of the l6 patients who relapsed 
had a completely normal C.S.F* prior to the onset of relapse, and that all 
of these survived. One patient relapsed a second time after having twice 
been restored to complete clinical and C.S.F. normality. In most of these 
patients, while the upper limit of 10 per c.mm. was accepted as normal, 
the cell-count had in fact fallen below 5 p©? c.mm. In 5 survivors, none 
of the C.S.F. elements had returned to normal before the onset of relapse;
4 of these, following treatment, had a completely normal C.S.F., but the 
other relapsed again and required a third course of treatment before 
normality was restored. As has already been seen, the C.S.F. did not 
return to normal in any of the fatal cases in this series. In one of the 
4 patients who relapsed before death, none of the C.S.F. constituents 
became normal after the first course, but the sugar-level was normal after 
the first relapse and both sugar and chlorides after the second. In the 
other 3 , the cell-count became normal in 1, the sugar in 2, and the 
chlorides in 3* A normal protein level was never restored in patients 
who ultimately died.
FEATURES OF THE RELAPSE ILLNESS.
Patients who recover from tuberculous meningitis (or, in the case of 
children/
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children, their relatives - if sufficiently interested!) are usually 
quick to recognise the symptoms of meningitis should they recur. On 
discharge from hospital, all patients (and relatives and practitioners) were 
warned of the possibility of relapse, and encouraged to return as soon as 
any suggestive symptoms presented themselves. Consequently, it is not 
surprising to discover from Tables 123 - 133 that in general, the relapse 
illness was shorter than the original one and its features less marked.
All the 20 relapses were taken into consideration in constructing these 
tables. The duration of the illness indicating the development of 
relapse was significantly less than that of the initial illness (Table 123). 
Thus, in nearly one-half of all the relapses, treatment was commenced 
within 3 days of the onset of symptoms (compared with just over 1 in 20 in 
the case of the initial illness) and only 1 patient had symptoms for longer 
than a week (compared with over one-half, in the case of the initial illness).
Symptomatic upset was the first indication of relapse in most cases. 
Only 2, indeed, were symptom-free when treatment was commenced, clinical 
deterioration being preceded by C.S.F. deterioration in these. In other 
2 patients, the relapse illness was little more than an exacerbation of the 
original illness occurring after discontinuation of treatment, the patients 
not having fully recovered. The prominent symptom (Table 124) in this 
series, as in reported series already referred to, was vomiting, which 
occurred in 14 of the 20 relapses (seven-ninths of those with clinical upset). 
Drowsiness, anorexia, and, to a lesser extent, headache, were the other 
main features. In a boy of 14* the onset of relapse was heralded by 
hysterical/
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hysterical attacks occurring at nights, the patient (still in hospital) 
sitting up in bed staring strangely, not recognising any of the staff 
and calling for "daddy". After a few minutes he was able to answer 
questions, but subsequently was incontinent of urine and faeces.
Incontinence of urine was the presenting feature in another patient, a man 
of 3 5* who bad been well for 8 months apart from some mental instability. 
Irritability was a prominent feature in 2 patients.
Comparing the relapse illness with the original illness - Tables 125 
to 133 - the main differences were: the relapse illness was less severe,
meningeal signs less marked, and temperature lower than initially. Hone 
of the patients was comatose when treatment of the relapse was commenced, 
but the proportions of "bright", "drowsy" and "stuporose" patients closely 
paralleled those for the original illness. The C.S.F. cell-count tended to 
be lower - not significantly so - but a significantly higher proportion of 
high protein levels were obtained in the relapse illness.
TREATMENT OF RELAPSE.
The development of symptoms or signs pointing to the occurrence of 
relapse was the signal in all cases for the immediate resumption of 
intensive treatment. Battle was once again joined with the invading organisms 
which had now on more than one occasion brought their victims to the verge 
of death. Thus began another uphill struggle - in three patients for the 
third time, and in one, the fourth - which was to entail just as long a 
period of suffering, in the form of intramuscular and intrathecal injections,
as had the first; indeed in some cases - those in Group B - this period was 
almost/
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almost twice as long as the first. In all cases, a complete 6 months' 
course of intramuscular treatment, with appropriate intrathecal therapy, 
was administered. The planned attack on the invader was neither mitigated 
nor intensified because this was the second (or third, or fourth) time the 
battle was waged. Not in every case, however, was the same course embarked 
upon as at the beginning. in some cases, new weapons, in the form of 
streptokinase or tuberculin, were introduced into the attack; in others 
the same weapons - streptomycin and P.A.S. - were relied upon but the plan 
of campaign was altered. The treatment course now adopted was the one 
"in vogue", in routine use, at the time when the relapse occurred, and in most 
cases, this differed from the course initially given. Table 134 indicates 
the treatment given to the 16 patients who relapsed, and Table I35 is a 
comprehensive table incorporating the figures in Table 34 - the initial 
treatment given to all cases - and those in Table 134» which includes only 
those who relapsed. The mortality rates in Column V differ somewhat from 
those given in Table 34* I33- the latter, the mortality rate applied to
patients who were given each course as their initial treatment (some of whom 
may have recovered, but later relapsed and died while having another course); 
in this table, only the deaths occurring while the treatment in question was 
in progress are recorded. Any deductions already made about the value of 
each treatment regime are unaffected by the slight differences between 
Tables 34 and 135. The mortality rate per course varied from 50$ in 
Treatment E (using dihydrostreptomycin and P.P.D.) to C$ in Treatment G 
(using streptomycin with reduced intrathecal therapy). The relapse-rate 
per course (column VI) is seen to vary little from one treatment to another, 
with/
with the exception, of course, of Treatment B which had 100$ relapse rate.
PROGNOSIS.
When confronted with a patient, who, having survived one attack of 
tuberculous meningitis at the cost of 6 months of arduous treatment, is once 
again the victim of attack by the same enemy, one might well ask if it is 
worthwhile waging war again against the invader and subjecting the patient 
once more to the rigours of 6 months of frequent injections. To what 
purpose? Fortunately, inasmuch as this series can give it, the answer is 
a favourable one; for the results correspond with those of MacCarthy and 
Mann who found them at least as good as for the treatment of the initial 
illness - and that despite the damage that may have already been done to the 
brain and spinal cord and their covering membranes; in spite, too, of the 
possible development of bacterial resistance in a few cases. Table 100 
shows that 75$ of patients who relapsed survived, compared with 62.8$ 
of 86 who did not relapse. Of 11 patients who relapsed after 6 months' 
treatment, 7 survived (63.6$)* Thus there is still a very reasonable
prospect of recovery even after relapse has occurred - just as reasonable
as there is at the outset of treatment.
PROGRESS MADE IN RESPONSE TO TREATMENT.
Since patients usually come under treatment at an earlier stage when 
they relapse than when they are first diagnosed, it is to be expected that 
the response to treatment would be correspondingly speedier and uninterrupted.
That this is not so is seen from Table 136 which shows that only 2 of the 16
relapses/
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relapses successfully treated "went according to plan1,' i.e. without 
delays or interruptions. This proportion is significantly low when 
compared with the proportion responding satisfactorily to the initial treatment. 
No doubt factors already mentioned were partly responsible for this - namely, 
damage previously done, and developing resistance of organisms which had 
acquired fresh defences against the drug attack; it was not without a 
harder struggle that the invaders surrendered what might be their final 
opportunity to destroy their victim. Despite this, it is seen from 
Tables 137 ~ 142 that the temperature settled more quickly and headache 
tended to disappear sooner in the relapses than initially. Appetite, 
however, seemed to return more slowly, and other features showed no marked 
differences. Laboratory restitution, as described by Choremis and his 
associates (1951)» Was "regular".
SUMMARY.
Relapses - recurrence of symptoms, or deterioration, after treatment 
was completed - occurred in 16 of the 102 patients in this series; two of 
these had 2 relapses and one had 3 t making a total of 20 relapses in 16 
patients. Since only 4 of these died, the prognosis was not materially 
different from that for the initial illness. Strangely enough, patients 
admitted in the first week of the original illness and those with initial 
C.S.F. cell-count less than 200 per c.mm. seemed more prone to relapse than 
others. Relapses were almost invariable when an initial course of 
3vr months was given, but the incidence was uniform in patients treated 
initially with different 6 -month courses. Twelve of the 20 relapses 
occurred/
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occurred within 3 months of completing the previous course of treatment, 
and no patient relapsed more than 1 year after the completion of treatment. 
Eleven of the patients who relapsed had been completely fit clinically, 
and 7 bad a completely normal C.S.F. before relapse occurred. The others 
had all improved but had one or more residual symptoms and some degree of 
C.S.F* abnormality. No patient with a completely normal C.S.F. died. 
Relapses were usually detected on clinical grounds in the first place, 
vomiting being the most frequent symptom. C.S.F. changes occurred later, 
but in 2 cases, C.S.F. abnormalities occurred before symptoms developed.
The relapse illness was of shorter duration and less severe, with features, 
in general, less marked than the initial illness. Treatment was by 
intensive intramuscular and intrathecal streptomycin, the regime being 
identical with that for patients admitted for the first time with 
tuberculous meningitis. Although the ultimate outcome was favourable 
in most cases, response to treatment tended to be delayed and interrupted.
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E. THE INCIDENCE OF SEQUELAE, ESPECIALLY DEAFNESS.
INTRODUCTION.
No study of tuberculous meningitis would be complete which did not 
take into consideration the residual mental and physical disorders from 
which, unfortunately, a proportion of survivors suffer. In examining 
prognostic factors, one must be concerned with not only the quantity but 
also the quality of results, and so must endeavour to assess what factors, if 
any, are particularly associated with the incidence of sequelae and, on the 
other hand, what prospects any given patient may have of complete recovery 
without after-effects.
It would have been surprising if a disease such as tuberculous 
meningitis, affecting, as it does, the central nervous system, and causing 
prolonged incapacity, did not leave in its wake, in many cases, severe 
physical and especially mental handicap. That such defects should occur in 
a comparatively small proportion of patients is a cause for satisfaction. 
Nevertheless, many survivors do have a heavy price to pay, in the incapacity 
with which they are subsequently burdened, for the recovery they make.
The first case reported to have been given intrathecal streptomycin by 
Cooke, Dunphy and Blake (1946) was a child who ultimately became mentally 
retarded and probably deaf. Since then, an increasing number of sequelae 
have been reported. The mental disorders that may follow vary from mild 
irritability - which may be the result of a combination of factors apart 
from the disease process, e.g. prolonged stay in hospital away from 
parental care and home influence - to grave mental deficiency. Various 
neurological/
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neurological sequelae may occur - e.g. palsies of different kinds up to 
complete hemiplegia; convulsions; visual upsets up to total “blindness; 
and, of course, deafness. Physical disabilities as varied as stiffness 
and contractures of legs, obesity, and bone and joint complications, have 
also been reported.
In a. comprehensive review of 549 cases (247 survivors) from 5 different 
hospitals in England, observed for a minimum of 2-§ years, Lorber (1954c) 
reported that 157 (64$ s u r v i v o r s )  had no after-effects at all, and that 
the incidence of sequelae was related to the severity of the original illness. 
75$ of early cases who survived had no sequelae, compared with 60$ of 
intermediate cases and 40$ of advanced cases. A proportion of survivors, 
varying from 5$ in patients with early disease to 20% in those with 
advanced disease, developed "moderate neurological sequelae" - hemiparesis, 
visual defects short of blindness, occasional fits, moderate degrees of 
mental and behaviour disorders. "Severe neurological disorders" - grave 
mental defect, often with blindness, deafness, and hemiplegia; severe 
behaviour disorders; complete hemiplegia; cauda equina syndrome - 
occurred in 10.5/^ of all survivors (4$ of early cases, 8.75k of intermediate 
cases and 35*5$ °£ advanced cases). 35 patients we re vegetating and 
were considered failures. He concluded that delayed diagnosis not only 
prejudiced the chances of survival but also made the chances of complete 
recovery remote. Patients with early disease had a 5 times better chance 
of complete or useful recovery than those with advanced disease.
In other reported series, there is a marked variation in the 
frequency with which sequelae developed. In a Ministry of Health report 
(1-953) on 102 survivors of 371 cases, 1 patient was blind, 1 had spastic 
paralysis of legs, 1 suffered from intermittent epileptiform attacks 
and a fourth from attacks of amnesia, dizziness and black-out. Choremis 
and his associates (1951) reporting a series of I32 cases, found that 
4 developed hemiplegia either at the onset or early in the course of the 
disease; the patients recovered but the hemiplegia persisted although 
improving. A large, proportion of children developed obesity of regular 
distribution, associated with a low 33.M.R. and sometimes accompanied by 
increased C.S.P. protein. Illingworth and Lorber (1951) classified the 
34 survivors of their series of 82 cases into 3 grades; (1) 22 who were 
mentally and physically normal, (2) 4 who were mentally normal but had some 
physical defect, and (3) 8 who were mentally retarded, with or without 
some physical defect. They pointed out that, when considering the 
patient*s condition after treatment, account must be taken of the previous 
intelligence and behaviour, and also of the effect of a long illness, of 
missing school and maternal love, and of the attitude of parents when the 
child returns home. In a subsequent paper, Lorber (1954a) reported that
755s/
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75$ survivors (in a series of 38» ^8 of whom survived) were free from 
any defect, compared with bl$ previously. 18$ had some physical disability 
and 1% grave mental sequelae. Rusicska (195^) noted that in his series of 
114 children (6l surviving), changes of behaviour occurred in children already 
difficult to handle before the onset of disease - lengthened reaction time, 
difficulty in establishing contact, apathy, need for sleep - all tended to 
disappear. Hypertrichosis occurred on the face, back and extremities in 
several children but disappeared after a few months. 3 children developed 
spasticity with extensor and adductor spasms, which improved before discharge 
and disappeared later. The majority showed no severe psychological or 
neurological symptoms, nor any decrease in intelligence. Visual 
disturbances up to blindness occurred in 10 children, 5 whom died. In 
Galnan's series (1951) of 114 cases (53 survivors), retarded development 
occurred in 6 children under 3 » hemiplegia in 2 , hemiplegia and homonymous 
hemianopia in 2 , blindness in 1 and mental defects in 2. Of 14 survivors, 
out of43 children treated by MacCarthy and Mann (1950)» 2 were mentally 
retarded (1 an idiot). On the other hand, l6 of 30 survivors treated by 
Havreby and his associates (1952) were disabled; mental retardation 
occurred in 11 (thought to be due to reparative processes; in 3 there was 
associated hydrocephalus); motor disturbances in one or more extremities 
in 4; blindness in 4 (3 bilateral), and speech disorders in 2. Only 9 
of 12 survivors reported by Russell and MacArthur (1953) were well (and 1 
of these was mentally backward and 1 of low intelligence); the other 3 were 
mentally defective, one with hemiplegia and frequent epileptic fits; one 
with hemiplegia, epileptic fits, sexual precocity and intracranial 
calcification; and one blind with epileptic fits.
In view of the relatively high incidence of serious sequelae reported 
from other centres, the results in this series gave grounds for satisfaction. 
Only 1 of the 66 survivors was mentally defective (Case 39)* He was an 
orphan child of 2 years admitted from a "reception centre", and his previous 
mental state was not accurately known; it seemed to be suspect to say the 
least. The child was admitted seriously ill, and comatose with a 
left-sided hemiplegia, which, however, receded during treatment. One other 
child of 6 (Case 44) was mentally backward and unstable, being very easily 
provoked to violent anger; the parents, however, when questioned, did not
admit/
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admit to having noticed much change in their son, so it is probable he 
was mentally backward before his illness. Two other patients (Cases 4 6, 56) 
were irritable and quick-tempered after the illness, but the prolonged spell 
in hospital may well have been sufficient to account for this in patients who 
may have previously been emotionally somewhat unstable. One of these (56) 
who relapsed twice was irritable after the first and second courses of 
treatment, but returned to normal after the third. In one patient 
(Case 89), hemiplegia was present from the beginning and persisted but 
improved; he was also in an advanced stage and was stuporose when treatment 
was instituted. Apart from the hemiplegia, he made a complete recovery and, 
following orthopaedic treatment given in another hospital, was able to walk 
reasonably well and had relatively little functional disability. Three 
other patients bad orthopaedic treatment in the same unit, after the course 
of streptomycin therapy was completed. One of these (Case 3 0) developed 
tuberculous infection of a knee-joint - the only case in this series of 
subsequent extrameningeal haematogenoi-is dissemination. The other 2 
(Cases 43, 93) developed marked contracture of the legs, resulting from 
long-persisting muscle spasm. Rive others had marked hamstring spasm and 
leg stiffness but did not develop contractures, and in response to further 
physiotherapy (a routine measure in all cases), the spasm gradually relaxed 
leaving no permanent disability. Two patients (Cases 9, 35) both aged 17 
on admission, were perfectly normal mentally and physically, apart from 
intermittent epileptic convulsions. The former gave a history of convulsions
at/
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at the age of 7 ; he was seriously ill on admission, drowsy, hut not in 
stupor or coma. The latter, who had no previous history of convulsions,
was moderately ill, mentally bright, hut with unilateral external rectus 
palsy; convulsions became sufficiently frequent in this case to consult a 
neurologist, who, however, found no underlying neurological abnormalities and 
prescribed pheno-barbitone; after this, the fits did not recur. One other 
patient (Case 67), while not developing convulsions, did have occasional 
dizziness and noticed an inability to concentrate when he was given 
responsible duties; he was helped by reassurance. Apart from deafness, 
the only other sequelae were obesity in 3 patients; foot-drop in 1 (Case 2 9) - 
responding to physiotherapy; and marked ataxia in 1 (Case 62). It is quite 
clear that with such small figures, it would be impossible to draw deductions 
about factors which may have played a part in the development of any of 
these sequelae.
During the years 1950 ^95^» the satisfaction of saving the lives
of a high proportion of patients who, but a few years previously, would 
certainly have succumbed to tuberculous meningitis, began to be tempered with 
apprehension and misgiving because an alarming number of patients who survived ■ 
as well as many of those who died - did so at the expense of their hearing.
In all too few of these, the impairment of deafness was slight; in most, 
it amounted to total or subtotal deafness, unrelieved by hearing aids and 
so constituting a most serious handicap. Tuition in lip-reading enabled many 
to enter to some extent into conversation but this was a very poor and 
inadequate substitute for normal hearing. It quickly became evident that the 
main/
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main weapon being used to combat the disease was itself responsible for 
the deafness; in other words, the auditory damage was not due to the 
disease process but was a toxic manifestation of the drug used - 
dihydrostreptomycin; a preparation that had been introduced because it was 
believed to have less neurotoxicity.
Even before the days of dihydrostreptomycin, however, deafness was 
a recognised complication of tuberculous meningitis whether untreated or 
treated with streptomycin. One of the earliest patients to be treated - 
by Vignec: (referred to by Lincoln et al, 1948) - became deaf while under 
treatment, and died after several months. As far back as 1947* DebrS and 
his associates had 15 cases of deafness in a series of 118 and were of the 
opinion that the number might really be higher were deafness not difficult 
or impossible to detect in unconscious patients. In the same year,
McDermott, in a review of the toxic effects of streptomycin, reported 7 out 
of 100 cases (not all with meningitis) who developed 50$ to 100$ deafness;
5 of these had prolonged intramuscular and intrathecal streptomycin for 
tuberculous meningitis and the other 2 had renal insufficiency. He 
suggested that the main actiological factor was overdosage (in those 
early days, intramuscular doses of up to 5 §• were not uncommon, and 
intrathecal doses of 0 .2 - 0 .4  g. were occasionally given), and that the 
drug caused a liquefaction necrosis in the cochlear nucleus. Deafness was 
sometimes preceded by low-pitched tinnitus. Considerable recovery took 
place in some cases. Barrington and his associates (1947) also considered 
overdosage to be the cause of deafness in 2 of l6 cases of tuberculous 
meningitis treated by them with 3 €• o f streptomycin intramuscularly and 
0 .1  g. intrathecally daily for 120 days, and in 3 o f Ip patients treated 
subsequently, 2 of 'whom had tuberculous meningitis and 1 impaired renal 
function. Seven of 100 cases of miliary and/or meningeal tuberculosis 
(40 of whom survived) reported by Bunn (1948),had significant hearing loss, 
and 4 others had a lesser degree of impairment. Three who became completely 
deaf during treatment, failed to regain hearing; some degree of restoration 
occurred in the remaining 8 , 6 being no longer deaf for conversational range 
of tones. By audiometric examination, hearing loss could be detected within 
the first month of therapy but it was not clinically evident till after 
60 days. In the writer's opinion, the deafness was probably due to the 
meningitis, as the hearing loss in both ears was unequal and as impairment 
occurred in 28$ of cases of meningitis but only in 1.2$ of other types of 
tuberculous disease treated with streptomycin in similar doses. Smith and 
his associates (I94S) audiometric tests on survivors who were old enough 
for the tests and found that all showed moderate high-tone deafness by the 
conclusion of treatment; one other patient developed a severe global deafness 
in the 4th month of treatment. Cairns and Taylor (1949) also found high-tone 
deafness/
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deafness in all of their 48 cases, occurring as early as the 11th day, 
and 6 had more serious deafness.
It was not, however, until the introduction of dihydrostreptomycin 
that the frequency of deafness assumed a magnitude that gave cause for alarm. 
Paradoxically, dihydrostreptomycin was the result of a search for a remedy 
less toxic than streptomycin, and Edison and his associates (1948) wrote of 
it that Hthe neurotoxic action has been reduced without sacrificing the 
antimicrobial efficiency”. Early reports of its use were favourable.
Hobson and his co-workers (1948) concluded that, while it might cause damage 
to the auditory apparatus, it was not more toxic in this respect than 
streptomycin and in all probability less so (although 3 patients became deaf 
out of 12 who were treated with 3 to 5 &• °f dihydrostreptomycin daily for up 
to 11 weeks). Hinshaw and his associates (1948) also found that it was much 
less toxic than streptomycin when given in comparable doses for similar periods. 
Further experience, however, failed to confirm these early reports.
Allison et al (1949) found audiometric loss in 7 of 20 patients treated with 
2 or 3 g. dihydrostreptomycin daily for 90 days, and Eomansky et al (1949) 
reported deafness in 14 of 6l patients who had the same dosage. O ’Connor 
et al (1952-) using a daily dose of approximately 20 mg. streptomycin per kgm. 
body weight, found that streptomycin had little toxic effect on the auditory 
mechanism, no hearing loss developing in their cases. Using dihydrostreptomycin, 
which was much less toxic to the labyrinth than streptomycin, they found that 
16 of 21 patients given a 6 months’ course had significant auditory impairment,
2 being totally deaf. They expressed the view that the hearing-loss 
caused by dihydrostreptomycin was generally much more disturbing than the 
loss of labyrinthine function - which could be satisfactorily compensated - 
associated with the use of streptomycin. Mouriquand et al (1952) were 
also of the opinion that deafness in the course of treatment of tuberculous 
meningitis was due to the treatment and not the disease. While deafness 
from streptomycin was rare and only occurred following the use of large 
intrathecal doses, total bilateral deafness from dihydrostreptomycin was 
common, developing 4 to 14 months after the beginning of treatment.
Biagi (1951) reiDortsd 4 cases of gross deafness among 8 recovered cases of 
tuberculous meningitis treated with dihydrostreptomycin, compared with none 
among 14 recoveries following streptomycin therapy. Grant (I95I) found 
deafness in 10 of 15 survivors (out of 23 cases) treated with 
dihydrostreptomycin and no deafness in 2 survivors (out of 9 cases) treated 
with streptomycin. Cathie and Garrow (1951) were not only disappointed with 
the incidence of deafness but also with the poor survival rate in 
dihydrostreptomycin-treated cases; they had only 3 survivors (2 of whom 
were deaf) out of 14 treated with dihydrostreptomycin, compared with 
22 survivors (with no deafness) out of 40 cases treated with streptomycin.
Sher (1951) found 3 cases of deafness in lb survivors treated with 
streptomycin but as many as 7 31 survivors treated with dihydrostreptomycin.
Somner (1952) reported deafness in 7 of 8 survivors treated with 
dihydro streptomycin, but only 1 of 6 survivors treated with streptomycin was 
slightly/
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slightly deaf in one ear, and the deafness did not increase despite 
continued treatment. Of the 7 cases of deafness with dihydrostreptomycin,
3 had been treated entirely with this drug and were totally deaf; 4 were 
treated partly with the calcium chloride complex of streptomycin and 1 of 
these was totally deaf, while the other 3 showed varying degrees of deafness. 
Ruziczka (1952) encountered no deafness while using streptomycin, but 
8 of 13 cases receiving dihydro streptomycin became deaf after 5 to 6 months.
I have previously rejjorted (1952) on 77 patients in this series. Of 26 
patients treated with streptomycin, only 1 had become slightly deaf, but 
20 of 53. patients treated with dihydrostreptomycin developed hearing loss, 
these forming more than half of the patients who survived longer than 
3 months, i.e. sufficiently long for deafness to occur.
‘With few exceptions - e.g. Riley (3-953) who found deafness in 4 of 3-5 
patients (26$) receiving dihydrostreptomycin and 9 o f 45 (20$) treated with 
streptomycin - the evidence from reported series of cases points overwhelmingly 
to dihydrostreptomycin being the cause of the increased incidence of deafness 
in patients treated with it during the years 1949 to 1953-. The subject was 
discussed in detail at the Royal Society of Medicine and reported in its 
Proceedings in 1952. Robson and Goulding stated that the degree of damage 
was related to the dosage level and suggested that 1 g. daily could be given 
without serious damage in the absence of impaired renal function. Ormerod, 
however, felt that, while 3 d* daily caused deafness in a number of patients 
and vertigo in most, 2 g. caused no deafness, but vertigo in two thirds; 
and 1 g. caused vertigo in one third. Dihydrostreptomycin very often caused
perceptive deafness which might appear late in the course of treatment or 
after its completion and was irreversible (see also Somner, 1952). He too 
felt it to be a much more serious disability than the vestibular damage 
caused by streptomycin, which was ameliorated or disappeared as a result of 
compensatory adaptation. The lesion he considered to be probably not in 
the eighth nerve but in the end organs. Whetnal and Lucas found extensive 
tuberculous infiltration in the sheath of the eighth nerve and slight changes 
in the cochlea and suggested that the deafness was due to the meningitis and 
not the drug. Walker described the deafness in 30 patients in the series 
of 93 cases; in 17$ it was subtotal. 65$ of the patients treated with 
dihydrostreptomycin had severe deafness. The critical time for deafness to 
occur was the or 6th month; in a few, it developed as early as the 3r& 
month or as late as the 15th month. He stressed the importance of detecting
the hearing loss as early as possible with a view to commencing auditory 
training and lip-reading.
The importance of dosage of dihydrostreptomycin in the causation of 
deafness was stressed by Johnston (1951) who concluded that deafness could be 
avoided by administering only 1 g. of dihydrostreptomycin every 12 hours to 
adults, provided renal function was normal. He quoted Hinshaw (1951) as 
saying, “there is at present no convincing evidence that either streptomycin 
or dihydrostreptomycin is more toxic to the auditory function of the eighth 
nerve than is the other drug." This conclusion does not accord with other 
views/
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views already referred to. Calnan (1951) did find, however, that deafness 
was more frequent since the prolongation of streptomycin treatment, 
especially intrathecally, and was of the opinion that the majority of deaf 
children would not have survived if the period of treatment had been 
appreciably shorter - no patient who became deaf had subsequently died.
This was probably due, however, to death occurring before hearing loss 
became evident.
INCIDENCE.
Varying degrees of hearing loss (detected on clinical grounds and 
not by audiometric tests which were carried out in a few to confirm the 
clinical findings) occurred in 32 (31.4$) of the 102 patients in this series 
(Table 147)• Four of these subsequently died and 28 survived. 42*4$ of 
the survivors became deaf, most of them to a marked degree. When 
streptomycin therapy was commenced in this series, it was realised that 
complications such as deafness (and blindness) might be expected to develop 
as part of the disease process, but it was felt that, if these were not 
very frequent, the price paid for life and health in the majority of 
survivors would not be too high. The formidable proportion of cases who 
did become deaf, however, was disappointing in the extreme, the more so 
because of the high hopes that had been established as a result of the very 
favourable early experience of treatment of the disease. Of the first 26 
patients, only 1 survivor had developed any hearing loss, and that of mild 
degree, and only after a second course of treatment given for relapse. 
Thereafter, streptomycin was replaced by dihydrostreptomycin, the intrathecal 
therapy was intensified and intrathecal adjuvants were introduced into the 
treatment regimes, these changes coinciding with a steep increase in the 
incidence of deafness in patients so treated. Hearing was impaired, however, 
in just as high a proportion of patients who were not given streptokinase or 
P.P.D./
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P.P.D. as of those who were, and deafness continued to occur when the 
intrathecal course was reduced in regime F (Table 148). The only 
satisfactory explanation seemed to be that dihydro streptomycin was the 
main, if not the only, aetiological factor. Of 66 patients who received 
dihydro streptomycin in the course of treatment (B - F), 65$ survived, and 
45$ became deaf, in most cases markedly so, compared with 64$ survivors in 
36 patients treated with streptomycin, only 2 of whom developed mild hearing 
loss. All the patients in Group B, while initially treated with streptomycin, 
relapsed and were subsequently given dihydrostreptomycin. One of these, 
however, had 2 relapses, the first of these being treated with another 3i 
months' course of streptomycin, and the second with a 6 months' course of 
dihydrostreptomycin. On careful review of this patient's illness, it was 
found that deafness had in fact developed during the first relapse, i.e. 
before the use of dihydrostreptomycin. In Table 149> therefore, this 
patient is included among the 37 patients who did not receive 
dihydrostreptomycin and is one of the 3 whose deafness could not be 
attributed to its use. It is clear that in this series, contrary to the 
findings of Cathie and Garrow (I95I), quoted above, the survival rate was 
not affected by the change to dihydro streptomycin. There is no doubt, 
however, from the highly significant difference between the two groups, 
that the latter drug was responsible for the sharp rise in the incidence of 
deafness in patients treated with it. In Table 150, the incidence of 
deafness is presented in relation to the treatment regime actually being 
given or completed when hearing became impaired. While this more accurately 
apportions/
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apportions the cases with deafness to their appropriate treatment groups, 
it does not substantially affect the proportions in each group except that
most of the cases of deafness in patients treated initially with treatment B
are now allocated to other groups. The figures in Group E are particularly 
affected; 6 of the cases of severe deafness were treated with P.P.D. when 
deafness occurred (50$ of the 12 in this group) compared with only 12 in
groups C, D and F (20$ of 6o patients in these groups) - the difference is not,
however, significant.
The adult dose of 2 g. dihydrostreptomycin per day was not exceeded 
in any patient in this series. This was regarded as a safe dose by 
Carr et al (1950)» Johnston (1952) and Ormerod (1952), but other writers 
(e.g. Glorig, 1950; Robson and Goulding, 1952) recommended a maximum dose of 
lg. daily. It was not considered justifiable to investigate the toxicity of 
this smaller intramuscular dosage in this series. Having continued to use 
dihydrostreptomycin, and reduced the intrathecal regime without apparent 
effect, one was rather loath to expose more patients to the risk of deafness 
and so decided to abandon dihydrostreptomycin and revert entirely to 
streptomycin. Don and Gregory (1952), however, did report a series of 
26 cases (none with miliary or meningeal tuberculosis) treated with lg. of 
dihydrostreptomycin per day, 4 o f whom showed auditory impairment - 1 severe 
and 1 moderate. In the present series, even the most intensive intrathecal 
therapy was less intense than that used in most other centres; yet the 
incidence of deafness was not less, nor was it reduced when the shorter
intrathecal/
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intrathecal course was used. It is seen from Table 150 that $2 prolonged 
courses were given (Groups C - E) and 19 cases of deafness occurred 
(36.5$) - including 14 (26.9$) cases of total or subtotal deafness;
20 shorter courses were used (Group D), and 10 patients became deaf (50$),
4 (20$) with serious deafness.
ONSET.
Impairment of hearing was not observed early in treatment, during 
the period of intensive therapy, when it might be expected to occur, but 
later, when intrathecal therapy, apart from weekly injections, had been 
completed, and usually when the intramuscular course was being tapered off.
In 8 cases, indeed (Table 152), it was detected after all treatment was 
stopped. In only 1 patient (Table 151) was deafness observed within 3 months 
of instituting treatment, occurring late in the 3ra month. The average time 
of onset was during the 6th month of treatment. Eight cases occurred in 
the course of treatment of a relapse. Deafness was usually preceded by 
buzzing or ringing in the ears, lasting a week or so. At first mild, the 
hearing loss rapidly increased, reaching its maximum severity in a week or two. 
In no patient observed in this series was it reversible. It would seem that 
dihydrostreptomycin has a delayed neurotoxic effect; by the time deafness 
was detected, it was already too late to modify its course by reducing or 
discontinuing treatment; in most cases, indeed, this was routinely being done.
Since impairment of hearing was not detected before the end of the 
third month, it is clear that patients who died within 3 months had not lived 
sufficiently long to develop it. Ead they survived, the incidence of deafness 
might/
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might well have been higher. In this series, 15 of the 65 patients who 
were treated with dihydro streptomycin died within 3 months, so only 50 lived 
sufficiently long for its neurotoxic effect to become evident (Table 153)•
58$ of these became deaf, nearly two-thirds being seriously handicapped.
59*5$ of the 42 survivors were found to be deaf, three-fifths of these 
severely so.
FACTORS INFLUENCING THE INCIDENCE OF DEAFNESS.
Very little seems to have been written about the types of patients, 
if any, who may be particularly susceptible to the neurotoxic effect of 
dihydrostreptomycin and therefore predisposed to develop deafness. Only a 
proportion of patients given the same regime of treatment became deaf; why 
should they and not the others be affected? In my previous communication (1952) 
I was unable to relate the develojjment of hearing loss to the stage of disease 
and degree of illness when treatment began, the X-Ray appearances, nor other 
factors that had been considered. Lorber also (1954c) could find no 
correlation between the stage of disease on admission and the incidence of 
deafness in the series of 549 cases, of whom 36 became deaf.
Tables 154 ~ 3-30 have been compiled in a further endeavour to 
discover, from this complete series, any pre-disposing factors concerned in 
the development of deafness. In making the assessments, I have taken into 
account only the 50 patients, already detailed, who were treated with 
dihydrostreptomycin and lived sufficiently long for deafness to be observed.
The inclusion of patients who died within 3 months among the “not deaf" cases 
would obviously vitiate the conclusions since over half of these would probably 
have /
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have had hearing loss had they survived. 29 of these 50 patients were 
deaf (13 with moderate, subtotal or total impairment) and 21 were not deaf.
Any significant difference between these 2 groups may have a bearing on the 
aetiology of deafness in dihydrostreptomycin-treated patients.
A* features of the Initial Illness (Tables 1^4 - 168). The following 
significant findings seem worthy of note:
Age - (Table 154): While the incidence of deafness in other age-groups
is fairly uniform, its absence in children under 5 years is of significance. 
It is, of course, possible that minor degrees of deafness were overlooked 
particularly in very young children, and, indeed, in at least one patient 
it was difficult to exclude hearing loss with certainty; nevertheless, 
no patient in this group was seriously handicapped.
Nutritional State (Table 1 5 8 )1 The significantly high incidence of 
deafness in well nourished patients - 80$ compared with 4 8.6$ of others - 
and the trend suggesting a direct relationship between the state of 
nutrition and the development of deafness, are surprising and difficult 
to understand. Possibly the exclusion, from this study, of 15 patients 
who died early in the illness may have affected these figures, as these 
almost certainly included a high proportion of poorly nourished patients, 
who may have become deaf had they lived longer.
Meningeal Signs (Table l6p): Absence of meningeal signs on admission
was associated with diminished risk of deafness - 0 of 6 such patients 
becoming deaf; but in the other groups, there was a decreasing incidence 
of deafness with increasing meningism.
Temperature/
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Temperature (Table l6l) : A significantly higher proportion of
patients with temperatures over 100°3T became deaf, - two-thirds, compared 
with only two-fifths of those with lower temperatures. Moreover, five- 
sevenths of the former group developed serious hearing loss compared with 
three-oighths of the latter.
E.S.R. (Table 164) : Rather surprisingly, two-thirds of 30 patients
with E.S.R, less than 20 became deaf compared with one-third of 12 patients 
with E.S.R, over 20. While this difference is not significant, the 
high incidence of deafness in patients with initial E.S.R. of 10 - 20 is. 
(12 of 15).
C.S.3T, Cell-Oount (Table 165) : Another surprising finding was the
significantly lower frequency of deafness in patients with fewer than 
200 cells per c.mrn. in the initial C.S.E. - in view of the higher mortality 
rate among such patients.
The incidence of deafness did not appear to be related to the sex 
■of.the patient, the duration of severity of the initial illness, the 
initial mental state, the presence of choroidal tubercles, the X-Ray 
appearances or the levels of other C.S.E. constituents on admission. 
Response to Ti-eatment (Tables 169 - l8o). The occurrence of deafness 
was not associated with any particular pattern of response to treatment; 
patients who made a steady rapid recovery being just as prone to develop 
it as those in whom recovery was delayed or interrupted. Symptomatic 
improvement occurred, on the whole, just as quickly in patients who 
became deaf as in those who didn't, although pyrexia, meningism and 
constipation/
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constipation tended to persist longer in the former. The significant 
finding that none of 7 patients who, at the end of a fortnight, had no 
meningeal signs, became deaf is doubtless closely connected with the 
absence of deafness in 6 patients who had no initial meningism.
Although normal C.S.P. protein and chloride levels were restored at an 
early stage in rather fewer patients who became deaf, there was no 
significant difference in the speed of restitution of C.S.P. constituents. 
A noteworthy feature, however, was the significantly high incidence of 
deafness in patients in whom higher C.S.P. protein levels were recorded 
during treatment and in those who developed spinal block. A high 
maximum C.S.P. protein seemed to be associated with increased risk of 
deafness.
SUMMARY.
32 of the 102 patients in this series became deaf, and 28 of these 
are still alive. In 17 the deafness was total or subtotal, in 2 it was 
moderate, and in 13, mild. The earliest date of onset was late in the 
3rd month of treatment; the average time, in the 6th month. In 8 cases, 
treatment had already been completed when deafness was detected, and in 
other 8 it was observed during treatment of relapse. Dihydrostreptomycin 
was being or had been used in all but 3 of the cases, and there seems no 
doubt that it was the main aetiological factor. Of the patients who 
received dihydrostreptomycin, three-fifths of survivors developed detectable 
hearing loss as well as half of those who died but lived long enough for 
deafness to develop; in three-fifths of all these the auditory impairment 
was/
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was moderate to total. There was no evidence that the dosage of the drug 
was an important factor; certainly, reduction in intrathecal therapy was 
not associated with diminished incidence of deafness. Ho patients under 
5 years of age became deaf, nor did any who had no meningism on admission.
The frequency with which deafness occurred was significantly higher in 
patients who were well nourished, or who had a higher initial temperature 
or an E.S.R. between 10 and 20 mm. in the first hour, or a C.S.P* cell-count 
over 200 per c.mm: but it did not appear to be affected by the duration or
severity of the initial illness. Satisfactory response to treatment - 
with clinical and C.S.P. recovery - was observed in just as high a proportion 
of patients who became deaf as of those who did not. A high C.S.P. protein 
level in the course of treatment, however, was more often seen in patients 
who developed some degree of hearing loss.
SUMMARY AND COUCLUSIOES.
Prom a study of 102 cases of tuberculous meningitis admitted to 
Ayrshire Central Hospital, Irvine, and Belvidere Hospital, Glasgow, between 
June, 1948, and December, 195^» endeavour has been made to analyse the 
factors that may have had a bearing on the ultimate outcome, expressed in 
terms of both quantity and quality of survivors. The patients were all 
treated with streptomycin, with or without adjuvants, in the pre-isoniazid 
era. Diagnosis was confirmed bacteriologically in 82/> of the cases and was 
not in doubt in any of the others. 66 (64*7/^ ) the patients survived for 
a minimum of 5 years.
In order to determine the inter-relation of all the factors that have 
been taken into consideration and ascertain the individual effects of each 
on the ultimate outcome and on the incidence of complications and sequelae, 
it is clear that a much vaster experience would be required than can be gained 
by one person - for example, an investigation of the dimensions of the trials 
conducted by the Medical Research Council using many centres. In a 
comparatively small series such as this, in which the figures tabulated were 
obtained in the experience of one person, the results may admittedly be 
vitiated by the interplay of different factors. An attempt has, however, 
been made to assess the major factors, and the following are the main 
conclusions reached. The study was divided into six sections.
A. Pactors prior to the institution of treatment. Prognosis was 
significantly better in patients (a) between the ages of 3 and 30 years,
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(b) with less advanced disease, (c) fully conscious, (d) well nourished,
(e) without radiological evidence of miliary or adult pulmonary tuberculosis,
(f) with high initial C.S.P. cell count and chloride content.
B. Treatment Regime: 7 different regimes of treatment were employed.
All patients were given intramuscular and intrathecal streptomycin (or 
dihydro streptomycin), and in all hut 6 the duration of the initial course 
of treatment was not less than 6 months. Allowing for the limited numbers
in each treatment group, it seemed justifiable to make the following deductions 
from the results; (a) less than 6 months’ treatment was inadequate;
(b) prolonged intrathecal therapy did not have any special advantage over 
shorter courses; (c) the use of dihydrostreptomycin was not associated 
with a significantly higher mortality rate compared with streptomycin;
(d) neither streptokinase nor P.P.D. enhanced the results; the latter, 
indeed, seemed to be detrimental.
C. Type of response to treatment; A good initial response was not 
necessarily an indication of a favourable outcome. 'Nor could an accurate 
prognosis be made on the basis of early disappearance or long persistence
of any or all of the main symptoms or signs. The C.S.P. sugar level was not 
found to have the same prognostic significance as other observers have 
attached to it. The C.S.P. protein level seemed of greater value in the 
assessment of prognosis than that of any other C.S.P. constituent; no 
patient died whose C.S.F. protein became normal - but 7 such patients relapsed.
D./
D. Incidence and influence of spinal block; A significantly higher 
mortality was noted in the 22 (21.6^) patients who developed obstruction 
to the flow of C.S.P. It seemed likely that patients with initial C.S.P. 
protein over 200 mg. per 100 ml. may have had incipient block as a 
significantly high proportion of such patients developed it. Neither 
streptokinase nor P.P.D. proved to be of any value in relieving the 
obstruction; indeed it appeared that both, especially the latter, may have 
been responsible for its development in some cases.
E. Incidence and influence of relapse; 20 relapses occurred in 16
patients who had completed a previous course of treatment; 1 of these 
patients succumbed after 3 relapses. The incidence of relapse did not 
appear to be related to the initial treatment regime provided this was of
6 months' duration, but a very high proportion of patients relapsed after an 
initial course lasting 3lT months. All relapses occurred within 1 year, and 
most within 3 months, of the completion of the previous course of treatment.
Most were detected by the recurrence of symptoms and signs and confirmed by
C.S.P. findings. A full course of treatment was instituted as soon as 
relapse was diagnosed, and the prognosis proved to be as good as for the 
initial illness.
p. Incidence of Deafness: Deafness developed in 32 patients and was
total or sub-total in 17 of these. In all but 3 of the patients who 
became deaf, dihydrostreptomycin was being or had been used and was undoubtedly 
the main aetiological factor - more than half of all patients so treated 
developed/
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developed some impairment of hearing. The dosage or duration of the drug 
did not seem to he important hut the differences in total dosages in 
different regimes was too slight to make comparisons possible. Deafness 
occurred significantly more often in patients who, at the beginning of 
treatment, were well-nourished, had a high temperature, an E.S.R. between 
10 and 20 mm. in the first hour or a C.S.F. cell count over 200 per c.mm. 
or who, in the course of treatment, developed a high C.S.P. protein.
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